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Factors that Mediate and Modulate Androgen Action
MJ McPhaul and M Young,
Department of Internal Medicine, University ofTexas Southwestern Medical Center, Dallas,TX
Androgens mediate a wide range of processes during embryogenesis and in the adult. In mammals,
although a number of steroids can be shown to exert androgenic e¡ects using in vitro and in vivo assays,
testosterone and its 5a reduced metabolite, 5a- dihydrotestosterone (DHT) are considered to represent
the principal androgens in mammals. Furthermore, although the e¡ects that androgens exert di¡er
widely between di¡erent tissues and cell types, genetic and biochemical data suggest that these e¡ects
are mediated via the protein products of a single androgen receptor gene, which is encoded on the
Xchromosome.
The last decade has witnessed an explosion of information regarding the manner in which steroid
hormones modulate gene expression. At present, a body of increasingly detailed information is avail-
able as to the mechanisms by which nuclear receptors, such as the androgen receptor, regulate the
activity of target genes. The studies have demonstrated the participation of a number of ancillary pro-
teins in modulating the activation or repression by nuclear receptors. These proteins have been shown
to possess a variety of activities, including the capacity to modify chromatin structure.
In parallel to experiments focused on the mechanism by which nuclear receptors regulate the tran-
scription of responsive genes, experiments have demonstrated the importance of androgen metabolism
in speci¢c cell types. A number of enzymes capable of catalyzing the inactivation or synthesis of active
androgens have been described. The complement of activities expressed in an individual tissue or cell
type is likely to a¡ect the degree of androgen - responsiveness.
The results of such investigations provide a perspective on the number of levels of complexity by
which di¡erential gene regulation by androgens may occur in di¡erent cell types. Such insights may
provide avenues by which to modulate the actions of androgens selectively in speci¢c tissues.
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The Molecular Basis of Tooth Development and Its Implications in Signaling Sys-
tems in Hair Development
Ichiro Satokata
Div. of Developmental Biology, Dept. of Oral Biological Science, Niigata University Graduate School of Medical
and Dental Sciences, Niigata, Japan
Epithelial-mesenchymal interactions govern the initiation of organ development, subsequent mor-
phogenesis and terminal cytodi¡erentiation. The developing tooth of the mouse is a good model for
studying the molecular basis of the signaling systems in epithelial-mesenchymal interactions. Re-
cently, a number of genes which encode growth factors, transcription factors and cell surface mole-
cules have been identi¢ed that play a role for tooth development and parts of the molecular details of
signaling systems have been elucidated, particularly in the signal families BMP, FGF, Shh and Wnt.
Antagonistic signaling of FGF8 and BMP2, -4 is suggested to determine the sites of dentition by
restricting the expression sites of a paired box gene Pax9. Shh and a homeobox gene Pitx2 are also
candidates for determinants of dentition sites. Subsequently, the four epithelial signal families induce
di¡erential activation of key transcription factors, resulting in determination of tooth identity and
morphogenesis. FGF8 induces homeobox genes Barx1, Lhx6, -7, Msx1, Dlx1, -2, and a member of
TGF-b superfamily ActivinbA. FGF4 induces Msx1. BMP2, -4 induce Msx1, -2, Dlx2, a HMG-box
gene Lef1 and inhibit Barx1.Wnts also induce Lef1. Shh induces zinc-¢nger genes Gli1, -2, -3. By the
analyses of gene knockout mice, several of these genes have been shown to perform essential functions
in determination of tooth identity and morphogenesis. The mesenchymal expression of Msx1which is
induced by the epithelial signals of BMP2, -4 at the lamina stage induces mesenchymal expression of
Bmp4 at the bud stage, resulting in formation of a positive feedback loop in the mesenchyme. The
mesenchymal BMP4 signaling in turn induces the expression of Msx2, Lef1 and a cyclin-dependent
kinase inhibitor p21 in the enamel knot of the epithelium. BMP2, -4, Msx2 and p21 in the enamel
knot inhibit epithelial cell proliferation and induce apoptosis, whereas FGF4, -9 in the enamel knot
stimulate cell proliferation of both epithelium and mesenchyme. Such an antagonistic signaling of
BMP and FGF in the enamel knot is thought to regulate the balance between cell proliferation and
apoptosis during tooth morphogenesis. Synergistic and antagonistic e¡ects of signaling molecules and
transcription factors are reciprocally and recursively used between epithelium and mesenchyme dur-
ing tooth development. As the several studies have shown that genes which regulate tooth develop-
ment are also required for development of other ectodermal organs such as hair follicle and mammary
gland, a better understanding of the molecular basis of tooth development may provide an important
clue to elucidate the signaling systems in hair development.
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Long-Term (5 Years) Multinational Experience with Finasteride 1-mg in the Treat-
ment of Men with Androgenetic Alopecia (Male Pattern Hair Loss)
Keith D. Kaufman, for The Finasteride Male Pattern Hair Loss Study Group
Merck Research Laboratories, Rahway, NJ, USA
We previously demonstrated the safety and e⁄cacy of ¢nasteride in the treatment of men with male
pattern hair loss based on pooled 2-year data from two large, replicate, double-blind, placebo-con-
trolled Phase III studies. The present analysis assessed the pooled long-term, placebo-controlled safety
and e⁄cacy data through 5 years in these studies.
In two 1-year Phase III trials, 1553 men aged 18 to 41 years with male pattern hair loss were rando-
mized to receive oral ¢nasteride 1 mg/day or placebo for 1 year, and 1215 men continued in up to 4
consecutive, 1-year, placebo-controlled, blinded extension studies. E⁄cacy was evaluated by scalp hair
counts, patient and investigator assessments, and global photographic assessment by an expert panel.
Finasteride treatment led to improvements in scalp hair compared to baseline and placebo by all
evaluation techniques during 5 years of treatment (po0.001 vs. placebo). Improvements in hair count
(baseline¼ 876 hairs), measured in a 1-inch diameter circular area (5.1 cm2) of balding vertex scalp,
were observed with ¢nasteride compared with placebo (di¡erence of 126, 171, 183, 219 and 277 hairs
at 1, 2, 3, 4 and 5 years, respectively; po0.001 for all between-group comparisons). Treatment with
placebo led to progressive hair loss over 5 years. Patient self-assessment demonstrated that ¢nasteride
treatment led to improvements in hair growth, appearance of hair, and satisfaction with appearance of
hair. These improvements were corroborated by the investigators’ assessments of patients. Global
photographic assessments demonstrated the superiority of ¢nasteride over placebo and con¢rmed that,
without treatment, progressive visible hair loss occurs. Finasteride was generally well tolerated in the
studies. Side e¡ects were minimal and no new side e¡ects were observed with increasing duration of
exposure to ¢nasteride.
In men with male pattern hair loss, treatment with ¢nasteride 1 mg/day was generally well toler-
ated and led to a durable reduction in the progression of hair loss and improvements in hair growth
over 5 years.
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TrichoScan: Combining Epiluminescence Microscopy with Digital Image Analysis
for the Measurement of Hair Growth in vivo
Rolf Ho¡mann
Dept. of Dermatology, Philipp University, Marburg, Germany
Numerous methods have been reported to assess the rate of hair growth, but most techniques are of
little use to the clinician, because they are time consuming, costly or di⁄cult to perform. Therefore,
an operator- and patient-friendly, inexpensive, validated and reliable method is a rational need. Such a
method must be able to analyze the biological parameters that constitute hair growth, which are: 1:
hair density (n/cm2), 2: hair diameter (mm), 3: hair growth rate (mm/day) and 4: anagen/telogen ratio.We have
developed such a method which combines an epiluminescence microscopy with a newly programmed
digital image analysis. The application of the technique is demonstrated in 30 volunteers (with or
without AGA) where a scalp area of 1.8 cm2 was clipped, dyed and landmarked with a central, single
black tattoo. Images were taken at 20 and 40-fold magni¢cation immediately and 2 days after shaving,
in three monthly periods. Our results show that the technique is able to automatically analyze the
anagen/telogen ratio (o18% telogen hairs in scalp una¡ected by AGA) and hair growth rate (mean
0.31 mm/day).We were able to demonstrate that within the very small analyzed area (0.225 cm2) the
total hair number and hair thickness at the occiput did not change during 6 months, but we observed
a decrease in hair number (0.43 hairs) and total thickness (1.85 mm) in AGA-a¡ected untreated
scalp in contrast to an increase in hair number (þ4.7 hairs; p¼ 0.059) and total hair thickness
(þ4.85 mm; p¼ 0.039) after six months of treatment with ¢nasteride. The advantage of this technique
is that it can be used for clinical studies to compare placebo versus treatment, or to compare di¡erent
capacities of di¡erent hair growth-promoting substances. This technique can be used for studying
AGA or other forms of alopecia, but in addition can be adopted to study the e¡ect of drugs or laser
treatment on hypertrichosis or hirsutism.
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A Novel Approach to Treating Excessive Facial Hair in Women. Results of Safety
and E⁄cacy Studies with E£ornithine Hydrochloride 13.9% Cream
Barbara M Mathes,Vasant Manna, Ferdinand J Huber, Joseph D Jackson, Jan Bogaerts, Kathy B Schrode
Bristol-Myers Squibb Pharmaceutical Research Institute, Princeton, NJ, USA and Brussels, Belgium
E£ornithine, an inhibitor of ornithine decarboxylase, which appears to inhibit hair growth, was eval-
uated for safety and e⁄cacy in the treatment of excessive, unwanted facial hair in women. Two dou-
ble-blind, randomized, multicenter comparative studies of e£ornithine hydrochloride 13.9% cream
(EF) vs its vehicle, were conducted in 596 women ages 18-83 years with excessive facial hair. Eligibil-
ity included removal of facial hair at least twice weekly and presence of at least 5 terminal hairs/cm2 in
each of four areas on the face 48 hours after shaving. Subjects were randomized to EF or vehicle cream
in 2:1 ratio, and applied study medication twice daily for 24 weeks followed by an 8 week no-treat-
ment phase. The primary e⁄cacy measure was a Physician’s Global Assessment (PGA) on a 4 point
scale of the condition relative to baseline. Clinical success was de¢ned as marked improvement or
better in the subject’s condition. Secondary e⁄cacy measures included a Subject Self-Assessment
Questionnaire (SSAQ) assessing degree of bother and discomfort using a 100-point visual analog
scale, and reduction in hair growth length and spatial mass using video analysis. Safety measurements
were based on adverse events, clinical laboratory tests and physical examinations.
Results of the studies showed EF to be superior to vehicle based on PGA at week 24. Overall, 35%
of EF-treated subjects were rated clinical successes vs 9% of the vehicle-treated group, some as early as
8 weeks. 70% of EF subjects had some improvement compared to 41% on vehicle, and the percentage
of subjects showing marked improvement or better increased throughout each study. Responses to the
SSAQ demonstrated a very high degree of bother and discomfort with facial hair at baseline. Treat-
ment with EF resulted in a signi¢cant improvement for all questions, and there was strong concor-
dance between results of the PGA and the SSAQ.Video-imaging showed reduction of hair length and
spatial mass for those treated with EF vs vehicle, consistent with the PGA and SSAQ results. Eight
weeks after stopping therapy, there was reversion to baseline in all e⁄cacy measures. E£ornithine
cream was well-tolerated and few subjects discontinued due to adverse events. The most common
adverse events were skin-related, transient and mild, not requiring dose reduction. Excessive and un-
wanted facial hair is a common, often distressing problem for millions of women of all ages. These
studies demonstrate the safety and e⁄cacy of treating excessive, unwanted facial hair in women with
e£ornithine hydrochloride 13.9% cream, by reducing the growth of hair, and provides another option
in the management of this troubling condition.
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A Phenotypic Variant of Marie Unna Hereditary Hypotrichosis Does Not Map to
Chromosomes 8p21
Jack Green1,3, David de Berker2, Elizabeth Fitzpatrick3, Susan Forrest3, Rod Sinclair1
1Department of Dermatology, St.Vincent’s Hospital, Melbourne, Australia; 2Bristol Royal In¢rmary, Bristol,
England; 3Murdoch Childrens Research Institute, Melbourne, Australia
The purpose of this study was to compare members of a family with Marie Unna Hereditary Hypo-
trichosis living in Scotland and Australia clinically and genotypically to previous described Marie
Unna families.
Twenty-two members of this family were examined and genomic DNA extracted. The known
Marie Unna locus at 8p21was analysed using microsatellite markers.
This family displayed a milder divergent phenotype of Marie Unna Hereditary Hypotrichosis seg-
regating in an autosomal dominant fashion over four generations. Thirteen members of the family we
examined (six male, seven female) were a¡ected.
Compared with previous reports, this family displays a milder phenotype. Onset of alopecia occurs
in the late 2nd decade or early 3rd decade. Eyebrows are either preserved or only mildly a¡ected. In
some a¡ected individuals, body hair is normal with two a¡ected males displaying a beard of normal
density. Most of those a¡ected had varying degrees of associated onycholysis with some also display-
ing koilonychia. Two of the a¡ected had cleft lip and palate. Two a¡ected ancestors also had cleft lip
and palate. This feature was not found in una¡ected individuals.
Linkage analysis using the markers D8S258 D8S282 D8S560 and D8S298 resulted in signi¢cant
negative LOD scores for three out of four markers at q¼ 0.05 ranging from ^6.99 to ^1.64.
This demonstrates that the gene causing this variant phenotype of Maire Unna Hereditary Hypo-
trichosis is not present at the 8p21 locus and that this condition is genetically heterogenous.
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Suppression of TGF- prevents Apoptosis Induction in the Catagen Hair Follicle
Y. Tsuji1,T. Soma1,2, L. Raftery2, and T. Hibino1
1Shiseido Life Science Research Center,Yokohama and 2MGH/Harvard Cutaneous Biology Research Center,
Charlestown, MA, USA
Hair loss is the result of premature entry into catagen by various causes. In male pattern baldness, we
have hypothesized the involvement of ‘‘catagen cascade’’, in which a TGF-b family member promotes
caspase activation, resulting in the apoptosis of epithelial cells. In the previous study, we showed that
TGF-b2 was localized at the boundary area between germinative cells and DPC during the transition
phase from late anagen to catagen. In the epithelial strand TGF-b2 was detected in the regressing hair
follicle. TUNEL-positive apoptotic cells and active caspase^3 and ^9 were also observed in the area. In
this study, we examined the role of TGF-b2 in relation to apoptosis. Human hair follicles were cul-
tured in the presence of TGF-b2. Using active caspase-9 and ^3 speci¢c antibodies, we found that
TGF-b2 enhances the activation of these caspases in two regions, including the lower part of germi-
native matrix cells and outer most layer of outer root sheath cells. Dual staining for active caspase-9
and TUNEL demonstrated that active caspase-9 and TUNEL-staining mostly co-localized. Active
caspase-3 positive cells were detected in the same region.We evaluated 400 plant extracts for activity
in a TGF-b suppression assay. An extract from Hydrangea macrophylla strongly inhibited TGF-b induc-
tion in this assay and also promoted hair elongation in a hair follicle organ culture system.We tested
the e¡ect of the extract in vivo by applying it onto C57BL6 mouse for 10 days and scored the catagen
stage of each hair follicle morphologically. Topical application of the extract remarkably delayed the
progression of catagen. We isolated an active substance from the extract using a TGF-b suppression
assay. This substance showed a strong potential for hair elongation and also reduced caspase activation
in cultured follicles. Collectively our results suggest that TGF-b2 can enhance the induction of catagen
via activation of caspases and that the suppressor of TGF-b could be e¡ective for the prevention of
male pattern baldness. We are presently investigating the role of TGF-b family members and their
signal pathways in the endogenous mouse hair cycle.
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Androgen-inducible TGF-beta1 Derived from Dermal Papilla Cells Mediates Hair
Growth Suppression in Androgenetic Alopecia
Shigeki Inui,Yoko Fukuzato,Takeshi Nakajima, KunihikoYoshikawa, Satoshi Itami
Department of Dermatology, Osaka University Medical School
Although androgen plays the central role in androgenetic alopecia (AGA), the pathomechanism is un-
settled at the present because of the absence of suitable in vitromodel system. It has been reported that
androgen inhibits the proliferation of outer root sheath cells cocultured with dermal papilla cells
(DPCs) from the frontal bald scalp of stump tailed macaques, a model animal for human AGA, while
this was not the case in human DPCs. In this study, we attempted establishing a coculture model of
human bald DPCs and keratinocytes to identify the pathogenic mediators for the inhibition of epithe-
lial cell growth in AGA. Since we found that the expression of mRNA of androgen receptor (AR)
decreased during subcultivation of DPCs in vitro, we transiently transfected the AR expression vector
into bald DPCs by lipofection and cocultured them with keratinocytes. In this coculture system, an-
drogen suppressed the growth of keratinocytes by 50%, indicating that exogenous overexpression of
AR can restore the phenotype of bald DPCs. The androgen-induced inhibition of keratinocyte pro-
liferation was antagonized by the addition of cyproterone acetate (CA), a potent antiandrogen, to the
coculture of keratinocytes and bald DPCs, suggesting the speci¢c role of AR in DPCs for the growth
inhibition of cocultured keratinocytes.We further examined the change of expression level of mRNA
of various factors in bald DPCs cocultured with keratinocytes after androgen treatment by semiquan-
titative RT-PCR and found that TGF-1 was increased by androgen in bald DPCs. Moreover, the
neutralizing anti-TGF-1 antibody antagonized the inhibition of keratinocyte proliferation in this
co-culture system in a dose dependent manner. From these data obtained using our novel powerful
coculture model for AGA, we suggest that androgen-inducible TGF-1 derived from DPCs mediates
hair growth suppression in AGA.
009
Recapitulation of the Hairless Mouse Phenotype Using Catalytic Oligonucleotides
Peter B. Cserhalmi-Friedman, Andrei A. Panteleyev, and Angela M. Christiano
Departments of Dermatology and Genetics & Development, Columbia University NewYork, NY
Ribozyme technology is widely used to target mRNA in a sequence speci¢c fashion, and thus change
the expression pattern of cells or tissues.While the goal of mRNA targeting is usually the cleavage of
mutant mRNAwith the prospect of gene therapy for inherited diseases, in certain instances targeting
of wild-type genes can be used therapeutically.
Lack of expression of the mouse hairless gene due to inherited mutations leads to the complete loss
of hair, known as atrichia.We designed this study to recapitulate the hairless phenotype in a restricted
manner by topical application of deoxy-ribozyme targeting molecules to speci¢cally cleave the mouse
hairless mRNA.The targeting oligonucleotides were designed using previously reported catalytic core
structure and the mRNA sequence of the mouse hairless gene.The targeting molecules were delivered
on the back of C57Bl/6J mice using a commercially available liposome reagent. The delivery began
immediately after birth, and was repeated daily until day 16. Patches of hair loss were grossly visible on
treated areas of dorsal back. Samples for pathology were taken at days 22 and 35, processed and stained
using standard techniques.
The pathology samples of the treated area from day 22 demonstrated a decreased number of hair
follicles, involution of the remaining follicles and separation of the dermal papillae, all characteristic
of the hairless phenotype. In contrast, the pathology samples from the non-treated area of the same
animal did not show these alterations. The pathology samples of the treated area from day 35 demon-
strated the presence of large dermal cysts characteristic of the hairless phenotype, but not normally
present in the skin of C57Bl/6J mice.
In this study, we successfully recapitulated the hairless phenotype using topically applied target spe-
ci¢c catalytic oligonucleotides designed to cleave the mouse hairless mRNA. Our results demonstrate
the feasibility of using ribozyme technology to alter gene expression in the skin via topical applica-
tion, and provide proof of principle for the development of this strategy for permanent hair removal.
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Molecular Control of Chemotherapy-Induced Hair Loss: Essential Roles for p53
and Its Target Genes
V.A. Botchkarev1, E.A. Komarova2, F. Siebenhaar1,3, N.V. Botchkareva1, P.G. Komarov2, M. Maurer3,
A.V. Gudkov2, and B.A. Gilchrest1
1Dept. of Dermatology, Boston University School of Medicine , 2Dept of Molecular Genetics, University of Illinois
at Chicago , 3Dept. of Dermatology, University of Mainz, Germany.
Anticancer drugs induce apoptosis in the hair follicles and hair loss, the most common side e¡ect of
chemotherapy. In C57BL/6 mouse model for chemotherapy-induced hair loss, we demonstrate that
p53 is essential for this process: (i) by immunohistology, p53 was upregulated in the hair follicles after
cyclophosphamide treatment, (ii) in contrast to wild type mice, p53-de¢cient mice show neither hair
loss nor apoptosis in the hair follicle keratinocytes that maintained active proliferation after cyclopho-
sphamide treatment, (iii) hair follicles in p53 knockout mice are characterized by downregulation of
Fas and insulin-like growth factor binding protein-3, and increased expression of Bcl-2. To con¢rm a
role for Fas as a p53 target gene in chemotherapy-induced hair loss, we show that Fas knockout mice
display signi¢cant (po0.05) retardation of cyclophosphamide-induced hair follicle regression and de-
crease of intrafollicular apoptosis. Furthermore, administration of Fas-ligand neutralizing antibody
signi¢cantly reduced a number of apoptotic cells in the hair follicle and retarded a rate of hair follicle
involution induced by cyclophosphamide. These observations indicate that local pharmacological in-
hibition of p53 and/or its target genes may be useful to prevent chemotherapy-associated hair loss.
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Prolactin Receptor Knockout Mice Have Altered Hair Growth Cycles
A.J. Craven1,2, C.J. Ormandy3, A.J. Nixon1, P.A. Kelly4, R.J.Wilkins2, A.J. Pearson1
1Ag Research, Ruakura Research Centre, Hamilton, New Zealand. 2University ofWaikato, Hamilton, NZ.
3Garvan Institute of Medical Research, Sydney, Australia. 4INSERM UniteŁ 344, Paris, France
Although prolactin has been shown to entrain hair growth cycles in seasonally responsive mammals,
no comparable role has been identi¢ed in the age-dependent pelage replacement of rodents.We there-
fore analysed hair growth cycles in prolactin receptor gene-disrupted mice (PRLR/) to determine
the in£uence of prolactin signaling on murine hair cycles.
The second (G2) hair cycle of PRLR/mice on the 129SV background, and their wildtype
(PRLRþ /þ ) and heterozygote (PRLRþ /) littermates, were visualized and compared by dyeing their
coats at 28 days post-partum and observing the emergence of undyed fur. Samples of mature pelage
were collected for measurement of ¢bre length and diameter distribution. The growth development
status of hair follicles in adult and neonatal mice was determined by skin histology. The expression of
PRLR in the skin was detected by RT-PCR and immunocytochemistry.
The hair growth phenotype of PRLR/mice consisted of a change in the timing of hair cycling
events. Although no hair follicle development di¡erences were noted in PRLR/neonates, G2 hair
replacement in PRLR/mice occurred earlier than in wildtypes. In female PRLR/mice, ¢bres
erupted on the dorsum by 33.070.7 days of age in mice in contrast to 61.972.8 days in PRLRþ /
þmice (Po0.001). PRLRþ /mice were intermediate (50.173.2 days). In males, a similar e¡ect, but
with a much reduced di¡erence between the PRLR/and PRLRþ /þgenotypes was observed
(31.071.0, and 34.970.7 days respectively; Po0.001). Thus PRLR de¢ciency eliminated the sexual
dimorphism associated with murine hair replacement. Once initiated, the pattern and progression of
hair replacement across the body was similar in all genotypes. All ¢bre types were present and ap-
peared structurally normal, but PRLR/mice had slightly longer (Po0.001), and coarser (Po0.05)
hair than wildtypes. mRNA encoding both the long and short-3 forms of prolactin receptor were
found in the skin of both adult and neonate wildtype mice. The receptor protein was immunoloca-
lized to the outer root sheath of the hair follicle as well as the epidermis, sweat and sebaceous glands.
These ¢ndings suggest that prolactin has an inhibitory e¡ect on murine hair cycle events.
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Gene Expression Pro¢le in dermal Papilla Cells and Construction of Hair Speci¢c
cDNA Microarrays
Kim Moonkyu, KimYoung-Hee, Im Sang-Uk, Hwang Sun-Young, Chung Eun-Jung, Kim Do-Won,
Kim Jung-Chul
Kyungpook National University, School of Medicine Department of Immunology
Partial sequencing of randomly selected clones from cDNA libraries of speci¢c tissues or cell types to
generate expressed sequence tags (ESTs) has proven to be a rapid and e⁄cient means of discovering
genes on a large scale and of providing both quantitative and qualitative information regarding gene
expression in a variety of tissues. To gain an insight into the genetic pro¢le of human dermal papilla
cells, we have constructed cDNA library from cultured dermal papilla cells and generated an ex-
pressed sequence tag (EST) database from them.
We constructed cDNA libraries from cultured human scalp hair dermal papilla cells. The 50 ends of
1,666 randomly selected plasmid clones, each contains one gene which expressed in dermal papilla cell,
were sequenced and searched for sequence homologies in the GenBank DNA data base by BLAST. It
generated human dermal papilla cell EST database with an average length of 180 nucleotides. Se-
quences of 351 clones (21.1%) showed no signi¢cant similarity to entries in the public databases;
1,229 (73.8%) were identical to known human sequences.
The most abundant mRNAs were for type 1(I) collagen chains and ¢bronectin (53 and 49 times,
respectively). mRNAs for osteonectin, a2(I) collagen, actin-beta, SM22-alpha, and glyceraldehyde-3-
phosphate dehydrogenase. Clones for gamma-actin, a1(VI) collagen, plasminogen activator inhibitor
1, IGH3, a2(VI) collagen, and ferritin heavy chain showed some redundancy.
Clones corresponding to a total of 1,229 speci¢c known genes were classi¢ed according to their
function. The most abundant class of genes expressed in dermal papilla, were those for cell structure
and motility, which comprises 366 cDNA clones (29.8%), including type I collagen, type IV collagen,
¢bronectin, osteonectin, beta-actin, alpha-SM22, gamma-actin, and IGH3.
All of the genes in human dermal papilla ESTdatabase are available through our web site at http://
hair.knu.ac.kr. We also have constructed hair-speci¢c cDNA microarrays containing 3,066 cDNAs
using dermal papilla EST clones. Those dermal papilla cDNA collection and microarray can provide
valuable information in the ¢eld of hair research.
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A Role for SCF/c-kit Signaling in the Morphogenesis and Cyclic Regeneration of
Hair Pigmentation Unit
N.V. Botchkareva1,V. A. Botchkarev1, M. Khlgatian1, A. A. Sharov1, B. J. Longley2, and B. A. Gilchrest1
1Dept. of Dermatology, Boston University School of Medicine, Boston, USA; 2Dept. of Dermatology, Columbia
University, New-York, USA
Stem cell factor (SCF) and its receptor c-kit are important for melanocyte survival during develop-
ment, and mutations in these genes result in unpigmented hairs. During hair follicle (HF) morpho-
genesis, melanocyte precursors migrate into developing HF and give rise to di¡erentiated melanocytes
that actively produce and transport pigment into keratinocytes of the hair shaft. Using multi-color
confocal microscopy and double immuno£uorescence of melanogenic proteins [tyrosinase-related
proteins 1 and 2 (TRP1/TRP2), tyrosinase], proliferative marker Ki67, and c-kit receptor, we show
that during HF morphogenesis and postnatal cyclic HF regeneration proliferating, di¡erentiating,
and melanin-producing melanocytes express c-kit, while presumptive melanocyte precursors do not.
During postnatal hair cycle, SCF overexpression in HF epithelium signi¢cantly increases the number
and proliferative activity of melanocytes, while administration of anti-c-kit antibody dose-depen-
dently decreases hair pigmentation and leads to partially depigmented (gray) or fully depigmented
(white) hairs, associated with signi¢cant decreases in melanocyte proliferation and di¡erentiation.
However, in the next hair cycle the previously treated animals grow fully pigmented hairs with the
normal number and distribution of melanocytes. This suggests that melanocyte stem cells are not
dependent on SCF/c-kit and when appropriately stimulated can give rise to di¡erentiated progeny that
migrate and function normally. Therefore, the blockade of c-kit signaling o¡ers a fully reversible
model for hair depigmentation, which might be used for the studies of hair pigmentation disorders.
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Growth Factor Secretion by Dermal Papilla Cells is Regulated by Neurotrophins
DJ Tobin1,VA Botchkarev2, P Welker3, NV Botchkareva2, and R Paus4
1Dept. of Biomedical Sciences, University of Bradford, Bradford, England, 2Dept. of Dermatology, Boston University
School of Medicine, Boston, USA; 4Dept. of Dermatology, University Hospital Eppendorf, Hamburg, Germany;
3and Dept. of Dermatology, ChariteŁ Humboldt-University Berlin, Germany
Neurotrophins have several non-neuronal functions in the skin. Previously we have shown that p75
kD neurotrophin receptor plays an important role during HF morphogenesis and that neurotrophins
(NT) accelerate hair follicle (HF) regression (catagen), most likely by stimulating keratinocyte apop-
tosis via binding to the p75 kD neurotrophin receptor. In addition, dermal papilla (DP) cells express
high a⁄nity NT receptors TrkB and TrkC during the HF anagen-catagen transition. Given that the
DP is inductive during hair follicle morphogenesis and cycling, NTmay contribute to the regulation
of this mesenchymal cell population by modulating their growth factor secretion. To test this hypoth-
esis, matched cultures of human scalp DP cells and dermal ¢broblasts (n¼ 6) were grown in the pre-
sence of 0.5^50 ng/ml of NGF, BDNF, NT-3 or NT-4. Secretion of di¡erent growth factors (SCF,
VEGF, TGFb2, KGF) known to be produced by DP cells during anagen was assessed after 48 h by
ELISA. Both DP cells and dermal ¢broblasts were found to express TrkA,TrkC, and p75 kD neuro-
trophin receptors by immunohistochemistry. TrkB receptors however, were detected on DP cells but
not on dermal ¢broblasts. The NT tested had no signi¢cant e¡ect on DP cell or dermal ¢broblast
proliferation. By ELISA, secretion of SCF by DP cells into supernatants was signi¢cantly down regu-
lated by BDNF and NT-3, while VEGF secretion was decreased after NT-4 treatment. BDNF also
signi¢cantly decreased TGFb2 secretion by DP cells. Interestingly, the secretion of these growth fac-
tors by dermal ¢broblasts was not a¡ected by NT, suggesting that in addition to TrkB expression on
DP, but not dermal ¢broblasts, this secretary response to NTmay aid the discrimination of interfolli-
cular dermal ¢broblasts from DP ¢broblasts.
These data suggest that NTmay modulate HF cycling by altering secretion of Dpderived growth
factors that control proliferation, apoptosis and/or di¡erentiation of hair matrix cells.
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Genetic and Pathological Analysis on a Novel mouse Hair Mutation, Hague
Atsushi Yoshiki1, Christophe Poirier1, Kyoko Fujiwara1, ChikakoYoshida-Noro1,Yasuaki Ichikawa2,
Jean-Louis Guenet3, Moriaki Kusakabe4
1Experimental Animal Research Division, RIKENTsukuba Institute, 2Dept. 1 st Anatomy, Nihon Medical
University, 3Unite de Genetique des Mammiferes, Institut Pasteur, 4Dept Anatomy,The Jikei University School of
Medicine
Mouse hair mutations are useful model to study molecular mechanism of hair development. A spon-
taneous mouse hair mutation was recovered in our C3H/HeN mice colony. The purpose of this study
is to clarify pathological characteristics of the developing hair follicle and to ¢nely map the causative
gene. For light microscopy dorsal skin tissues were ¢xed with 4% paraformaldehyde and embedded in
polyester or Technovit resin. For transmission electron microscopy tissues were ¢xed with Ito-Kar-
novsky ¢xative. A high resolution linkage map was constructed by crossing the mutant mice with
wild-derived strains, M. m. castaneus and PWK. The original mutation was recovered as wavy-hair
mouse. Cross experiment indicated that the mode of transmission of the mutation was semidominant
with incomplete penetrance at the heterozygous state. In homozygote mice lost most hairs around 1
month of age. Linkage analysis indicated that this trait was controlled by a single locus Hague (Hag)
which was mapped to telomeric region of mouse Chromosome 15. This mutation was shown to be
unstable since its transmission could be switched from semi-dominant to recessive. Moreover, Hag can
interact with Caracul mutation, another dominant hair mutation on Chr 15. Interestingly, double het-
erozygotes of Hag and Ca showed patch pattern of hairy and bald regions. Histopathological analyses
of homozygotes by light and transmission electron microscopy clearly demonstrated that the signi¢-
cant cell degeneration was detected especially in the Henele’s and Huxley’s layers of inner root sheath.
To identify the causative gene and the nature of the mutation, Hague was introduced into a high
resolution and high density molecular genetic map. Over 1000 meiosis were analyzed and the muta-
tion was mapped to the keratin 2 complex genes. AYAC and BAC physical map of the critical region
was then constructed and the gene involved was located in a 600^800 kb long segment. From this
region several candidate genes including 3 epidermic cytokeratin and four hard keratin genes were
analyzed but none were mutated in the Hague mice. In conclusion the Hague mutation occurred
within keratin 2 complex region will be a unique model to study the molecular mechanism of hair
follicle development.
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Signal Transduction Pathways and Cytokines Involved in Restoration of Hair
Growth with Topical Anthralin in Alopecia Areata Rats
Liren Tang, Liping Cao, Steven Pelech, Harevey Lui, David I. McLean and Jerry Shapiro;
Department of Medicine, University of British Columbia andVancouver General Hospital,Vancouver, Canada
We have shown that anthralin is very e¡ective on hair restoration in the Dundee experimental bald
rats (DEBR). All 15 rats showed near complete hair regrowth on the treated sides, while the control
sides remained balding. The aim of the present study was to investigate the underlying molecular
mechanisms of the therapeutic e¡ects of anthralin on AA-a¡ected rats. Skin biopsies were collected
from both treated and control sides. RNA and proteins were extracted. Proteins were used for Kinet-
workt analytical screens for cell signaling proteins (Kinexus, Canada) to determine the expression of
various protein kinases, phosphatases, and their down stream trascriptional regulators which might be
responsible for the signal transduction pathways mediated by anthralin in rat skins. RNA protection
assay was performed to determine the gene expression of various cytokines mediated by anthralin.
Among the cytokines we have tested by RNA protection assay (RPA), interleukin 1b (IL-1b), IL-1a,
IL-10 and IL-1 receptor antagonist (IL-1Ra) showed remarkable induction after anthralin treatment,
while tumor necrosis factor a(TNF-a) and interferon g(INF-g) were decreased upon successful treat-
ment with anthralin. Protein kinase screening revealed that growth factor mediated signal transduc-
tion involving Erk1 & 2, their upstream regulators (Raf, Mek 1 & 2) and downstream kinases (p70S6K
and p90S6K), are all activated. The stress-activated pathways involving SAPK 1 & 2 and their upstream
regulatory kinases (Mek 4 & 7) were also induced by anthralin, presumably owing to the free radicals
generated by anthralin on the skin. In addition, another pathway mediated by PKB and GSK-3 ki-
nases were also activated. Cytokine-mediated signals transduction pathways through Jak kinases were
only weakly detected. But the downstream STAT-3 showed dramatic increase in its phosphorylation.
We conclude that the molecular mechanism underlying the e⁄cacy of anthralin on hair regrowth in
AA rats might be mediated by the interplay of cytokines produced locally in the skin. The signal
transduction pathways involving various protein kinases and their regulators may represent the initial
molecular events in rat skin upon successful anthralin treatment.This line of information will help our
understanding of the molecular mechanisms of anthralin’s e⁄cacy on AA rats.
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Label Retaining Cells (Presumptive Stem Cells) of Mice Vibrissae do not Express
Gap Junction Protein Cx43
Maja Matic, Marcia Simon
Department of Oral Biology and Pathology, SUNY/Stony Brook, Stony Brook, NY USA
Homeostasis of self-renewing tissues rely on the presence of stem cells. Stem cells are thought to reside
in well protected and well vascularized regions, nishes. Due to their slow cycling nature, stem cells
have been identi¢ed in vivo as label retaining. Markers that can distinguish epidermal stem cells from
transient amplifying cells are still lacking.We have previously shown that some cells in the limbus
(outer rim of the cornea that harbors corneal epithelial stem cells) lack expression of gap junction
protein, connexin 43 (Cx43). Subsequently, using immunohistochemistry, we have shown that some
cells in the basal layer of neonatal foreskin, and in the bulge region of human hair follicle (regions
purported to harbor epidermal stem cells) lack Cx43. Flow cytometry analysis of neonatal foreskin
keratinocytes revealed that basal cells which lack Cx43 expression comprise a minor subpopulation
of cells (B10%) characterized with small size and low granularity, characteristics of stem cells. Corre-
lation between [3H] thymidine retention and Cx43 expression in pelage hair of SENCAR mice de-
monstrated that most of the label-retaining cells (LRC) lack Cx43 expression. In the present study, we
analyzed LRC in mouse vibrissae for the expression of Cx43. Vibrissae, the major tactile organ of
rodents, although morphologically similar to pelage hair, di¡er from pelage in several respects includ-
ing their larger size and di¡erent length of hair cycle. As reported previously (Lavker et al.) LRC were
identi¢ed in the outer root sheath of the vibrissae follicle at the level of the ringwulst and ring sinus
(area analogous to the bulge in palage hair). Label retaining cells in the mouse vibrissae did not express
Cx43. These results support the hypothesis that Cx43 can serve as a negative marker for epidermal
stem cells.
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Targeted Disruption of LIG-1 Gene Provides New Insight into Keratinocyte Stem
Cells
H. Miura1,Y. Suzuki2, K. Kobayashi3, G. Kondoh4, S. Sano1, K. Ozawa1, S. Inui1, A. Nakata2,T. Takagi2,
M. Tohyama5, K. Yoshikawa1 and S. Itami1
1Department of Dermatology, 4Department of Social and Environmental Medicine, 5Department of Anatomy and
Neuroscience, Graduate School of Medicine, Osaka University, Osaka, Japan, 2Read generation Laboratory, 3Safety
Research Laboratory,Tanabe Seiyaku Co. Ltd., Osaka, Japan
Epidermis that covers the skin surface is continuously regenerated throughout the lifetime of the
mammalian adult through proliferation of keratinocyte stem cells.While keratinocyte stem cells play
a central role in tissue homeostasis, wound healing, cancers, and skin-based gene therapy, the precise in
vivo localization of the cells is not yet settled because of the scarcity of appropriate molecular markers.
LIG-1, a transmembrane glycoprotein of which extracellular region is uniquely organized with the
leucine-rich repeats and immunoglobulin-like domains, is expressed predominantly in the brain. Here
we show that the cutaneous expression of LIG-1was restricted to the cells in the bulge of hair follicles
and the subpopulation of epidermal basal cells that were considered to be the keratinocyet stem cells
in mice and human. About 40 % of a6 -integrin positive rapidly adherent keratinocytes that were
enriched in keratinocyte stem cells strongly expressed LIG-1 on their cell-surface. To clarify the phy-
siological roles of LIG-1 in vivo, we disrupted the gene in mice by gene targeting. The LIG-1 de¢cient
mice developed a skin change on their tail and facial area after birth. The a¡ected skins were histolo-
gically characterized by epidermal hyperplasia, hyperkeratosis with parakeratosis, neutrophil in£ux,
and the subcorneal pustules similar to Munro’s microabscesses. The keratinocytes in the lesion were
highly proliferative with perturbed terminal di¡erentiation. Therefore, we infer that LIG-1 is a new
cell-surface marker for keratinocyte stem cells and regulates the growth and di¡erentiation of kerati-
nocyte stem cells.
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Cyclin D-Interacting Myb-Like Protein: A New Regulator of Cortical Cell Prolif-
eration and Di¡erentiation in Hair Follicles
Z.D. Yu1,2, A.J. Nixon1, R.J.Wilkins2, and A.J. Pearson1
1AgResearch Ruakura, Hamilton, New Zealand. 2Dept. Biological Sciences, University ofWaikato, Hamilton,
New Zealand
Hair arises from the proliferation of epithelial cells in the follicle bulb which subsequently undergo a
highly regulated di¡erentiation programme. This study reports the discovery of a transcription factor
expressed in the keratogenous zone of hair follicles which potentially in£uences this process.
Flank skin samples were collected from prepubertal ferrets between 0 and 14 days after treatment
with melatonin to synchronise the winter moult. Di¡erential display was used to analyse RNA ex-
tracts. Di¡erential expression was con¢rmed by Northern blot and in situ hybridisation. Additional
sequence was generated using rapid ampli¢cation of cDNA ends (RACE).
A cDNA band of approximately 170 bp, which was present only in skin samples with anagen fol-
licles, was identi¢ed and cloned. The cDNA sequence showed high homology to a region within the
coding sequence of human and mouse cyclin D-interacting myb-like protein 1 (DMP1). Northern
blot analysis con¢rmed that a mRNA of 0.9 kb existed only in skin samples containing follicles in
which keratinisation had commenced. In situ hybridisation demonstrated that this gene was expressed
uniformly across the cortex only in the keratinisation zone of late proanagen and anagen hair follicles,
but not in liver, footpad skin or muscle. A 760 bp sequence was extended to the 50 end by RACE.
The ¢rst 176 encoded amino acids of ferret DMP1were 98% identical to the human homologue.
DMP1 is known to be expressed in a variety of human and mouse tissues and to inhibit cell divi-
sion by arresting the cell cycle in the G1 phase in a pRb-independent manner. It is phosphorylated by
cyclin D-dependent kinase and cyclin D represses DMP1 transactivation activity by preventing DNA
binding and transcription of the targeted genes. Disruption of DMP1 thus facilitates cell transforma-
tion and tumorigenesis. Based on its restricted expression in anagen follicles and its smaller size, the
ferret homologue is possibly an alternatively spliced form of DMP1 with hair follicle speci¢c func-
tions. As keratinocyte replication ceases in the area of the follicle where fDMP1 is expressed, this gene
product may be associated with arrest of cortical cell growth and promotion of di¡erentiation.
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Analysis of Hair Development in Follistatin-De¢cient Mice and BMP-7 Knockout
Mice
M Nakamura1, K Foitzik1, S Liotiri1, M Matzuk2, R Godin3, E J Robertson3, and R Paus1
1Dept. of Dermatology, University Hospital Eppendorf, Hamburg, Germany; 2Dept. of Pathology and Cellular
Biology, and Molecular and Human Genetics, Baylor College of Medicine, Houston,Texas, USA; 3Dept. of
Molecular and Cellular Biology, Harvard University, Cambridge, Massachusetts, USA
Follistatin usually antagonizes the action of activin, BMP-2, BMP-4, and BMP-7 by binding them.
Expression of BMP-7 has been reported in the inner root and outer root sheath as well as in the
follicular dermal papilla. Since follistatin-de¢cient mice show abnormalities in vibrissae follicle devel-
opment, we have further explored the role of follistatin and one of its signalling partners, BMP-7, in
murine hair follicle development. In situ hybridization revealed that follistatin is expressed in the outer
and inner root sheath, all layers of the interfollicular epidermis and most strongly in hair matrix cells.
Compared to wild type controls, follistatin knockout mice showed a signi¢cant retardation of hair
follicle morphogenesis (po0.01). The follistatin null mutation also signi¢cantly reduced keratinocyte
proliferation in stage 1^2 hair follicles. However, BMP-7-de¢cient mice showed no signi¢cant ab-
normalities in hair follicle morphogenesis, keratinocyte proliferation, hair follicle density, or epider-
mal thickness. Immunohistological analysis of apoptotic cells (TUNEL), selected adhesion molecules
(NCAM), morphogens (KGF), or growth factor receptors (FGFR-2, m-met) failed to reveal any sub-
stantial changes in both knockout strains, compared to wildtype controls. In organ culture of human
anagen VI scalp hair follicles, recombinant human follistatin inhibited hair shaft elongation and in-
duced premature hair follicle regression (catagen). Taken together, these data suggest that follistatin is
involved in the control of both hair follicle morphogenesis and hair cycling, while BMP-7 does not
play an indispensable role in hair and skin biology.
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Minoxidil Stimulated Hair Growth in Organ Culture is Inhibited by the Potassium
Channel Blocker,Tolbutamide
GC Davies,TJ Jenner,YC Chen,VA Randall, MJ Thornton
Department of Biomedical Sciences, University of Bradford, Bradford,WestYorkshire, UK
Although potassium channel openers such as minoxidil promote hair growth in vivo, the mechanisms
by which they do so are unclear. Using a red deer whole hair follicle culture system we have pre-
viously demonstrated that the potassium channel openers, minoxidil and diazoxide stimulate hair fol-
licle growth in vitro. In order to further explore the role of potassium channels in hair growth, we have
investigated the e¡ect of the potassium channel blocker, tolbutamide on red deer hair growth in organ
culture.
Anagen follicles were microdissected from the mane of 6 red deer stags, washed with sterile phos-
phate bu¡ered saline, and incubated inWilliams E medium supplemented with 5 mM glucose, 100 U/
ml penicillin and 2.5 mg/ml amphoterin B. A minimum of six follicles were incubated in each experi-
mental group; control vehicle (0.01 % dimethylsulphoxide), 0.1, 1, 10, 100 mM minoxidil, tolbutamide
(1 mM), or minoxidil (10 mM)þ tolbutamide (1 mM).
Hair follicles grew under all experimental conditions for up to 8 days. Follicles consistently grew
faster in the presence of all concentrations of minoxidil compared to control conditions. In contrast,
tolbutamide slowed follicle growth compared to the vehicle control. Incubation of isolated follicles
with a combination of minoxidil and tolbutamide resulted in an inhibition of the stimulatory e¡ects
of minoxidil; the follicles grew at the same rate as the control follicles.
The stimulatory e¡ect of minoxidil at 4 di¡erent concentrations supports our earlier studies using
this culture system. The absence of any growth potentiation by minoxidil in the presence of the po-
tassium blocker, tolbutamide, implies that minoxidil is stimulating hair growth in this system via
potassium channels. Further studies should help us to elucidate the exact mechanisms involved in the
stimulation hair growth by minoxidil.
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Nitric Oxide Production of Human Dermal Papilla Cells: Basal and Androgen sti-
mulated Expression of Constitutive and Inducible Nitric Oxide Synthase
R.Wolf1, G. Sch˛felder2, M. Paul2, C.E. Orfanos1, and U. Blume-Peytavi1,
1Dept. of Dermatology and 2Inst. of Pharmacology, University Medical Center Benjamin Franklin,The Free
University Berlin, Berlin, Germany
Nitric oxide (NO) has been identi¢ed as an important mediator in various hysiological and pathophy-
siological processes of the skin, such as regulation of blood £ow, melanogenesis, wound healing, and
hyperproliferative skin diseases. However, little is known about the role of NO in the human hair
follicle and in hair cycling processes.
By measuring nitrate and nitrite levels in culture supernatants we demonstrate that dermal papilla
cells (DPC) derived from human hair follicles spontaneously produce NO.This biomolecule is appar-
ently formed by the endothelial isoform of nitric oxide synthase (NOS), which could be detected by
reverse transcription polymerase chain reaction (RTPCR) and immunological protein analysis. Re-
markably, basal NO level was markedly enhanced by stimulating DPC with 5a-dihydrotestosterone
(DHT) but not by testosterone. Addition of N-(3-(aminomethyl)benzyl-acetamidine (1400 W), a
highly selective inhibitor of human inducible NOS, restrained the elevation of NO level induced by
DHT. Analysis of androgen-stimulated cells on RNA as well as on protein level, respectively, con-
¢rmed the expression of inducible NOS.
Thus, we suggest that endothelial NOS accounts as a constitutive enzyme for a physiological role
of NO in hair follicle cells, whereas, upregulation of NO production by androgens via stimulating
inducible NOS expression may indicate an involvement of NO in the pathogenesis of androgen-de-
pendent hair loss, such as androgenetic alopecia. These ¢ndings indicate that NO could be part of an
important signaling pathway in the human hair follicle.
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A Signi¢cant Role of Aromatase Cytochrome P450 on Hair Re-growth and Pig-
mentation
A. Ohuchi1, K. Ohguchi1, N. Tsuji1, S. Moriwaki1,Y. Takema1, S. Honda2, N. Harada2
1Biological Science Laboratories, Kao Corp.Tochigi, Japan and 2Dept. of Bio-chemistry, Fujita Health University
School of Medicine, Aichi, Japan
It is well known that sex hormones such as androgen and estrogen in£uence the hair growth in several
animals. Aromatase is a member of cytochrome P-450 gene superfamily and catalyzes the conversion
of androgen to estrogen, a rate-limiting step of estrogen biosynthesis. Previous reports have suggested
that aromatase exists in various extra-gonadal tissue as well as in gonadal tissue, and that the expres-
sion is regulated by alternative use of multiple exons 1 and promoters. In this study, in order to exam-
ine the involvement of aromatase in hair growth, we investigated the localization of aromatase at hair
follicles in human and murine, and evaluated the role of this enzyme on hair re-growth using aroma-
tase knockout mice. Immunohistological technique for anagen hair follicles revealed that aromatase
positive cells localized in outer root sheath tissue while were not observed in hair matrix, follicular
papilla and epidermis. RT-PCR analysis of aromatase mRNA in plucked human hair suggested that
aromatase transcripts were mainly composed of placenta-speci¢c exon 1. Next, we examined the e¡ect
of aromatase inhibitor on the hair re-growth of C3H mouse. The topical application of 1% amino-
glutethimide signi¢cantly promotes the hair regrowth. Moreover, hair re-growth was signi¢cantly
accelerated in aromatase knockout female mice in compared with wild type. Intriguingly, the color
of re-grown hair of those mice was blacker than wild type and heterozygotes. Alteration of hair color
was caused by the increase of melanin contents (total melanin and eu-melanin). These results suggest
that aromatase plays an important role on hair growth and melanin synthesis in hair follicles through
the local synthesis of estrogen.
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Atrichia with Papular Lesions Resulting from Compound Heterozygous Mutations
in the Hairless Gene: A Lesson for Di¡erential Diagnosis of Alopecia Universalis
Wolfram Henn1, Abraham Zlotogorski3, Andrei A. Panteleyev, Hansotto Zaun2, and Angela M.
Christiano
1Institute of Human Genetics, and 2Dept. of Dermatology, Saarland University, Homburg/Saar, Germany;
3Hadassah Medical Center, Jerusalem, Israel; Departments of Dermatology and Genetics & Development,
Columbia University, NewYork, NY, USA
Atrichia with papular lesions (APL) is a rare, autosomal recessive form of total alopecia, in which
mutations in the hairless (hr) gene have been shown to underlie the penotype.We suspect that APL
is actually much more common than previous population estimates suggest, because we believe the
disorder is frequently misdiagnosed as alopecia universalis. To date, mutations identi¢ed in the hairless
gene have all been homozygous mutations in probands within families with extensive consanguinity,
where identity-by-descent (IBD) was anticipated.We sought to investigate whether APL might also be
found among patients in small families without obvious IBD, particularly those giving a history of 1)
normal hair at birth that was shed and never regrew; and 2) ‘alopecia universalis’ that is recalcitrant to
any treatment. In this study, we identi¢ed a small family of German origin in which two of four
siblings were a¡ected and gave this clinical history. Direct sequence analysis of the hr gene in one
proband revealed distinct mutations on each allele. The ¢rst was a 2 bp deletion of the splice acceptor
site of intron 13 (2847-2delAG), and the second was a nonsense mutation in exon 19 (Q1176X). This is
the ¢rst demonstration of compound heterozygous mutations in the hr gene. These ¢ndings support
the hypothesis that APL can exist in small families without IBD, and underscore the possibility that
APL may be masquerading clinically as alopecia universalis.We anticipate that an increased recogni-
tion of this disorder will result in accurate discrimination between APL and alopecia universalis, thus
sparing unnecessary treatment to a¡ected patients.
ABSTRACTS 129VOL. 8, NO. 1 JUNE 2003
025
New Developments in Alopecia Areata Using Rodent Models
K.J. McElwee
Philipp University, Marburg, Germany
Rodent models of human disease provide an important tool in the investigation of genetic and envir-
onmental activation factors, disease pathogenesis, and the development of new and improved treat-
ments. Several inbred rodent models have been identi¢ed for alopecia areata (AA), a non-scarring
in£ammatory hair loss disease with suspected autoimmune elements. Up to 20% of C3H/HeJ mice
and 70% of Dundee Experimental Bald Rats (DEBR) develop AA-like, patchy hair loss that may
progress to universal alopecia. Hair loss is associated with peri- and intra-follicular lymphocyte and
macrophage in£ammation, but no signi¢cant scarring.
These two rodent models have been employed in examining the mechanisms involved in AA.
Manipulation of in£ammatory cells by selective in vivo cell depletion or transfer between a¡ected
and una¡ected C3H/HeJ mice indicates AA is primarily a cell mediated disease. Successful induction
of AA by skin graft transfer between a¡ected and una¡ected mice has been used to examine changes
in gene expression within AA-a¡ected skin using £ow cytometry and gene array technology. Rodents
are now utilized to evaluate a variety of current treatments and for developing new therapies.
The ability to follow the full course of AA throughout life including events prior to the onset of
actual hair loss makes rodent models a considerable asset in AA research. The ability to induce AA-
like disease with visible hair loss several weeks after surgery in the mouse AA model provides a con-
sistent, controllable model for disease investigation and novel drug e⁄cacy studies. Ultimately, animal
models will be used to determine the genetic basis of AA, the potential endogenous and/or environ-
mental trigger(s), the mechanism(s) of disease initiation and progression, and allow evaluation of new
treatments.
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Alopecia Areata: Treatment Today and Tomorrow
Rolf Ho¡mann
Dept. of Dermatology, Philipp University, Marburg, Germany
Alopecia areata is a tissue-restricted,T-cell mediated autoimmune disease of the hair follicle. Current
treatments for alopecia areata involve immunosuppression by corticosteroids or PUVA. So far, at-
tempts to treat alopecia areata with immunophilin-ligands such as FK506 or ASM981 have not been
succesful. The most e¡ective treatment for severe alopecia areata is the use of contact sensitizers such as
diphenylcyclopropenone and squaric acid dibutylester. Although their mode of action is not precisely
known, there is evidence that they mediate their bene¢cial e¡ect in alopecia areata via the induction of
the immunosuppressive cytokines TGF- and IL-10.
Dictated by the autoimmune pathogenesis of AA, improved future treatments may be immuno-
suppressive, immunomodulatory, or protect the hair follicle from the injurious e¡ects of the in£am-
mation. As disease onset inhibitors are unlikely to be developed in the foreseeable future, research into
new treatments must ¢rst focus on disease symptoms. Such possible future treatments are discussed,
including the use of cyclosporine- or FK506-loaded liposomes, application of immunosuppressive cy-
tokines like TGF- and IL-10, inhibition of apoptosis mediated by the Fas-FasL system, inhibition of
the lymphocyte homing receptors CD44v10 or CD44v3, induction of tolerance with tolerogenic den-
dritic cells and gene therapy.
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Cicatricial Alopecia: Consensus Conference Guidelines
Olsen EA1, BergfeldW2, Cotsarelis G3, Price V4, Shapiro J5, Sinclair R6, Solomon A7, Sperling L8,
Stenn K9,Whiting D10, and the Cicatricial Alopecia Research Group
1Duke University Medical Center, Durham, NC, USA; 2Cleveland Clinic, Cleveland, Ohio, USA; 3University of
Pennsylvania, Philadelphia, PA, USA; 4University of California- San Francisco, San Francisco, CA, USA;
5University of British Columbia,Vancouver, BC; 6University of Melborne, Melborne, Australia; 7Emory University,
Atlanta, GA, USA; 8Armed Services Institute, Bethesda, MD, USA; 9Skin Biology Research, Johnson and
Johnson, Skillman, NJ, USA; 10Baylor Hair Institute, Dallas,TX, USA
Advances in the understanding and treatment of cicatricial alopecia have been hampered by di⁄culties
in making an early diagnosis, terminology that currently is subject to widely varied interpretation,
lack of uniformity in selection and timing of biopsy sites and pathologic evaluation, lack of easily
reproducible endpoints to use to evaluate di¡erent therapies and lack of information on potentially
confounding hair care factors. A meeting was held February 10^11, 2001 at Duke University Medical
Center to discuss the above. Consensus recommendations for 1) clinical evaluation, 2) biopsy and
pathologic evaluation, and 3) therapeutic endpoints were made as well as a working pathologic classi-
¢cation based on type of in£ammatory in¢ltrate seen histologically and will be presented in further
detail.
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Hair Follicle Stem Cells: An Overview
Robert M. Lavker1 and Tung-Tien Sun2
Departments of Dermatology, 1University of Pennsylvania School of Medicine, Philadelphia, PA and 2NewYork
University School of Medicine, NewYork, NY, USA
Hair follicle stem cells are important because they play a central role in the control of the hair growth
cycle, help in the maintenance of the epidermis, and represent a major target of tumor initiation. One
of the most accepted means to identify keratinocyte stem cells takes advantage of the fact that they are
normally rarely cycling in vivo, and can be detected experimentally as the ‘‘label-retaining cells’’
(LRCs).When this approach was used to localize the rarely cycling cells of the hair follicle, all of the
follicular LRCs were exclusively con¢ned to the bulge ^ the part of the outer root sheath marking the
lowest point of the upper, permanent portion of the follicle. Furthermore, in studies of mouse and
human skin, the great majority of LRCs have been observed in the bulge region of the hair follicle,
with very few, if any in the epidermis. Cells within the follicular bulge satisfy almost all of the criteria
for keratinocyte stem cells. Bulge keratinocytes have a higher proliferative capacity than other regions
of the follicular epithelium as well as the epidermis; have a primitive ultrastructure; are in contact
with a specialized smooth muscle; are physically well protected; and are believed to be a major target
of chemical carcinogens. Most recently, it has been demonstrated that the progeny of bulge cells can
emigrate into the epidermis in normal mouse skin. These data suggest that the bulge represents a
major repository of skin keratinocyte stem cells that may be bipotent as they can give rise to not only
the hair follicle, but also to the epidermis.
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Multipotent Stem Cell and Hair Follicle Morphogenesis
H. Oshima1,2 and Y. Barrandon1
1Department of Biology, Ecole Normale SupeŁ rieure, Paris, France;
2Department of Plastic Surgery, St Marianna
University School of Medicine, Kawasaki, Japan
Hair follicles are self-renewing skin appendages that contain stem cells. Several lines of evidence in-
dicate that stem cells reside in the upper part of the follicle. In the pelage follicle of the mouse, 3HtdR
or BrdU-labeling experiments have revealed that slow cycling cells reside in the bulge. Clonal analysis
has demonstrated that 95% of the colony forming cells of rat vibrissal follicle are located in the bulge.
Furthermore, the cells located in this region proliferate infrequently to the opposite of those located in
the hair matrix which proliferate actively. These previous works led us to question if the bulge serves
as a reservoir of stem cells to sustain hair growth and there is a £ux of stem cells from the bulge to the
bulb.
OF1, B6/D2F1/Jico, athymic mice and Rosa26 mice that constitutively express lacZ gene were ob-
tained and bred in our animal facility. We have microdissected the bulge of vibrissal follicles from
wild-type mice and replaced them with bulges of Rosa26. Chimeric follicles were then transplanted
under the kidney capsula of athymic mice. Eventually the bulges of Rosa26 follicles were transplanted
in utero onto the back of embryos of OF1. Several weeks after operation, their kidneys with implant
of follicles and the bulge-transplanted back skin of embryos were harvested and ¢xed with 4% par-
aformaldehyde, then were stained in X-gal solution.
Over 6-8 weeks after implantation, all the lineages involved in the formation of pilo-sebaceous
units were constantly generated from the transplanted bulges. Furthermore, epidermis, multiple hair
follicles and sebaceous glands formed when the bulges of Rosa26 follicles were transplanted onto the
back of mouse embryos.
We demonstrate i) that multipotent stem cells are present in the bulge of vibrissal follicles of adult
mice, ii) that they can generate epidermis, all hair follicle lineages and sebaceous glands, iii) that they
migrate in the outer root sheath from the bulge down to the hair bulb to participate in whisker
growth. These results suggest important implications in skin morphogenesis and plasticity of stem
cells.
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Hair Follicle Stem Cells in Human Skin Development
M. Akiyama
Department of Dermatology,Teikyo University School of Medicine, Ichihara Hospital, Ichihara, Japan
Knowledge of localization and the characteristic features of hair follicle stem cells in developing hu-
man hair follicles contributes to a further understanding of the mechanisms underlying human hair
follicle morphogenesis. The sequential localization and morphological characteristics of hair follicle
stem cells were investigated. In addition, the expression of hemidesmosomal components including
laminin 5, b4 integrin, and type VII collagen were also studied in the stem cell sites during human
hair follicle development. Immunohistological observation revealed that b1 integrin-rich, E-cadherin-
and b- and g- catenin-poor cells, possible stem cells, were localized to the entire hair germ (65-84 d
estimated gestational age (EGA)) and later to the outermost cells of the hair peg (85^104 d EGA). In
the bulbous hair peg (105^135 d EGA) as well as the di¡erentiated lanugo hair follicle (4135 d EGA),
these putative stem cells were settled in the bulge and the outermost layer of the outer root sheath.
The putative stem cells were also high in EGF receptor expression and positive with keratin 19. Ultra-
structural observation of human fetal skin specimens revealed that these b1 integrin-rich, E-cadherin-
and b- and g-catenin-poor cells showed similar, undi¡erentiated morphologic features. In particular,
the bulge cells had abundant free ribosomes and glycogen particles, but almost no cytoplasmic orga-
nelles indicative of di¡erentiation. Concerning the expression of hemidesmosomal components, posi-
tive stainings were continuously observed in the basement membrane zone of the hair germ and the
hair peg, although the stainings were weak or negative in the lower portion of the hair peg. In the
bulbous hair peg and the di¡erentiated lanugo hair follicle, the hemidesmosomal components were
expressed in the basement membrane zone from the interfollicular epidermis to the bulge, and also
in the contact area between the matrix cells and the dermal papilla cells. These results support the idea
that the human fetal hair follicle bulge is a stem cell site for follicular epithelium from the bulbous
hair peg stage and suggest that hemidesmosomal components are continuously expressed in the stem
cell sites during hair follicle morphogenesis.
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Corneal Epithelium Basal Cells Can Activate Epidermal Genetic Programs by Re-
verting First to Hair Stem Cells
C. Ferraris1, G. Chevalier1, B. Favier1, C.A.B. Jahoda2 and D. Dhouailly1
1Biologie Di¡eŁ renciation EpitheŁ liale, UMRCNRS 5538, Institut A. Bonniot, UniversiteŁ J. Fourier, Grenoble, Fr,
2Dept. of Biological Sciences, University of Durham, U.K.
The capacity of the epithelial component of rabbit adult central cornea to follow an alternative di¡er-
entiation pathway was investigated by associating it with a mouse embryonic dermis from a hair-
forming region. In the dermal-epithelial recombination experiments presented, because the nuclei of
cells from these two components belong to two di¡erent species, they are easily recognizable: Hoechst
staining allows easy discrimination of mouse and rabbit cell nuclei. Adult corneal epithelium, under
the in£uence of embryonic skin dermis, undergoes a transition to an epidermal-type phenotype and
produces hair follicles, corresponding to the regional identity of the dermis. The ¢rst stage of the
transformation process appears to be the restoration of a more primitive limbal cell-like phenotype
from amongst a TA cell population, which express corneal-type keratins, as shown by the use of a
monoclonal antibody speci¢c for K12. The second stage is the formation of hair buds, which can be
considered to contain potential stem cells, the stem cell niche becoming subsequently progressively
limited to the bulge region of the hair follicle. The third stage is the formation of an epidermis, char-
acterized by the expression of epidermal-type keratins and the formation of a granular layer. The ¢rst
epidermal cells expressing K10 always appeared at the top of the developing hair follicles. We thus
con¢rm that follicles may be the primary source for epidermal homeostasis. Finally, the corneal layers
which remains at the top of the new formed epidermis are progressively shedded.
Our results provide the ¢rst indication that a distinct transient amplifying cell population can be
reprogrammed, and they imply that they do so by reverting to a stem-like condition. They also show
the equivalence of corneal epithelium and epidermal stem cells, which is perhaps a consequence of
their common embryological origin.
032
The Hypothesis of Hair Follicle Predetermination
Andrei A. Panteleyev1, Colin A.B. Jahoda2, and Angela M. Christiano1
1Departments of Dermatology and Genetics & Development, Columbia University NewYork, NY, USA;
2Department of Biological Science, Univ. of Durham, Durham, UK
Despite substantial progress in genetic and molecular studies of hair follicle (HF) biology, the mole-
cular data, including expression patterns, cannot be properly appreciated without understanding the
basic cellular rearrangements and interactions that maintain HF cyclic transformations. Here, we pre-
sent a further attempt to understand the interaction between di¡erent HF cell populations and outline
the major cellular processes that take place during its cyclic progression through periods of growth,
regression, and quiescence. The Hypothesis of Hair Follicle Predetermination, as put forth here, repre-
sents an extension of the previous models of HF cellular kinetics with one critical modi¢cation: the
timing of the recruitment of HF stem cells. The patterns of cell proliferation during anagen-telogen
transition, together with morphological evidence, suggest that there are two separate cell populations
with proliferation potential in the late telogen HF: the cells of the bulge region (stem cells) and the
hair germ. Further, based on our studies of the hairless phenotype in mice, immunohistochemistry
data, and extensive analysis of the recent literature, we provide evidence to suggest that the activity
of hair germ cells is the initiating event of anagen, which precedes the activity of the cells in the bulge
region. The hair germ cells give rise to the ascending part of the growing HF, including the hair shaft
and IRS, while the downgrowing ORS is a product of the bulge (stem) cell activity. Thus, the mature
anagen HF has a dual origin. During anagen, some cells with clonogenic potential migrate from the
bulge region along the ORS and reside on the hair bulb periphery. During catagen, these cells get
into direct contact with follicular papilla and undergo a process of ‘‘maturation’’ (follicular papilla-
guided formation of hair germ), thus acquiring the ability to respond to follicular papilla signaling
and produce a plurality of ascending layers of the new HF. In conclusion, we suggest that the growth
characteristics of the HF and hair shaft are predetermined by the previous hair cycle, during the re-
cruitment of stem cells from the bulge region and consequent process of hair germ formation.
033
Introduction to in vivo and in vitro Models for the Study of Hair Follicles
Randall VA
Department of Biomedical Sciences, University of Bradford, Bradford, UK
The way in which the complex organ system of the hair follicle functions in health and disease is not
well understood. Greater knowledge is essential to improve treatments for hair disorders. Studies on
human follicles are hampered by ethical considerations and limited amounts of tissue. A number of
alternative models have been devised based on human and other mammalian tissues to answer speci¢c
questions. These range from in vitro models based on isolated cell types to whole organ culture and in
vivomodels involving natural and genetically manipulated animals. These systems will be discussed in
this workshop.
034
Dermal Papilla Cells from Follicles withVarious Responses to Androgens in vVivo
Retain Di¡erences in Gene Expression in Culture
Randall VA
Department of Biomedical Sciences, University of Bradford, Bradford, UK
The mesenchyme derived dermal papilla situated at the base of the hair follicle controls many aspects
of hair growth. Dermal papilla cells have now been successfully cultured from many species.
Human hair follicles di¡er from many species in that their size varies dramatically in di¡erent parts
of the body. In many regions the type of hair produced varies with age. The hairs vary from short,
¢ne non-pigmented vellus hair on the child’s face to the long, thick, pigmented terminal hairs in the
male beard. These changes, like balding on the scalp, are produced by androgens and are believed to
occur via the dermal papilla.
Cultured dermal papilla cells from follicle with di¡erent responses to androgens in vivo have been
investigated in vitro. Cells from androgen-sensitive follicles such as beard and balding scalp contain
speci¢c androgen receptors at higher concentrations than those from control areas. Testosterone meta-
bolism to 5a-dihydrotestosterone re£ected hair growth in 5a-reductase de¢ciency patients. Androgen-
sensitive cells also produced greater (beard) or fewer (balding scalp) mitogenic factors in response to
testosterone. Thus, these cells o¡er a useful in vitro model system for investigating androgen action.
035
Hair Growth in vitro
M.P. Philpott
Centre for Cutaneous Research, St Bartholomew’s and the Royal London School of Medicine and Dentistry, QMW
College, University of London, UK
Since methods for the isolation and in vitro culture of human hair follicles were ¢rst published many
researchers have used these models to investigate hair follicle biology. The major application of these
models has been to investigate possible roles for growth factors in controlling hair follicle growth and
di¡erentiation. These studies have identi¢ed IGF-I, HGF and members of the FGF and TGF-b/BMP
family as being possible key hair growth regulators. Moreover, these in vitro observations have been
con¢rmed by in vivo data such as knockout mice, immunohistochemistry (IHC), in situ hybridisation
(ISH) and RT-PCR. Human hair follicles can be switched from anagen to catagen by insulin/IGF-I
withdrawal and some of these follicles appear to progress to a catagen like state. However, full human
hair cycle in vitro is not achieved. To address this problem several workers have shown that cultured
vibrissa follicles grow at rates that appear to re£ect their in vivo status and also show cyclical changes in
morphology. These observations suggest that cultured vibrissa follicles will prove to be an excellent
model for in vitro hair cycle study. Human hair follicles have been used to investigate both the inter-
mediary metabolism of hair growth, and the process of hair ¢bre formation.
The next major step for those of us involved in the use of in vitro models will be to develop meth-
ods that permit genes to be knocked out in vitro using either antisense oligonucleotides, neutralising
oligonucleotides or blocking peptides. Further work is required to characterise in vitro models of hair
follicle cycling, especially those that use cultured vibrissa follicles. Such models could also be used to
investigate stem cell tra⁄cking. Also the development of mice, such as the c-Myc-ER transgenic, in
which 4-hydroxytamoxifen (4OHT) is used to induce c-Myc overexpression may permit genes to be
activated in vitro and their e¡ects on hair follicles studied. Finally, the ultimate in vitro model would be
one in which embryonic hair follicles can be stimulated to develop in vitro in skin equivalent models.
With recent advances in which it has been demonstrated that, in vivo, embryonic mesoderm can sti-
mulate adult epithelium to undergo hair follicle development. Perhaps such in vitro models are not so
distant.
036
Mouse Models for Studying Hair Biology
JP Sundberg
The Jackson Laboratory, Bar Harbor, Maine, USA
Domestic animals develop hair diseases and many species, primarily sheep, have been used to study
hair biology. Mice develop many of the same diseases as humans and have become the premier in vivo
model for studying biology, pathology, genetics, and molecular mechanisms of many hair diseases.
Examples of characterized mutant mice with abnormal pilosebaceous unit phenotypes will be pre-
sented to illustrate the value of these animals as models to help understand human diseases such as
scarring alopecias (sebaceous gland abnormalities of asebia and bareskin), hair cycle (angora, hairless,
and others), structural defects of hair ¢bers (most common cause of mouse baldness), and autoimmune
diseases (alopecia areata, £aky skin, and chronic proliferative dermatitis). Genetically engineered mice
have de¢ned the role of many genes involved in hair biology. Spontaneous mutant mice have been
long studied and provide a wealth of historical information on the biology surrounding the function
of these genes since many were characterized in great detail before the advent of bioengineering tech-
ology.
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Role of Stat3 in Hair Development Revealed by the Conditional Gene Targeting
Takeda J.
Department of Social and Environmental Medicine, Osaka University Graduate School of Medicine, 2-2
Yamadaoka, Suita, Osaka, Japan
Signal transducer and activator of transcription 3 (Stat3) is involved in many signaling pathways for
growth factors and cytokines. Its de¢ciency in mice therefore causes early embryonic lethality, pre-
venting analysis of the functions of the Stat3 gene in adulthood.
To circumvent this di⁄culty and explore the functions of Stat3 in the epidermis, the keratinocyte-
speci¢c conditional gene targeting using the Cre/loxP system was utilized. Despite functional ablation
of Stat3 in the keratinocytes from the mutant mice, no developmental abnormality was observed.
However, skin remodeling such as wound healing and second hair cycling was profoundly impaired
in the mutant mice. In an in vitro culture system, the migration of keratinocytes from the mutant mice
stimulated with various growth factors and cytokines was severely attenuated, which is thought to
account for the defect of skin remodeling in the mutant mice. Although the molecular mechanism
of Stat3 involvement in keratinocyte migration remains unknown, focal adhesion is enhanced in the
mutant, suggesting that Stat3 might be involved in the detachment of keratinocytes from the extra-
cellular matrix rather than the attachment to it.
However, the migration by PKC signalling was intact in the mutant mice. These data suggest that
Stat3 and PKC pathway were independent for the keratinocyte migration.Wortmannin, an inhibitor
of PI3K, impaired the migration of both pathways, implicating PI3K is critically involved in the ker-
atinocyte migration.
038
Principles of Hair Follicle Cycling
Ralf Paus
Dept. of Dermatology, University Hospital Hamburg-Eppendorf, University of Hamburg, Hamburg, Germany
The hair follicle (HF) is the only mammalian organ that permanently undergoes cyclic transforma-
tions from long stages of growth (anagen), via rapid, organ involution driven by programmed kerati-
nocyte death (catagen) to a stage of relative quiescence (telogen). In addition, extrusion of the hair
shaft may represent a fourth, independently regulated hair cycle phase (exogen). The HF may exit
from cycling only by entering into ‘‘programmed organ death’’, which may be a physiological pro-
gramme for the deletion of malfunctioning follicles, or of follicles that have exhausted the number
of cycles they can traverse.
HF cycling begins with the ¢rst entry into catagen, immediately after the completion of HF mor-
phogenesis. The ¢rst hair cycle in both man and in rodents is synchronized, and only subsequent
cycles become desynchronized. Thus, the basic regulation of HF cycling is likely to follow the same
fundamental regulatory controls in all mammalian species, irrespective of the fact that there are pro-
found di¡erences in the hair cyle-modulatory e¡ects, e.g., of steroid hormones and growth factors
between species and de¢ned hair follicle-subpopulations.
The molecular nature and organisation of the autonomous ‘‘hair cycle clock’’ (HCC) that dictates
HF cycling and is located in the skin itself is still unkown. The HCC exploits controlled switches in
the local epithelial-mesenchymal signalling milieu of growth factors, cytokines, hormones, neuropep-
tides and adhesion moelcules as well as in the expression of cognate receptors form the basis of the
HCC, with an intriguing predominance of hair growth-inhibitors over stimulatory signals. Basic cri-
teria that any convincing HCC theory should meet are de¢ned, and several previously proposed the-
oretical concepts that attempt to explain the HCC are critically discussed. In this context, possible
analogies between the molecular controls of hair follicle induction/morphogenesis and cycling will
be critically discussed. Finally, various chronobiological devices that the hair follicle employs during
its development and cycling are distinguished, and their clinical relevance is explored.
039
Noggin is Required for Induction and Cyclic Activity of the Secondary (Nontylo-
trich) Hair Follicles
V. A. Botchkarev1, N.V. Botchkareva1, M. Nakamura2, O. Huber3, K. Funa4, R. Lauster5, R. Paus2 and
B. A. Gilchrest1
1Dept. of Dermatology, Boston University School of Medicine, Boston, USA; 2Dept. of Dermatology, University of
Hamburg, Hamburg, Germany; 3Free University Berlin, Germany; 4University of Geteborg, Sweden; 5Deutsche
Rheumaforschunzentrum, Berlin, Germany
Increased evidence of data suggests that morphogenesis of the hair follicle (HF) and its cyclic activa-
tion during postnatal development are both regulated by similar mechanisms. Here, we show that
embryonic skin of mice with constitutive deletion of the bone morphogenetic protein (BMP) antago-
nist noggin, after transplantation into SCID mice, is characterized by the lack of induction of second-
ary HF, which make up 90^95% in mouse fur. The loss of noggin activity is associated with failure to
express genes that specify HF cell fates in skin (Lef-1, b-catenin, Shh, p75NTR). By semi-quantitative
RT-PCR, in situ hybridization, and immunohistology of C57BL/6 murine postnatal skin, BMP4 and
BMPR-IA are prominently expressed in the resting (telogen) HF, while hair growth phase (anagen)
initiation is associated with upregulation of noggin message. Furthermore, BMP4 causes selective ar-
rest of the telogen-anagen transition and anagen development in the secondary HF, while noggin
induces new anagen in the telogen skin. As a hair growth inducer, noggin increases Shh in the HF,
while BMP4 downregulates Shh. This suggests that molecular mechanisms, driving induction and
anagen initiation in the secondary HF, are more highly conserved than previously appreciated and
both require modulation of BMP signaling by noggin.
040
Epithelial-Mesenchymal Interaction and Hair Cycling
Jiro Kishimoto,Tsutomu Soma,Toshihiko Hibino, Bruce Morgann, Robert Burgesonn
nShiseido Life Science Research Center, MGH/Harvard Cutaneous Biology Research Center
Hair dermal papilla cells are specialized mesenchymal cells, which send reciprocal signals to hair folli-
cular stem cells to maintain hair elongation and cyclic regeneration. Several epithelial derived signal-
ing molecules such as Shh andWnt ^beta catenin have shown their essential roles for anagen induction
in transgenic mouse model but direction of signal and actual targets in dermal papilla cells are to be
elucidated.
Versican is a large chondroitin sulfate proteoglycan and in situ hybridization results showed anagen
dermal papilla (DP) speci¢c versican expression in mice as well as previous immunohistochemical
study. Localization of versican in human hair follicle by core-protein speci¢c monoclonal antibody
also demonstrated anagen dependent staining in human DP similar to mice, suggesting a common
role of versican across the species. We have generated lacZ reporter transgenic mouse with versican
promoter and successfully obtained DP speci¢c promoter activation in vivo during development and
postnatal hair cycling. Pelage dermal papilla cells are isolated from versican transgenic line with GFP
reporter by FACS. A¡ymetrix gene chip analysis using isolated DP cells indicates abundant gene ex-
pression characteristic to DP cells previously reported such as collagen I and III.These isolated DP cells
have proved to possess hair inductive activity by hair reconstitution grafting assay, however, without
stimulation from epithelial cells they lose this inductivity during passages in culture. This inductivity
was able to maintain by feeding biologically activeWnt protein in culture, indicatingWnt signaling
from follicular epithelium toward DP has an essential role for hair elongation. Current e¡ort is fo-
cused to reactivate cultured inactive DP cells including by simultaneous stimulation of multiple sig-
naling molecules and forced expression of versican itself.
041
Preliminary Studies of Exogen, the Shedding Phase, of the Mouse Hair Cycle
Kurt Stenn,Yoram Milner, Menas Kizoulis
Juvenir Biosciences, Skillman, NJ USA
At the end of the normal hair cycle the hair ¢ber sheds. This step was recognized, e.g., as animal
molting, long before the phases of the cycle were otherwise de¢ned. In the past, the shedding process
has been thought to be a part of the telogen phase. In view of the trichostatic follicles in animals and,
incidentally, in humans, in fact every telogen phase is not associated with hair shedding. Hair shed-
ding then occurs separate from the telogen phase.The latter prompted us to consider that the shedding
process is indeed a separate phase of the hair cycle and we refer to it as exogen. We have recently
established methods for quantitatively collecting and quantifying shed hair. These methods have al-
lowed us to study shedding in the mouse.We found that exogen is closely coupled to anagen and that
the shed hair base di¡ers morphologically from telogen.We postulate that exogen occurs in two steps
^ an initiator step and a proteolytic e¡ector step.
042
Morphological Approach To Hair Disorders
R Sinclair
Dept. Dermatology, University of Melbourne,Victoria, Australia
All medical research begins and ends with the patient. Patients present to doctors who by careful ob-
servation of the morphology of their complaint establish a diagnosis. Patient needs motivate us to
research their disease and ¢nd novel therapeutic interventions to take back to the patient to alleviate
morbidity. Interaction between clinicians who are hair morphologists and scienti¢c researchers is pi-
votal. Hair morphology research involves many aspects. Careful observation of the physical presenta-
tion of the patient and correlation of these ¢nding with the histological features of biopsy specimens
enhances the speci¢city of both. Many conditions associated with structural abnormalities of the hair
¢bre are caused by single gene mutations. Cataloguing these conditions based on their clinical presen-
tation and hair microscopy ¢ndings allows them to be methodically studied. Kindreds with inherited
disorders are amenable to gene discovery procedures. Reverse genetics, whereby the causative muta-
tion is found, the gene product identi¢ed and the biological consequences of the altered protein pro-
duct studied, allows determination of abnormal molecular function on hair biology to be understood.
In turn this sheds light on the requirements for normal follicle function.
Hair morphology also involves sub-classifying patients who present with multifactorial diseases on
clinical grounds. Female pattern hair loss is an example of a multifactorial disease whereby careful
observation of the patient’s clinical presentation helps predict which patients are likely to respond to
therapy.
One common problem that confounds all clinical hair research is the di⁄culty in accurately mea-
suring hair growth, monitoring the hair cycle and documenting patient response to therapy. Improve-
ments in photographic methodologies have allowed clinical trials to be conducted into the treatment
of androgenetic alopecia but further work is required, particularly in the assessment of scarring alope-
cia, alopecia areata and the study of normal hair growth and cycling.
Just as laboratory research has produced many recent advances in hair biology, clinical research is
also continuing at a rapid pace with new clinical insights and new syndromes being regularly de-
scribed, that will impact on the future direction of hair research.
132 ABSTRACTS JID SYMPOSIUM PROCEEDINGS
043
The Reliability and Reproducibility of Horizontally Sectioned Scalp Biopsies in
the Diagnosis of Chronic Di¡use Telogen Hair Loss inWomen
R Sinclair1, D Jolley2, R Mallari3, and J Magee4
1Dept. of Dermatology, University of Melbourne, 2School of Health Sciences, Deakin University, Melbourne
Australia, 3Dept. of Dermatology, St Luke’s Medical Centre, Manila, Philippines 4Dorovitch pathology, Melbourne
The diagnostic and predictive value of horizontal sections of scalp biopsy specimens has been studied
in male pattern androgenetic alopecia. As women with female pattern balding (FPB) have di¡use hair
loss over the crown, a single 4 mm horizontal section biopsy may not be accurate. To assess this 207
women presenting with chronic di¡use telogen hair loss were studied prospectively. Three 4mm
punch biopsies were taken from immediately adjacent skin in a line on the vertex scalp. The terminal
to vellus hair ratio (T:V) at the mid-isthmus level was used to categorize women as: FPB (T:Vo4:1),
chronic telogen e¥uvium (CTE) (T:V48:1) or indeterminate (T:V¼ 5:1, 6:1 or 7:1).
Among 207 women, 159 (77%) were diagnosed with FPB on the basis of consensus over 3 biopsies,
44 (21%) as CTE and the remaining 4 women (2%) were indeterminate. Using each single biopsy as
the criterion for diagnosis, there were 621 biopsies from the 207 women. Of these 398 (61%) would be
classi¢ed as FPB on the basis of T:V alone, 99 (16%) as CTE and 124 (20%) as indeterminate. Overall
in 493 (79%) biopsies, the single horizontal biopsy conclusion was identical to the 3 biopsy. Of the
remaining 21% of biopsies for which disagreement was seen, most were classi¢ed as indeterminate,
rather than a wrong diagnosis. Of the 477 ‘‘true’’ FPB biopsies, only 3.3% were wrongly classi¢ed as
CTE. To measure the consistency between repeated quantitative measurements on the same subject,
the interclass coe⁄cient was determined using a one way analysis of variance (ANOVA), and found to
be 0.53 with a 95% con¢dence interval from 0.45 to 0.60. The within-person standard deviation (SD)
was 3.3, which is large given the diagnostic cutpoint for FPB is aT:V of 4r0.When calculated within
diagnostic categories, for FPB the ICC is 0.30 with a SD of 1.66. For CTE the ICC is 0.16 with a SD of
6.6-unacceptable when a cuto¡ between 4 and 8 is used to distinguish the diagnosis.
These results demonstrate that a single 4mm horizontal scalp biopsy is not su⁄cient for a de¢nitive
diagnosis and multiple biopsies are required for accurate diagnostic de¢nition.
044
What’s New on Hair Disorders
A. Tosti
Dept. of Dermatology, University of Bologna, Bologna, Italy
Telogen e¥uvium: Hair loss is a common complaint in patients receiving highly active anti-retroviral
therapy (HAART), especially the protease inhibitor indinavir. Hair loss involves both the scalp and
the body hair. Other possible side e¡ects of indinavir therapy include development of curly hair and
discoloration of the eyebrows. Contact dermatitis should be included among possible causes of telo-
gen e¥uvium. Four out of eight women developed mild to moderate hair loss 2 to 4 months after an
acute contact dermatitis of the scalp due to hair dyeing. The pathogenesis of telogen e¥uvium caused
by contact dermatitis is unknown but may be related to cytokine release during the in£ammatory
process. Temporary patchy alopecia may follow endovascular surgery for cerebral arterovenus malfor-
mations. This is due to prolonged scalp exposure to radiation during £uoroscopic imaging. Di¡eren-
tial diagnosis with alopecia areata with ophiasis pattern may be di⁄cult.
Congenital hypotrichosis due to short anagen: This recently described disorder is characterized by
short blond hair due to a short anagen phase. The condition can be familial with an autosomal domi-
nant inheritance. The disorder appears to resolve spontaneously during puberty and adulthood.
Scalp mosaicism: A 32 year-old woman presented with an epidermal nevus following Blaschko’
lines. She also presented an alopecia distributed in a spiral pattern on the left parietal region. The
alopecic area was covered by short vellus-like hairs. Topical minoxidil produced improvement of alo-
pecic areas with gradual elongation and thickening of the vellus-like hairs.
Cicatricial alopecias: In the last few years two clinical variants of lichen plano pilaris have been
recognized; frontal ¢brosing alopecia and ¢brosing alopecia with a pattern distribution. These clinical
variants are characterized by the fact that the in£ammatory process does not a¡ect randomly the scalp
follicles but a¡ects selectively the hairline follicles in frontal ¢brosing alopecia or the miniaturized
follicles of the androgen dependent scalp in ¢brosing alopecia with a pattern distribution. A case of
lichen plano-pilaris limited to the follicles of an epidermal nevus of the scalp has also been described.
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Scalp Hair Photography and Hair Follicle Regression in Androgenetic Alopecia
D.Van Neste
Skinterface sprl,Tournai, Belgium and HairTechnology, Brussels, Belgium
Evaluation of hair loss in androgenetic alopecia (AGA) - requires an accurate noninvasive method for
diagnostic, prognostic and monitoring purposes. Because of known weaknesses of existing photo-
graphic methods, a new procedure has been developed.
The new procedure (1) unravelled the presence of usually undetected thick and thin hair even from
very severely miniaturised but still functionally active hair follicles (hair as thin as 8mm). In a com-
parative study with photographs and scalp biopsies taken from the same sites, the analysis also ap-
peared very precise but less tedious than the examination and 3-D reconstruction of hundreds of
serial histological sections. More recently we investigated hair densities with the new method on the
scalp of male subjects with AGA and una¡ected controls.We found a statistically signi¢cant and spe-
ci¢c reduction of hair counts on androgen sensitive sites before clear-cut clinical involvement (de-
tailed ¢ndings presented during this meeting).
These ¢ndings and technological improvements seem to indicate that the new method is more
suitable for detailed analysis of hair cycling in AGA. Indeed, this scalp disorder is characterised by
gradual hair follicle hypotrophy. The ensuing shortening of the duration of anagen, decreased hair
pigmentation and hair thinning result into clinically less visible hair and less hair detection with the
conventional photographic methods.
1.Van Neste, D. An improved phototrichogram technique for measurements of scalp hair dynamics
in androgenetic alopecia ^ a comparative and validation study against histology. European Journal of
Dermatology. In press
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The Morphology of the Human Hair Follicle in Vertical and Horizontal Sections
David A.Whiting
Baylor Hair Research andTreatment Center
The human hair follicle comprises a permanent upper follicle with infundibulum andisthmus, and an
impermanent lower follicle extending down from bulge to bulb.
In anagen, the dermal papilla penetrates the bulb and forms a continuous unit with the dermal
sheath, which surrounds the bulb. It nourishes the hair matrix containing transient amplifying cells,
which form the hair shaft. The developing hair shaft is molded by the inner root sheath, which kera-
tinizes in layers, ¢rst Henle, then cuticle, then Huxley. It is surrounded by external root sheath (tri-
chilemma), hyaline membrane, and dermal ¢brous sheath. The downward pointing cuticular cells of
the inner root sheath interlock with the upwardly projecting cells of the hair shaft cuticle. The inner
root sheath is shed in the isthmus, where it is replaced by trichilemmal keratin, which is in turn re-
placed by the keratinizing epithelium from the infundibulum.
The dermal papilla is dragged upward in anagen when the hair bulb ascends the follicle to the level
of the bulge, its path marked by the trailing ¢brous tract or stela. The trichilemma is shrunk by apop-
tosis and the hyaline membrane thickens and convolutes. In telogen, the clubbed hair root is cush-
ioned by a sac of trichilemmal keratin with the remains of the convoluted hair bulb below, forming
the telogen germinal unit. The next anagen phase is indicated by a downward budding from the rest-
ing telogen root.
The anatomy of the cycling and resting follicle will be displayed by matching vertical and hori-
zontal sections.
047
Mapping of Monilethrix and Papular Atrichia
A. Zlotogorski1, and A.M. Christiano2
1Dept. of Dermatology, Hadassah Medical Center, Jerusalem, Israel and 2Dept of Dermatology and Genetics &
Development, Columbia University, NY, USA
Monilethrix is a rare autosomal dominant inherited defect of the hair shaft resulting in hair fragility,
hair loss, and follicular hyperkeratosis. Light microscopic examination is diagnostic and reveals alter-
nating regions of thin and thick hair. Seven mutations in monilethrix were found only in the helix
initiation motif and the helix termination motif of keratins hHb6 and hHb1 (chromosome 12q13).
In 6 out of 12 Israeli families with monilethrix, mutations were found in the helix termination
motif of keratin hHb6, which was found to be the most common cause for this disease. One of the
families with the E413D mutation had 15 clinically a¡ected members who were available for study.
Three members who were found to be homozygous for this mutation had a more severe involvement
in terms of both hair and skin involvement. Twelve subjects were heterozygous for the mutation and
showed variable expression.
Atrichia with papular lesions is a rare form of irreversible alopecia which is inherited in an auto-
somal recessive pattern. In individuals a¡ected with this form of hair loss, hairs are typically absent
from the scalp, axilla and body, and patients are almost completely devoid of eyebrows and eyelashes.
APL patients are unique in that, along with total atrichia, papules and follicular cysts ¢lled with cor-
ni¢ed material start to appear during the ¢rst year of life, particularly under the midline of the eye, on
the face and extremities. Recently, this form of atrichia was linked to chromosome 8p12, and fourteen
mutations have been identi¢ed in the human hairless (hr) gene in Arab families and others from
around the world showing a similar phenotype. Based on personal observation of ten Arab families
and retrospective analysis of other families described in the literature, we propose an algorithm that
easily di¡erentiates this disorder from alopecia universalis.
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An Approach to the Diagnosis of Hair Dysplasias
J. Ferrando, and R. Grimalt
Department of Dermatology, Hospital Cl|¤ nic, University of Barcelona, Spain
Clinical observation and microscopy investigation of hair shaft are the clues for the diagnosis of hair
dysplasias. X-ray microanalysis and chromatography of hair aminoacids may also help in some condi-
tions.
From the clinical point of view the presence of hyperkeratosis follicularis in patients with conge-
nital hypothrichosis focusses the diagnosis to monilethrix or keratosis follicularis decalvans. The shin-
ning aspect of hair with the incidence of light on it suggest pili torti or pili annulati. The presence of
nodes is indicative of trichorrhexis nodosa (TN), trichorrhexis invaginata (TI), trichonodosis or bub-
ble hair.
Optical microscopy is essential in current practice. Speci¢c abnormalities are easily detected: peri-
odic narrowing of hair/monilethrix, ringed hair/pili annulati, trichoschisis and ‘‘tiger tail’’ hair/tri-
chothiodystrophy, atypical pili torti/Menkes’ syndrome, TI/Netherton syndrome, TN versus bubble
hair, ‘‘ru¥ing’’/loose anagen hair.
Scanning electron microscopy allows to di¡erenciate monilethrix from pseudomonilethrix (irregu-
lar intermitent £attening of hair), and con¢rms the diagnosis of woolly/curly hair conditions or pili
canaliculi. SEM is also useful for the study of hair weathering and cosmetic damage. X-ray microana-
lysis permits to detect sulfur aminoacids de¢ciencies (trichothiodystrophy) and the increase of a single
element (cooper/green hair).
Reference: Ferrando J, Grimalt R. Atlas of Diagnosis in PaediatricTrichology. Madrid:IM&C,2000.
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Spatial relationship between Merkel Cell and Langerhans Cell in Human Hair Fol-
licles
Y. Narisawa, K. Taira,T. Tanaka, and J. Nakafusa
Division of Dermatology, Department of Internal Medicine, Saga Medical School, Saga, Japan
The distributions of Merkel cell and Langerhans cell within human hair follicles have been reported,
respectively. Merkel cell and Langerhans cell share some similar characterizations such as the localiza-
tion of the bulge area, the close association with peripheral nerves and the expression of several neu-
ropeptides. Serial vertical sections and extracted hair follicles obtained from human skin enabled us to
investigate the anatomical relationship between Merkel cell and Langerhans cell in two- and three-
dimensions. Merkel cell was stained with CK20 or CAM5.2, while Langerhans cell was decorated
with CD1a or S-100 protein.We con¢rmed the preferential localization of Merkel cells and Langer-
hans cells in normal human hair follicles and analyzed their distribution. Using a double staining
technique, two- and three-dimensional observations demonstrated that a small proportion of Merkel
cells were closely contacted with Langerhans cells. It was observed that two cells connected directly or
approached with each dendrite. These morphological observations may suggest a functional interac-
tion between Merkel cell and Langerhans cell in human hair follicles.
050
Expression of the Proteins Associated with Epidermal Di¡erentiation During Hu-
man Hair Growth Cycle
Yong-Jun Piao, Ki-Beom Suhr, Jeung-Hoon Lee, and Jang-Kyu Park
Department of Dermatology, School of Medicine, Chungnam National University Daejeon, Korea
The profound morphological and molecular changes in the human hair follicles are involved in the
transition from anagen to catagen or telogen. In order to investigate how the expression of epidermal
proteins associated with di¡erentiation also occurs in hair follicles according to its cycle, we per-
formed immunohistochemistry and western blotting, using anagen and catagen hair follicles. In im-
munohistochemical staining, trichohyalin was expressed at inner root sheath (IRS) and medula in
anagen hair follicle, but disappeared in catagen stage. Involucrin was expressed at IRS and innermost
cell (IMC) of outer root sheath (ORS) in anagen hair follicle, and di¡usely spreaded into wider area
of ORS in catagen stage. Small protein rich proteins (SPR) was expressed in IMC layer in anagen and
catagen stage. Filaggrin, positive staining was observed upper portion of keratinization in IMC of
anagen hair follicles, it was disappeared in catagen stage. Transglutaminase (TGase) 1 and 3 were ex-
pressed in the greater part of areas of anagen hair follicles.Western blotting showed that the expres-
sions of the proteins for epidermal di¡erentiation (THH, involucrin, TGase1, TGase3, cytokeratin17)
were observed in anagen and catagen hairs, similarly. These data may be helpful to understand the
relationship between human hair cycle and the expression of epidermal proteins associated with dif-
ferentiation.
051
Visualisation of hair cortex ¢laments in situ by transmission electron microscopy:
A simpler procedure revisited
G.E. Rogers
South Australian Research and Development, Glenside, Adelaide South Australia, Australia
The standard procedure for introducing contrast into thin sections of hard alpha (and also beta kera-
tins) for electron microscopic studies was introduced over forty years ago (GE Rogers, J. Ultrastruc-
t.Res.2, 309 1959). For example, hairs collected in a bundle are submitted to partial reduction of
disulphide bonds by a thiol reagent (thioglycollic acid or b- mercaptoethanol) at pH5 followed by
bulk staining with osmium tetroxide and resin embedding. Thin sections are then stained with uranyl
acetate and Reynold’s lead citrate. This procedure produces excellent visualisation at high resolution of
all of the major components of a variety of hairs.
The standard method takes about three days to prepare specimens. A more rapid procedure was
brie£y described for visualising keratin ¢laments in thin sections of porcupine quill tip (GE Rogers,
& BK Filshie, Proceedings of 5th Int. Conf. Electron Microsc. Philadelphia, 1962, 2, O-2) that dis-
pensed with the reduction-osmium step and used 1% potassium permanganate at pH 6.0 for 30 min
on thin sections of untreated resin-embedded ¢bres followed by lead staining.
It has now been observed that the organisation of the keratin intermediate ¢laments in cross-sec-
tions, cell membrane complex and internal organisation in the cuticle of human and mouse hairs can
be rapidly visualised as follows: Small bundles of say 10^20 hairs depending on diameter, without
dehydration or other pretreatment, are directly resinembedded with orientation and thin sections cut
and £oated on 1% potassium permanganate in 0.1M phosphate bu¡er pH6 for only 10 min. and the
dried grids examined in the EM. If necessary, contrast can be increased by 5 min staining with 4%
aqueous uranyl acetate. The processing mainly involves the overnight curing of the resin.
The mechanism probably depends on oxidation of disul¢de bonds and deposition of a manganese-
protein complex in the inter¢lamentous matrix. The uranyl cation probably binds to sulfonate groups
produced by this oxidation. The procedure produces some debris on the grid but its identity has not
been established.
052
Asymmetrical Expression of a Keratin Intermediate Filament in Ferret Hair Folli-
cles
Z.D. Yu1,2, A.J. Nixon1, R.J.Wilkins2, and A.J. Pearson1
1Ag Research Ruakura, Hamilton, New Zealand, 2Dept. Biological Sciences, University ofWaikato, Hamilton,
New Zealand
The cortex of hair ¢bres is largely comprised of keratin intermediate ¢lament (IF) and keratin-asso-
ciated proteins (KAPs).The highly ordered and sequential expression of di¡erent keratin IFs and KAPs
underlies the formation of the mature hair ¢bre.Whereas some KAPs have been found to be asymme-
trically expressed within the follicle, previously reported IFs are expressed uniformly across the cortex.
Here, we report on the unusual pattern of expression of a ferret keratin IF gene.
This transcript was identi¢ed by di¡erential display of RNA extracted from the skin of prepubertal
ferrets administered with melatonin to synchronise winter hair growth. Two adjacent cDNA bands
speci¢c to the mid/late proanagen stage were cloned and sequenced.The sequences were found to have
limited homology to a region in the 30 untranslated region (UTR) of human hair acidic keratin 8
(hHa8). Northern blot analysis con¢rmed that a mRNA of 2.8 kb existed only in skin samples con-
taining hair follicles in which ¢bre keratinisation was advanced. In situ hybridisation using probes la-
belled with digoxigenin demonstrated that the expression of this gene was restricted to the cortex of
the keratinisation zone. Although expression of fHa8 was in a similar zone of keratinisation to that
observed in human hair follicles, it showed a distinct asymmetry, varying from small patches to half
of the follicle in both longitudinal and transverse sections. The full ferret Ha8 cDNA generated by
rapid ampli¢cation of cDNA ends (RACE) was 2769 bp; of similar length to the human orthologue
(2837 bp).The two transcripts had high sequence homology in the coding region, but reduced homol-
ogy in the 30 UTR. Both encode proteins of 456 amino acids, which share 83% positive and 76%
identical residues.
The asymmetrical expression of ferret Ha8 distinguishes it from that previously reported in hu-
mans, and suggests additional functions in ferret hair follicles. The expression of this keratin may also
represent a marker of a di¡erent cell di¡erentiation pathway.
053
Two Novel Human Keratin-Associated Proteins Expressed in the Cortical Layer of
the Hair Follicle Have been Termed hKAP1.6 and hKAP1.7
Y. Shimomura1, N. Aoki1, L. Langbein2, M. A. Rogers3, J. Schweizer3, and M. Ito1
Department of Dermatology, Niigata University School of Medicine, Niigata, Japan1;The Divisions of Cell
Biology2and Biochemistr,3ofTissue Speci¢c Regulation, German Cancer Reserch Center, Heidelberg, Germany
Hair follicle di¡erentiation involves the expression of hair keratin-associated proteins (KAPs) as well as
both epithelial or cytokeratins and hair keratins. In the present study, we have isolated two cDNAs
coding for new members of human KAP1 family from human genome and hair follicle mRNA dur-
ing the analysis of hKAP1.1 gene in the patient with fragile hairs. PCR and RT-PCR results using
hKAP1.1 speci¢c primers showed the presence of a novel hKAP1 member. To thus isolate the 30 end
of its cDNA, we developed a twofold strategy, 30 RACE and screening of a human scalp cDNA li-
brary with the hKAP1.1 probe, and isolated two cDNAs. The predicted amino acid sequences derived
from two clones, revealed a homology with a number of keratin-associated proteins, indicating that
these proteins belong to new members of human KAP1 family. RNA in situ hybridization study of
human anagen hair follicles demonstrated the predominant expression of their transcripts in the cor-
tical layer throughout the keratogenous zone. Taken together the multi-alignment of the members of
KAP1 family analyzed, we have termed two novel keratin-associated proteins hKAP1.6 and hKAP1.7.
054
Evidence for Proto¢brils in Trichocyte Keratin Intermediate Filaments
PM Steinert, LN Marekov, and DAD Parry
Laboratory of Skin Biology, NIAMS, NIH, Bethesda, MD; and Institute of Fundamental Sciences, Massey
University, Palmerson North, New Zealand
Since their ¢rst visualization by electron microscopic and X-ray di¡raction analyses, there has been
much speculation about the organization of sub¢lamentous units in trichocyte keratin intermediate
¢laments (TKIF). One popular model has proposed that axially aligned rows of pairs of coiled-coil
molecules are bundled into proto¢laments, two of which form a proto¢bril, of which several in turn
(four or more) assemble to form a KIF. However, to date only indirect evidence, such as electron
microscopic images of unraveling ¢bers or the existence of mass quanta, has been adduced in support
of the existence of proto¢brils.We have re-examined this issue in TKIF. First, we have devised meth-
ods for the e⁄cient in vitro assembly of mouse Type Ia and IIa chains intoTKIF in high yield. Second,
crosslinks were induced in reduced and oxidized forms with disulfosuccinimidyl tartrate using im-
proved conditions. Analyses of crosslinks documented that molecules in reduced TKIF are aligned as
in cytokeratin KIF, allowing a 1 nm overlap between molecules in the same axial row. However, in
oxidized TKIF, molecules in the A11 alignment mode are shifted forward by 2 nm, allowing a 1 nm
gap instead. This presumably confers substantial additional stability to the TKIF due to maximal for-
mation of intermolecular disul¢de bonds. In addition, several crosslinks were shown to correspond to
links between molecules four rows apart on two-dimensional surface lattice models. Such data a⁄rm
and provide robust support for the concept of an eight-chain (four-molecule) proto¢bril substructure
in TKIF. Interestingly, in the reduced TKIF, crosslinks were found between any adjacent four rows of
molecules in groupings of six or more. Thus there may be redundancy or promiscuity in proto¢bril
organization since any adjacent grouping of four rows of molecules could bundle together. These data
might explain the di⁄culty of prior reproducible visualization of proto¢brils in microscopic images.
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The Distribution of Estrogen Receptor beta (ERbeta) is Distinct to that of ERal-
pha and the Androgen Receptor in Human Skin and the Pilosebaceous Unit
M J Thornton, A H Taylor1, K Mulligan1, F Al-Azzawi1, C C Lyon2, J O’Driscoll2 and AG Messenger3
Dept Biomedical Sciences, University of Bradford, UK, 1Dept Obstetrics & Gynaecology, Leicester Royal In¢rmary,
UK, 2Dept Dermatology, Hope Hospital, Salford, UK, 3Dept Dermatology, Royal Hallamshire Hospital, She⁄eld,
UK
Androgens and estrogens have signi¢cant and distinct roles in hair and skin physiology. However, the
exact roles and sites of action of these molecules are currently unknown and the presence of an estro-
gen receptor (ER) in human skin by immunohistochemistry has been di⁄cult to prove. The recent
identi¢cation of a second estrogen receptor (ERb) with a distinctly di¡erent immunolocalisation pro-
¢le to the classical ER (ERa), suggests separate speci¢c roles for ERa and Erb. Therefore, we have
examined the distribution of ERa and ERb and correlated their expression with the androgen recep-
tor (AR) in human scalp skin from men and women by immunohistochemistry.
4 mm para⁄n-embedded sections were incubated with either mouse anti-human ER a (1:50), rab-
bit anti-human ERb (1:50) or mouse anti-human AR (1:25) antibodies at 41C overnight. After ampli-
¢cation with speci¢c secondary antibodies and avidin-biotin complexes, immunoreactive sites were
visualised with diaminobenzadine (DAB) staining and unstained nuclei identi¢ed with light haema-
toxylin counterstaining. Endometrium, ovary, prostate and testis were used as positive control tissues.
No staining was observed in the absence of the primary antibody or an equivalent concentration of
isotype mouse or rabbit IgG. ARwas present only in dermal papilla cells and basal sebocytes, whereas
ER awas only detected in sebocytes. By contrast, ERbwas widely distributed and strongly expressed
in the epidermis, sebaceous glands, eccrine glands, dermal papilla and outer root sheath. There ap-
peared to be no di¡erences in the expression pattern of ERb between men and women, suggesting
that the expression of ERb is not gender speci¢c.The widespread distribution of ERb in human skin
and the pilosebaceous unit suggests it may play an important role in the maintenance of human skin
and the regulation of the pilosebaceous unit.
056
Expression of the CCAAT/Enhancer-Binding Protein Transcription Factor Family
in the Sebaceous Gland
J.J. Bull1, S. Mˇller-R˛ver2, C.C. Zouboulis3, R. Paus2, I.A. McKay1 and M.P. Philpott1
1Centre for Cutaneous Research, St Bartholomew’s and the Royal London School of Medicine and Dentistry, Queen
Mary College, University of London, UK, 2University Hospital Eppendorf, University of Hamburg, Germany,
3Department of Dermatology, Free University of Berlin, Germany
Although the precise function of the sebaceous gland remains to be determined, it appears to play a
crucial role in the pathogenesis of pilosebaceous unit disorders such as acne vulgaris. The di¡erentia-
tion programme of basal sebaceous gland epithelia into lipid rich sebocytes has been hypothesised to
be analogous to adipocyte di¡erentiation in adipose tissue. The CCAAT/enhancer-binding proteins
(C/EBPs) are a family of transcription factors known to play a crucial role in adipocyte di¡erentiation
and lipogenesis. We speculated that C/EBP family members (C/EBPa, C/EBPb, C/EBPd and
Gadd153) have similar roles in the sebaceous gland.
To determine C/EBP expression in sebaceous gland, immunohistochemistry was performed on
cryo-sections of human hair bearing skin and dorsal skin from C57BL/6 mice. By use of immunocy-
tochemistry,Western blotting and RT-PCR, we have also investigated C/EBP expression patterns in
the human immortalised sebaceous gland cell line SZ95.
Immunohistochemistry of both human and murine skin showed intense immunoreactivity for C/
EBPa, C/EBPb and C/EBPd in the nuclei of both the basal undi¡erentiaited cells of the sebaceous
gland and in the more di¡erentiated sebocytes. Gadd153 was not detected in either human or murine
sebaceous glands. In SZ95 cells, we detected C/EBPa, C/EBPb and C/EBPd expression by both RT-
PCR andWestern blotting. Immunocytochemistry of cultured SZ95 cells showed di¡use nuclear lo-
calisation of C/EBPb and C/EBPd, whereas C/EBPa exhibited a punctate, intranuclear localisation
pattern. C/EBPa has previously been reported to trans-activate the adipocyte speci¢c gene stearoyl
CoA desaturase 1, a key enzyme in fatty acid synthesis. By RT-PCR, we have also detected stearoyl
CoA desaturase 1 expression in SZ95 cells.
Our results show speci¢c C/EBP family members are expressed in the sebaceous gland and may
therefore regulate the expression of genes crucial to sebocyte di¡erentiation and lipogenesis.
057
Localization of lysosomal and cytoplasmic proteases in pelage of neonatal rats
K. Morioka1, K. Sato-Kusubata1, S. Kawashima1,T. Ueno2, E. Kominami2, H. Sakuraba1, and S. Ihara3
1Tokyo Metropolitan Organization for Medical Research,TheTokyo Metropolitan Institute of Medical Science,
Tokyo, Japan, 2Dept. Biochemistry, Juntendo University School of Medicine,Tokyo, Japan, 3Dept. Biological
Science, Faculty of Life and Environmental Science, Shimane University, Shimane, Japan
The major cause of the extinction of organelles during di¡erentiation of erythroid cells was found to
be ascribable to the digestion in autolysosomesa. Epidermal keratinocytes and hair follicle cells share
the fate with the erythrocytes with respect to the loss of organelles during the course of di¡erentia-
tionb. Immunohistochemical analyses demonstrated that cathepsins (B, D, L), lamp-1 and m-calpain
co-localize at the areas rich in the cells on the way of keratinization, such as s.granulosum, s.spinosum,
keratinizing Henle’s layer, and lower part of hair shaft etc., suggesting a coordinated contribution of
lysosomal and cytoplasmic proteolytic systems to the di¡erentiation of epidermal and hair follicle cells
through overall decomposition of intracellular structural components except keratin ¢bers.
aAuto phagy of organelles in embryonic erythroid cells: its role in maturation. H.Takano-Ohmuro
et al., Eur.J.Cell Biol. 79, 759^764(2000). bExtinction of organelles in di¡erentiating epidermis. K.
Morioka et al., Acta Histochem. Cytochem. 32, 465^476(1999).
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E¡ect of Increased Expression of High Glycine/Tyrosine Proteins Targeted to the
Fibre Cortex in the Follicles of Transgenic Sheep
L. N. Jones1, G. E. Rogers2, S. M. Bawden2, M. G. Huson1 and P. S. Turner1
1CSIRO,Textile & FibreTechnology, Belmont,Vic, Australia and 2SARDI, Adelaide, SA, Australia
The aim of the research is to determine the relationship of structure and physical properties of hair
keratin using the sheep model. A selected keratin gene is constructed with a promoter for targeting to
the follicles and transgenic sheep are produced following transfer of single cell embryos microinjected
with the transgene to surrogate ewes and subsequent lambing after 5 months. The wool from trans-
genics that are expressing the inserted gene (or genes) is collected after su⁄cient growth and sub-
mitted to biochemical and structural analysis. The most e⁄cient follicle speci¢c promoter is K2.10
(see Powell & Rogers [1990] EMBO J. 9, 1485^1493) and is both follicle speci¢c and ¢bre cortex spe-
ci¢c. If necessary, sheep are bred to the ¢rst generation to overcome chimerism.
We report here results from the overexpression of one of the high glycine/tyrosine (HGT) proteins
(KAP6) that together with other HGT members and also the cysteine-rich family of KAP proteins,
constitute the protein matrix between the cortical intermediate ¢laments.
Wool ¢bres, follicles and control specimens have been examined using techniques of gel electro-
phoresis, amino acid analysis, scanning and transmission electron microscopy and mechanical testing.
Gel electrophoretic studies of protein composition and amino acid content have shown that the wool
has signi¢cantly increased contents of HGTand markedly reduced amounts of ultrahigh sulphur pro-
teins compared to controls.We have also observed changes in cell ultrastructure of cuticle and parti-
cularly the cortex where orthocortical cells were found to predominate. E¡ects on mechanical
properties include a reduction in tensile modulus, intrinsic strength and strain at break. Overall, com-
parison of transgenic and control wool ¢bres have indicated changes in structure and formation which
support our existing knowledge of the composition and properties of HGT together with their func-
tion and location within the ¢bre.
The characteristics of these modi¢ed ¢bres indicate they possess new physical properties that might
have application in the ¢bre industry.
059
The E¡ect of Age on Hair Root Amino Acid Levels in Human Subjects
G. Harrap, S. Dolphin and L. Albiston
Unilever Research Port Sunlight, Bebington,Wirral, UK
Hair production requires high rates of protein synthesis within follicles and may be a¡ected by amino
acid availability. The objective of the study was to determine whether age a¡ects the concentration of
free amino acids in hair roots in men from the UK.
Plucked vertex roots of 31 volunteers (mean age 40.6 yr.; range 21 ^ 73 yr.) with minimum andro-
genetic alopecia, were homogenised in an aqueous protease inhibitor solution to extract free amino
acids which were analysed by HPLC of dabsyl derivatives. Soluble protein was measured by a Coo-
massie Blue dye-binding method and used to correct amino acid levels for variations in amount of
root material.
22 amino acids were detected in roots from all subjects. Glutamate, glutamine, aspartate, serine,
glycine and alanine were the most abundant amino acids making up approximately 60% of the total.
Cysteine and methionine were the least abundant amino acids. The composition was distinct from
that of free amino acids in serum and the total amino acid composition of hair ¢bres. Percentages of
individual amino acids for subjects grouped above and below the mean age were not signi¢cantly
di¡erent (p40.05) for any amino acid. The total amount of free amino acid as ug per mg soluble
protein declined signi¢cantly with age (po0.05), this change being equivalent to a fall of 32.7% from
20 to 70 years of age.
It is concluded that amino acid concentrations fall in hair roots with age with little change in pro-
portions.
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Phytoestrogen genistein a¡ects susceptibility to alopecia areata in C3H/HeJ mice
K.J. McElwee1, S. Niiyama1, E.Wenzel1, P. Freyschmidt-Paul1, J.P. Sundberg2, and R. Ho¡mann1
1Philipp University, Marburg; 2The Jackson Laboratory, Bar Harbor, ME, USA
Alopecia areata (AA) is a complex, multi-factorial disease where genes and the environment may af-
fect susceptibility and severity.We considered dietary soy oil content and soy derived phyto-estrogen,
genistein, as potential modifying agents for C3H/HeJ mouse AA.
Prior to the experiment, all mice received a standard commercial diet of 1% soy oil (4% total fat).
Normal haired C3H/HeJ mice were grafted with AA a¡ected skin, a method previously shown to
successfully induce AA. Grafted mice were given one of three diets. Two groups of twenty eight mice
received a 1% or 5% (7.5% total fat) soy oil diet. Eleven mice received a diet with 20% soy oil (23%
total fat) formulated by the animal diet manufacturer using the 1% soy oil diet as a base and addi-
tional soy oil from the same source. In a separate study, mice on a 1% soy oil diet were injected with
1mg genistein three times per week for 10 weeks or received the drug vehicle control. Mice were
monitored for at least 20 weeks after skin grafting and then necropsied.
Of mice on 1%, 5%, and 20% soy oil diets, 20 of 28 mice (71%), 11 of 28 mice (39%), and 2 of 11
mice (18%) developed AA respectively. Four of 10 mice injected with genistein and 9 of 10 controls
developed AA. Mice with AA had hair follicle in£ammation consistent with observations for sponta-
neous mouse AA, but no signi¢cant association was observed between the extent of hair loss and diet
or genistein injection. Mice that failed to develop AA typically regrew white hair from their skin
grafts with no associated in£ammation.
Soy oil and derivatives have previously been reported to modify rodent in£ammatory conditions.
Hypothetically, soy oil compounds may act on C3H/HeJ mice through modulating estrogen-depen-
dent mechanisms and/or in£ammatory response activity to modifyAA susceptibility.
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Histologic and Ultrastructural Features of Alopecia Areata in C3H/HeJ Mice
K.J. McElwee12, K. Silva2, D. Boggess2, L. Bechtold2, R. Ho¡mann1, L.E. King Jr3, and J.P. Sundberg2
1Dept. of Dermatology, Philipp University, Marburg, Germany; 2The Jackson Laboratory, Bar Harbor, ME, USA;
3Dept. of Dermatology,Vanderbilt University, Nashville,TN, USA
Alopecia areata (AA) can be induced in C3H/HeJ mice by grafting AA a¡ected skin. An 8-12 week
delay between surgery and overt hair loss onset provides an opportunity to examine disease pathogen-
esis. Normal haired C3H/HeJ mice were sham grafted or grafted with AA a¡ected skin. Mice were
euthanized at 2, 4, 6, 8, 10, and 12 weeks post surgery along with chronic AA-a¡ected mice as a positive
control.
Until 6 weeks post grafting, in£ammation was only evident around anagen stage hair follicles in
host skin adjacent to, but not distant from, the AA a¡ected graft. From 8 weeks AA grafted mice, but
not sham grafted mice, exhibited a di¡use dermal in£ammation at distant sites that progressively fo-
cused on anagen stage hair follicles at 10 and 12 weeks. Peri-follicular in£ammation was primarily
composed of CD4þ and CD8þ cells associated with follicular epithelium ICAM-1 expression.
Only CD8þ cells penetrated intra-follicularly by 12 weeks post surgery, although both CD4þ and
CD8þ intra-follicular cells were observed in chronic AA a¡ected mice. By electron microcscopy,
intra-follicular lymphocyte and macrophage in¢ltration was prominent by 10 weeks post surgery, pri-
marily within the di¡erentiating outer and inner root sheaths associated with hair follicle dystrophy.
This time course study illustrates that focal follicular in£ammation may develop some time in ad-
vance of overt hair loss and focuses on the di¡erentiating root sheaths in C3H/HeJ mice. The severity
of in£ammation and the degree of hair follicle dystrophy induced by the in¢ltrate appears to reach a
threshold level before overt hair loss occurs. The root sheath focus of intra-follicular in£ammatory
in¢ltration of C3H/HeJ mice suggests candidate stimulatory antigens forAA activation may be present
within these morphological structures.
062
Further Con¢rmation of the Involvement of Fas and Fas ligand in Alopecia Areata
of C3H/HeJ Mice
P Freyschmidt-Paul, KJ McElwee,V Botchkarev, JP Sundberg, R Happle, and R Ho¡mann
Dept. of Dermatology, Philipp University, Marburg, Germany; Dept. of Dermatology, Boston University School of
Medicine, MA, USA;The Jackson Laboratory, Bar Harbor, ME, USA
Alopecia areata develops spontaneously in 20% of C3H/HeJ mice and can also be experimentally in-
duced by grafting of AA a¡ected skin to normal haired C3H/HeJ mice or mice from other histocom-
patible strains in graft recipients.We have shown, that Fasde¢cient C3H.MRL-Faslpr and Fas ligand-
de¢cient C3H/HeJ-Faslgld mice are resistant to experimental induction of AA. Fas has been shown to
be expressed on hair follicles and FasL on cells of perifollicular in¢ltrates in alopecia areata (AA) pa-
tients. These ¢ndings suggest an important pathogenetic role of the Fas-Fas ligand system in AA.
To further con¢rm this pathogenetic role of the Fas-Fas ligand system in AAwe adressed the ques-
tion, whether skin of Fas-de¢cient C3H.MRL-Faslpr and Fas ligand-de¢cient C3H/HeJ-Faslgldmice is
resistant to the development of alopecia areata. To answer this question, we grafted haired skin of
C3H.MRL-Faslpr and C3H/HeJ-Faslgld mice and of normal C3H/HeJ mice as a control onto C3H/
HeJ mice with widespread alopecia areata. Before grafting, the skin grafts were shaved. 8 weeks after
grafting, skin grafts from C3H.MRLFaslpr and C3H/HeJ-Faslgld mice showed dense and long hair
growth within the bald alopecia areata skin of the recipients. By contrast, normal skin grafts were bald
or showed only thin, short hairs, comparable to those which can be found in alopecia areata of C3H/
HeJ mice.
Our results show, that skin of Fas-de¢cient C3H.MRL-Faslpr and Fas ligand-de¢cient C3H/HeJ-
Faslgld mice is resistant to the development of alopecia areata. Therefore we conclude, that Fas ligand
and its receptor Fas play a crucial role in the development of alopecia areata.
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Study onVibrissa Immune Privilege of Mouse
Akio Nagase, Naoya Sato, Hiromi Tsuboi,Takao Fujimura, and Norio Katsuoka
Dept. of Dermatology, Kitasato University School of Medicine, Kanagawa, Japan
Purpose: Hair follicles are a tissue having immune privilege with the absence of MHC-Class I anti-
gen expression. They are, however, known to be rejected when allografted between humans. A study
reported recently indicates that a certain part of the hair follicle does not cause rejection when allo-
grafted between humans. The region that facilitates hair growth was identi¢ed in that report.We con-
ducted an experiment using the mouse vibrissa allograft system to study hair bulb immunogenicity
and the function of immunocompetent cells of the host from the standpoint of the immunocompe-
tent cell.
Method: The vibrissa below the infundibulm of C57BL/6 mouse was allografted under the back skin
of a group of BALB/c mice. Results were observed immunohistologically over time. The allografted
vibrissa below the infundibulm was found to be rejected on Day 11. On this day, the hair bulb con-
taining dermal papilla and dermal sheath was separated from the vibrissa of C57BL/6 mouse and allo-
grafted under the back skin of another group of BALB/c mice. On Day 11, cellular cytotoxicity was
measured on the mice on which the hair bulbs were implanted using the 51Cr release assay with its
spleen cell as e¡ector cell, and EL-4, the thymoma cell strain of C57BL/6 mouse, as the target cell.
Result: Classical MHC-Class I antigen was not expressed immunohistologically in the vibrissa below
the infundibulm either before or after the implant. On Day 11, however, small round cells including
lymphocytes had in¢ltrated around the implant, leading to subsequent damage, degeneration and re-
jection. MHC-Class I antigen was not expressed immunohistologically in the hair bulb. The spleen
cells of the mice on which the hair bulbs have been grafted, possessed cellular cytotoxicity against
EL-4.
Discussion: The rejection and cellular cytotoxicity induction of the allograft in the hair follicle allo-
graft system can be caused either by speci¢cT-cell cytotoxicity that recognizes the MHC-Class I anti-
gen of non-classical, or by non-speci¢c NK cells which are not related to MHC-Class I antigen. This
¢nding indicates that hair tissue may be expressing a still-unknown antigen.
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New Zealand Black KN Mouse, a Novel Model for Autoimmune Alopecia
A. Hiroi1,T. Ito2,T. Yoshimasu1,T. Otani1, N Seo2, K Uede1, and F. Furukawa1
1Dept. of Dermatology,WakayamaMedical University,Wakayama, Japan1 and 2Dept. of Dermatology, Hamamatsu
University School of Medicine, Hamamatsu, Japan2
New Zealand Black (NZB)/KNmouse is an SLE-prone mouse associated with arthritis, and the male
mouse shows alopecia spontaneously.We have reported that the male NZB/KN mouse is an autoim-
mune alopecia model, which suggests that the gender is an important factor in£uencing the develop-
ment of alopecia. To verify the male predominance, we studied the relationship among alopecia,
gender, and other clinical symptoms using NZB/KN, the F1 hybrid mouse with NZ White (NZW)
mouse and the F2 hybrid mouse of (W/BKN F1xW/BKN F1).The incidence of alopecia of male NZB/
KN,W/BKN F1, BKN/W F1, and F2 mice at 12 months (mo) were 88%, 9.5%, 0%, and 44% respec-
tively. Male NZB/KN mouse initially developed hair loss and a slight indurative change around the
tail, and then on the upper back. Fully developed alopecia lesions were observed in 25%, 75% at 3 mo
and 6 mo. Hair density at alopecia lesion of male NZB/KN mouse was lower than its peripheral skin
and control skin, although there was no di¡erence in diameter. Histologically, intrafollicular lympho-
cyte in¢ltration were seen at the primary lesion and intradermal perivascular mononuclear cell in¢l-
tration were observed in the fully developed lesion. In the serum antibodies against follicular
structure, mainly Ig M type, were detected at 3 mo, and 75% of male NZB/KN showed the positive
titer until 12 mo. Immuno£uorescence study revealed IgM deposition at basement membrane zone of
both epidermis and/or hair follicle. In female NZB/KN mice a slight hair loss was found in 24% on
the upper back at 12 mo, but the lesion was not fully developed. FemaleW/BKN F1, BKN/W F1, and
F2 mice showed alopecia in 6%, 0%, and 7.3% respectively. F2 mice showed signi¢cant correlation
among gender, alopecia and proteinuria, but not among alopecia, H-2, and splenomegaly. The alope-
cia in male NZB/KN mouse is a novel model of autoimmune alopecia and found to be closely asso-
ciated with male gender based on the studies on F1 and F2 hybrid mice.
065
Unique Form of Murine Alopecia: A Mouse Model for Human Hair Disorders
Liren Tang1, Liping Cao1, Michele Surbey2, Jackie Jacob3, Harvey Lui1 and Jerry Shapiro1
1Division of Dermatology, University of British Columbia,Vancouver, Canada; 2School of Psychology, James Cook
University,Townsville, Australia; 3Department of Psychology, Mount Allison University, Canada
The rodent has been a useful model and biomedical tool for studying human hair disorders. An un-
documented form of alopecia in CD-1mice has been maintained over several years by selective breed-
ing. Spontaneous alopecia occurs in 25^30% of the selected population and a¡ects females 3 times
more often than males. The process of hair loss normally begins after sexual maturity in both sexes.
In a¡ected mice, normal hair growth occurs until approximately 40 days of age and is subsequently
followed by rapid hair loss (few days) from a rectangular area between the ears. This localized alopecia
lasts for months and the hairs appear to grow back in a majority of mice following a variable period of
time. Over the generations, some mice became thinned rather than bald in the rectangular area. His-
topathology from the established bald patches reveals an absence of matured hair follicles and exhibits
no peri- or intra-follicular lymphocyte in¢ltration. Initial pedigree analysis suggests the involvement
of two or more recessive alleles, with further genetic analysis necessary to elucidate the mode of trans-
mission. This localized and rectangular pattern of murine alopecia may be a potentially useful model
for one of the major types of human alopecias.
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Gene Expression Pro¢ling of Alopecia Areata in Human Disease and the C3H/HeJ
Mouse Model Reveals the Importance of T-cell ActivationVia Costimulation
JP Sundberg1, KJ McElwee1,2, D Boggess1, K Silva1, LE King3, M Byrney4, and J Carroll4
1The Jackson Laboratory, Bar Harbor, ME; 2Currrent address: Phillipp University, Marburg, Germany; 3Vanderbilt
University and the NashvilleVAMedical Centers, Nashville,TN; 4and the Genetics Institute, Andover, MA, USA
Alopecia areata is an autoimmune disease that targets anagen hair follicles resulting in patchy to dif-
fuse baldness. C3H/HeJ mice may develop spontaneous alopecia areata-like hair loss that closely re-
sembles this human disease. Alopecia areata can also be induced in normal haired littermates using
full thickness skin grafts. Since activated lymphocytes are postulated to play a role in this disease, this
study focused on the activation of lymphocytes via costimulation as being important in onset and
perpetuation of alopecia areata in mice. Transcript analysis using A¡ymetrix gene chips was done on
RNA from skin of human alopecia totalis patients compared with normal age, sex, and biopsy site
matched people. Similar studies were done on RNA from skin of mice with and without alopecia
areata as well as sequentially after grafting alopecia areata a¡ected skin or normal skin onto C3H/
HeJ mice. Early upregulation of genes involved in lymphocyte activation and late upregulation of
genes coding for viable chains of immunoglobulins were found. Using the inducible mouse model,
alopecia areata could be blocked using monoclonal antibodies directed against either B7-1/B7-2 or
mCTLA4Ig, supporting the lymphocyte co-stimulatory cascade as being important in early onset alo-
pecia areata. Array technology has de¢ned several in£ammatory mechanisms involved in alopecia
areata that could be targets for new treatment interventions.
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Genetic Basis of Alopecia Areata in C3H/HeJ Mice
Sundberg JP1, Levin E1, Boggess D1, Silva K1, Churchill G1, McElwee KJ1, King LE2, and Cox G1
1TheJackson Laboratory, Bar Harbor, ME; 2Vanderbilt University and the NashvilleVAMedical Centers, Nashville,
TN, USA
Alopecia areata is a relatively common dis¢guring autoimmune disease that targets hair follicles in the
actively growing anagen phase of the hair cycle. Alopecia areata is often associated with many other
systemic autoimmune diseases. An alopecia areata-like phenotype occurs spontaneously in the C3H/
HeJ inbred mouse strain as a complex polygenic trait with low penetrance. An extensive intercross
breeding study between C3H/HeJ and C57BL/6J mice and subsequent genome wide screening has
revealed at least 4 genetic loci involved in spontaneous mouse alopecia areata. The most signi¢cant
locus is on Chromosome 17 at 18.8 cM. This region of the mouse H2 complex is homologous with
the human HLA locus. In human alopecia areata, two loci have been linked to HLA-DR and HLA-
DQ. The homologous mouse loci are located at 18.64 and 18.68 cM, respectively, on mouse Chromo-
some 17, less than 0.2 cM from the most signi¢cant locus found in this mapping study for mouse
alopecia areata. Additional loci of lower signi¢cance were identi¢ed on mouse Chromosomes 1, 15,
and X. The mouse results indicate potential associated human AA loci in these locations. Genome
wide screening of rodent alopecia areata models and use of comparative mouse-human genome maps
may con¢rm previously de¢ned human AA associated susceptibility genes and may identify new can-
didate gene loci for further investigation in human patients.
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Cytokine Expression Modulated byAnthralin in C3H/HeJ Mice: Correlation to Ef-
¢cacy on Hair Regrowth
Liping Cao, Liren Tang, John P Sundbergn, Harvey Lui, David I McLean and Jerry Shapiro;
Division of Dermatology, University of British Columbia andVancouver General Hospital,Vancouver, Canada;
nThe Jackson Laboratory, Bar Harbor, Maine, USA
Anthralin is one of the mostly widely using anti-psoriatic drugs and has also been suggested to have
potential e⁄cacy in alopecia areata (AA). It may have a non-speci¢c immunomodulating e¡ect on AA
as it does in the topical treatment of psoriasis. The aim of the present study was to investigate the
therapeutic e¡ects of anthralin on AA-a¡ected mice and the underlying mechanisms at the molecular
levels. C3H/HeJ AA mice were treated daily for 12 weeks on half of the dorsal skin with 0.2% anthra-
lin ointment. The contralateral side was treated with the vehicle ointment. The percentages of surface
hair coverage and hair density were graded weekly for both sides and hair growth indices were calcu-
lated using these two variables. Biopsies were taken before the treatment as baselines. At the end of the
treatment, skin biopsies were collected from both treated and control sides. RNAwas extracted and
RNA protection assay was performed to determine the gene expression of various cytokines which
might be speci¢c for hair regrowth promotion by anthralin. Hair regrowth was observed in 9/13
(69%) mice on the treated sides. The untreated sides showed either no change or continued hair loss
in all the animals. Among the cytokines tested by RPA, interfron g (IFN-g) and tumor necrosis factor
a (TNF-a) showed reduction after anthralin treatment. Interleukin 1b (IL-1b) was increased in the
majority of responding mice, while decreased in 2/3 non-responders. Similarly, IL-1 receptor antago-
nist (IL-1Ra) was increased in all of the responding mice by anthralin and only 1/3 of non-responders
showed increased expression of IL-1Ra after treatment. We conclude that a signi¢cant number of
C3H/HeJ mice with AA-like hair loss respond to topical anthralin. The molecular mechanism under-
lying the e⁄cacy of anthralin on hair regrowth in this AA model might be mediated by the interplay
of the cytokines produced locally in the skin.
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Cytotoxic E¡ects of Alopecia Areata Serum on the Cultured Follicular Outer Root
Sheath Cells and Dermal Papilla Cells
Won-Soo Lee, and Yun Chul Kang
Department of Dermatology,Yonsei UniversityWonju College of Medicine,Wonju, Korea
The exact primary cell target in the a¡ected hair follicle of alopecia areata (AA) lesion is not de¢nitely
known. The possible role of humoral factor(s)/circulating antibodie(s) in inducing hair loss in AA has
been suspected for many years. We investigated the e¡ect of serum from AA patients on cultured
normal human outer root sheath (ORS) cells and dermal papilla (DP) cells to determine whether it
has a role in the process of hair loss and contains any cytotoxic factors to ORS cells and/or DP cells.
The ORS cells and DP cells from healthy human occipital scalp hair follicles were isolated and
cultured in a de¢ned serum-free media. Sera were obtained from ¢ve patients with active AA lesions
and added to the single cell suspension of the ORS cells and the DP cells. To determine cytotoxicity,
we assessed cell viability by using MTT assay.
Cell viability, expressed as percent of control absorbance, showed a typical dose-dependent curves
in both ORS and DP cell lines. The decrease in the number of viable cells was statistically signi¢cant
from the control sera. There were no marked variations in the response between individual patient’s
sera or between individual cell lines.
Our data suggest that ORS cells and DP cells may somehow be involved in the pathogenesis of AA
and provide clear evidence for involvement of circulating factors in AA.
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Growth Inhibition in Human Microendothelial Cells by Proin£ammatory Cyto-
kines and ProApoptotic Molecules Released from Peripheral Mononuclear Blood
Cells in Alopecia Areata
A. Schudrowitz, N. Mandt, C. Sommer, C.E. Orfanos, and U. Blume-Peytavi
Dept. of Dermatology, University Medical Center Benjamin Franklin,The Free University of Berlin, Berlin,
Germany
Etiopathogenesis of alopecia areata (AA) is not yet fully elucidated; however, AA is considered to be a
T-cell mediated immunologic disease with disappearance of the vascular network surrounding the
hair follicle in the early in£ammatory phase of the disease.
The aim of the present study is to investigate signaling molecules previously identi¢ed as key med-
iators in alopecia areata as well as peripheral mononuclear blood cells (PMBCs) for their signi¢cance
in regulating endothelial cell growth.
Cultured human microendothelial cells (HMECs) were treated with di¡erent signaling molecules
as well as activated and non-activated PBMCs of both AA patients and non-a¡ected individuals. After
3h incubation HMECs were analyzed for their apoptotic behavior using a photometric enzyme-im-
munoassay (cell death detection ELISA). Necrosis was evaluated by measuring lactate dehydrogenase
activity released into cell culture supernatants.
IL-1a, IL-1b, IL-2 (all 10 ng/ml), TNF-a (20 ng/ml) and TGF-b (4 ng/ml) induced apoptosis in
HMECs without necrosis. In contrast IL-4 (100 ng/ml), IFN-g (0.5 ng/ml), IL-8, IL-10, and IGF-1
(all 10 ng/ml) did not lead to apoptosis or necrosis in HMECs. Furthermore, supernatants of Phytha-
magglutinin (PHA) stimulated PBMCs induced signi¢cant apoptosis without necrosis in a 1:8 dilu-
tion only in AA patients but not in nona¡ected individuals. However, using a lower concentration
(1:1) of supernatants from PMBCs apoptosis and also necrosis were detected in both supernatants from
AA and in nona¡ected individuals.
We suggest that proin£ammatory cytokines like IL-1a, -1b and TNF-a as well as proapoptotic
molecules released from PMBCs are responsible in AA for the disappearance of the capillary network
surrounding the hair follicle, subsequently leading to initiation of the catagen phase.
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Transcriptional Regulation of Type II 5a-Reductase in Human Dermal Papilla
Cells
Jotaro Nakanishi and Toshihiko Hibino
Shiseido Life Science Research Center,Yokohama, Japan
Previous studies suggested that type II 5a-reductase (5aRII) contributed to androgenetic hair loss.
This was supported by the facts that 1) androgenetic alopecia is not observed in patients with 5aRII
de¢ciency, and 2) ¢nasteride, a speci¢c inhibitor of 5aRII, is e¡ective on the treatment of androge-
netic alopecia. In spite of its importance, regulatory mechanism of 5aRII is still unclear.
In this study, we tried to ¢nd out the transcriptional regulation of 5aRII in human dermal papilla
cells (hDPCs). First, we isolated a genomic clone containing 6-kb of the 50 -£anking region of 5aRII
gene from a human genomic library. In the immediate upstream sequence from the transcription start
site between ^1 to ^200, there are three GC-boxes resembling recognition sites for Sp1/Sp3, but no
TATA or CAATsequences. Analysis of the promoter activity revealed that the second GC-box at ^47/^
42 was responsible for the minimal promoter activity. Although there are many candidate molecules
to control the transcriptional activity of 5aRII, we focused on SRY (sex-determining region Y), a
male speci¢c transcriptional factor.Within the ^2400/^1850 region, multiple SRY binding sites were
observed. The mRNA level of 5aRII was in proportion to the expression level of SRY in hDPCs
from beard and frontal scalp with androgenetic alopecia. To con¢rm the function of SRY, hDPCs
were transfected with SRY expression plasmid. The expression of 5aRII in the transfected cells was
remarkably stimulated as compared with control cells. These results suggest that SRY is a male-speci¢c
transcriptional stimulator for 5aRII in hDPCs.
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17a-Estradiol Induces Aromatase Activity in Isolated Human Hair Follicles
S. Niiyama, and R. Ho¡mann
Dept. of Dermatology, Philipp University, Marburg, Germany
Women tend to develop AGA later and milder than men, but with the decline of serum estrogens
during menopause many women show an accelerated progression of AGA. Estrogens may play a pro-
tective role against the development of AGA, because pregnant women are in some way protected
form androgenetic hair loss, but lose their hairs again postpartum. In Europe, topically applied estro-
gens such as 17 -estradiole are used to treat androgenetic alopecia, both in women and men. The
female hormone 17-Estradiol can be used only in women, whereas the hormonally almost inactive
isomer 17a-estradiol can be used in men as well. Although some clinical studies show considerable
success of such an approach, the underlying pathways of 17a-estradiol-induced hair regrowth are un-
known. It is likely not a receptor mediated hormone e¡ect, since 17-Estradiol is a hormone and 17a-
estradiol is not. Recently it has been shown that hair follicles from women with AGA express more
aromatase activity compared to male hair follicles, and interestingly those women taking aromatase
inhibitors tend to develop rapidly progressive AGA. These circumstantial lines of evidence indicate a
role of aromatase during the pathogenesis of AGA.
In order to unravel the pathways of 17a-estradiol-mediated e¡cets on the hair follicles, we measured
aromatase activity in isolated intact human occipital hair follicles by incubating hair follicles with H3-
1-androstenedione with or without 17a-estradiol (1nM, 100nM, 1mM) for 24 or 48 hours. In compar-
ison to the controls (female, 444fmol/mm3¼100%), we noticed a concentration- and time-dependent
increase of aromatase activity in 17a-estradiol-incubated female hair follicles (e.g., 24h: 1nM¼ þ18%,
100nM¼ þ 25%, 1mM¼ þ 57%; 24h: 1nM¼ þ18%, 48h: 1nM¼ þ 25%). Our ex vivo results sug-
gest that under the in£uence of 17a-estradiol an increased conversion of testosterone to 17-estradiol
and androstendione to estrone takes place. In theory this pathway may diminish the amount of intra-
follicular testosterone available for conversion to DHT, and because DHT is the major mediator of
AGA, this pathway may explain the bene¢cial e¡ect of 17a-estradiol on the development and progres-
sion of AGA.
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The In£uence of Testosterone Propionate on the Expression of Several Growth
Factors in Scalp Dermal Papilla Cell
Kyung-Ho Kim,Yong-Jun Piao, Ki-Beom Suhr, Jeung-Hoon Lee, and Jang-Kyu Park
Department of Dermatology, Chungnam National University, College of Medicine, Daejeon, Korea
The dermal papilla (DP) plays a central role in follicle development and cycle control. Its role is
mediated by many factors including growth factors. It is now generally believed to be the actual site
of androgen by passing appropriate message to the epithelial cells, possibly in the form of growth
factors. Androgens may stimulate DP cells to produce androgen-dependent di¡usible growth factors,
such as IGF-1, HGF, bFGF, KGF,TGF-b1, 2, which act not only on the DP cells themselves, but also
stimulate follicular epithelial cells. In this investigation we have designed to ¢nd out whether DP cells
secrete those growth factors and the e¡ect of androgen on their expression of above growth factors
using reverse northern hybridization.We also tried to determine whether several growth factors gene
expression by cultured DP cells was a¡ected by concentration of testosterone propionate using RT-
PCR.We here reported 1) the e¡ect of androgen on the expression of these growth factors, each of the
genes for these were con¢rmed to be expressed in the control DP cells which were not treated with
testosterone as well as in the 108M testosterone-treated cells. However, other conditions were the
same except length or CG contents of each probe, but KGF, bFGF,TGF-b1was highly expressed fac-
tors among those factors tested. 2) the expression of IGF-1was increased by testosterone propionate in
a concentration-dependent manner, with a maximal e¡ect at 108 M, but other growth factors
mRNA expression was una¡ected by the additional of testosterone propionate. These studies, there-
fore, report that several speci¢c molecules such as IGF-1 that are synthesized by DP cells and whose
production is regulated by androgen at the transcriptional level might mediate the action of androgen
to miniaturize hair follicles. The androgen-induced upregulation of the expression of IGF-1 might be
one of the plausible mechanisms that lead to androgenic alopecia.
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5a-Dihydrotestosterone and Testosterone Induce Apoptosis in Human Dermal Pa-
pilla Cells by Downregulation of the bcl-2 Pathway
A.Wro¤ bel1,2, N. Mandt1, A. M. Hossini1, Ch. Sommer1, H. Seltmann1, C.C. Zouboulis1, C.E. Orfanos1,
and U. Blume-Peytavi1
1Dept of Dermatology, University Medical Centre Benjamin Franklin,The Free University of Berlin, Berlin,
Germany, 2Department of Dermatology &Venereology,Warsaw Medical School,Warsaw, Poland
In androgenetic alopecia (AGA) terminal hair follicles undergo transformation to vellus hair type with
miniaturisation of the dermal papilla (DP). Pathogenetic mechanisms in AGA are not yet fully under-
stood; however, it is generally agreed that androgens, especially 5a-dihydrotestosterone (5a-DHT),
inhibit hair follicle activity with shortening of the anagen and early induction of the catagen phase.
In the present study we investigated the ability of potent androgens, i.e. testosterone (T) and 5a-
DHT to induce apoptosis in the mesenchyme-derived DP, possibly leading to early catagen induction
in AGA. It is well known, that the DP is protected against apoptosis under physiological conditions,
possibly due to overexpression of the anti-apoptotic protein bcl-2. Thus, we investigated the in£uence
of testosterone and 5a-DHT on proliferation, apoptotic and necrotic cell death in cultured human
scalp dermal papilla cells (DPC). The in£uence of T and 5a-DHT at 107 M to 105 M on the prolif-
erative activity of DPC after 24 h and 48 h was evaluated by MTT assay. Induction of apoptosis byT
and 5a-DHTat 105M to 107M after 4 h, 24 h and 48 h was measured by DNA fragmentation using
a cell death detection ELISAplus. Necrosis of 5a-DHT and T on DPC was measured by lactate dehy-
drogenase activity. Furthermore, the expression of bcl-2 resp. bax at the mRNA and protein level was
detected inT/5a-DHT-treated DPC by reverse transcription polymerase chain reaction and con¢rmed
byWestern blot.
T and 5a-DHT induced apoptosis in DPC in a dose-dependent and time-related manner, with a
necrotic e¡ect induced byT at 105 M. In addition,T and 5a-DHT inhibited proliferation of DPC at
105 M. Interestingly, the decrease of bcl-2 protein expression in T and 5a-DHT treated cells corre-
lated with the increase of the bax protein level. The present study provides a new interesting approach
in understanding possible pathomechanism in androgenetic alopecia.
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Antisense Oligonucleotides Targeting Fibroblast Growth Factor Receptor (FGFR)-
1 Stimulate Hair Follicle Growth in an in vitro Organ Culture System
R. Tsuboi, RUeki, and H Ogawa
Dept. of Dermatology, Juntendo University School of Medicine,Tokyo, Japan
The hair cycle is regulated by various molecules, among which FGF-5 has been shown to promote the
transition from anagen to catagen. FGFR-1, a trans-membrane receptor of FGF-5 with the tyrosine
kinase activity, was found to be localized in the follicular papilla of hair follicles. In order to apply
antisense oligonucleotides targeting FGFR-1 as a treatment for baldness, we examined the e¡ect of the
oligonucleotides on hair follicle growth in a serum-free organ culture system. Vibrissal hair follicles
isolated from variously aged C3H/He mice were cultured in the presence of a reagent at 311C in 95%
O2^5% CO2 for 72 h. Several 20-mer antisense nucleotides and their randomly arranged counterparts
were prepared by predicting the e¡ective target site of FGFR-1 mRNA. Elongation of the hair shaft
was measured and cellular activity in the hair bulb was estimated by measuring the £uorescence in-
tensity (FI) of the medium after incubation with AlamarBlue dye. Incorporation of the oligonucleo-
tides into the outer root sheath, hair matrix and follicular papilla was histologically con¢rmed by
incubation with FITC-labeled oligonucleotides for 24 h. Addition of 30 mM of antisense oligonucleo-
tides (A1561TS) to the media, but not their control (RA1561TS), increased FI byAlamarBlue from 30
to 50%.This e¡ect was reproducible and dose dependent with maximal stimulation at 30 mM. How-
ever, signi¢cant elongation of the hair shaft was not observed during the 72 h incubation. Treatment
with antisense nucleotides maintained the intact morphological structure of the hair bulb after 72 h
incubation.These results suggest the clinical utility of antisense nucleotides targeting FGFR-1. Further
experiments using the mouse model are now underway.
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Cultured Human Dermal Papilla Cells Secrete Adrenomedullin: E¡ect of Testoster-
one, 17beta Estradiol and Phenol Red
MJ Thornton, AJ Reed1, AG Messenger2, R Pio2 and A Martinez
Dept Biomedical Sciences, University of Bradford, UK, 1Royal Hallamshire Hospital, She⁄eld, UK, 2Dept Cell
and Cancer Biology, NIH, Bethesda, USA
Adrenomedullin (AM) is a recently discovered pluripotent peptide, which can act as a mitogen, an
angiogenic factor and an apoptosis survival factor. Therefore we have investigated the production of
AM by cultured human dermal papilla cells derived from beard and scalp hair follicles.
Cells were cultured in 25 cm2 £asks in DMEM and 10% FBS until sub-con£uent. The media was
removed, cells washed twice with PBS and incubated with either serum-free DMEM þ / 10nM
testosterone or serum-free, phenol red-free DMEM þ / 10 nM 17beta-estradiol. Conditioned med-
ium was collected after 15 min and 24 h, and the concentrations of AM determined by RIA.
All cells (n¼ 6) secreted AM. The concentration of AM after 24 h was 10x that detected after 15
min. Scalp cells appeared to secrete slightly more AM than beard cells at both time points. However,
there was a big di¡erence in the amount of AM produced by cells incubated in the presence of phenol
red. Cells incubated in medium containing phenol red secreted 1.5^2x the level of AM after 24 h
compared to those incubated in phenol red-free medium. There was no e¡ect on AM secretion by
cells incubated with 17beta estradiol on either cell type. There was no e¡ect on AM secretion by scalp
cells incubated with testosterone; however, the production of AM by beard cells incubated with tes-
tosterone after 24 h was almost double that of corresponding beard cells incubated in the absence of
testosterone.
Cultured human dermal papilla cells secrete AM in signi¢cant amounts. The increased production
of AM by beard cells in the presence of testosterone suggests that AM may have a signi¢cant role in
androgen-dependent hair growth. Since phenol red also has a stimulatory e¡ect on AM secretion,
future studies should consider its e¡ect on the production of mitogenic factors by cultured dermal
papilla cells.
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Further Evidence for an Involvement of Hepatocyte Growth Factor /Scatter Factor
(HGF/SF) and Met Signaling in Hair Growth Control and in Follicular Pigmenta-
tion
Gerd Lindner1, Glenn Merlino2, Sven Mueller-Roever1 and Ralf Paus1
1Dept of Dermatology, University of Hamburg, Germany, 2Laboratory of Molecular Biology, National Cancer
Institute, USA
HGF/SF and its cognate receptor Met are principal mediators of mesenchymal-epithelial interactions.
HGF/SF overexpressing transgenic mice, under the control of the MT-1 promoter, display accelerated
HF morphogenesis and show retarded catagen development (FASEB J 2000;14:319) suggesting an im-
portant role of this factor in the control of hair follicle (HF) growth.
Therefore, HF morphology and immunoreactive (IR) expression patterns of HGF/SF and Met, as
well as that of TRP-1 (a key melanogenesis-associated protein) were studied in HGF/SF-transgenic
mice during HF morphogenesis and cycling.
Similar to pharmacologically-induced hair growth by cyclosporin A (JID 1998; 110;632a), HGF-
transgenic mice displayed premature HGF/SF IR in the dermal papilla of very early anagen HFs, sug-
gesting a potential mechanism of accelerated anagen development in these mice. Interestingly, the
stringently localized appearance of HGF/SF expression within dermal papilla ¢broblasts of WTmice
was abrogated in the regressing epithelial strand and germ capsule of transgenic catagenVII HF. Here,
HGF/SF IRwas co-expressed with Met IR in keratinocytes, i.e. within the epithelium. At the epider-
mal/dermal border, ectopic melanocytes were detected, which highly expressed HGF/SF IR. Sporadi-
cally, adult transgenic mice developed a severe skin phenotype with highly abnormal HF morphology.
In these sections, follicles showed a grossly enlarged epithelial strand and displayed two dermal papil-
lae in one single HF.
This further supports that HGF/SF and Met operate as powerful hair follicle morphogens and sug-
gests that this signaling system is involved in the control of intrafollicular pigmentation.
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Basic Fibroblast Growth Factor Functions as a Survival Factor for Normal Melano-
cytes: Signi¢cance of HumanWhite Hair
Kenji Ohguchi, Mitsuyuki Hotta, and Yoshinori Takema
Biological Science Laboratories, Kao Corporation,Tochigi, Japan
Whitening of human scalp hair is usually a manifestation of ageing process and is caused by the dis-
appearance of hair follicle melanocytes.We previously analysed that the expressions of various mole-
cules in single anagen hair follicles from human white and black scalp hair. Intriguingly, basic
¢broblast growth factor (basic FGF) mRNA level was observed to be down-regulated in white hair
follicles, as inferred by reverse transcription-polymerase chain reaction (RT-PCR). Melanocytes are
known to support the proliferation by basic FGF secreted from surrounding keratinocytes. Recently,
several reports have provided evidence that basic FGF may also act as a survival (anti-apoptotic) factor
for melanocytes, but the exact mechanism is not well. The present study was designed to gain more
insight into the mechanisms underlying the survival function of basic FGF in normal human mela-
nocytes. In cell culture, apoptotic cell death was initiated by the addition of oxidative stress (0.1 mM
hydrogen peroxide) and assessed by DNA fragmentation detection (ELISA) and LDH assay.With oxi-
dative stress treatment, apoptotic cells increased in a time-dependent manner. The oxidative stress-in-
duced apoptosis was inhibited in a concentration-dependent manner by basic FGF. Because recent
studies have demonstrated the implication of Bcl-2 family proteins (Bcl-2, Bcl-xL, Bax, and Bak) as
regulatory factors of apoptosis-signaling, changes in the contents of these proteins in melanocytes
were examined.Western blot analysis revealed that the contents of Bcl-2 protein in melanocytes, a
suppressive e¡ector of apoptosis, were strongly elevated in the presence of basic FGF. Furthermore,
Bcl-2 antisense oligonucleotide e¡ectively suppressed basic FGF-induced protection from apoptosis.
These ¢ndings suggest that basic FGF might be essential for the maintenance of appropriate life span
of melanocytes by up-regulating intracellular Bcl-2 levels. Thus, whitening of human scalp hair can
be explained, at least in part, by down-regulation of basic FGF in hair follicle.
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079
Expression of Protease-Activated Receptors and Urokinase-Type Plasminogen Ac-
tivator Receptor in Epithelial and Mesenchymal Portion of Human Hair Follicles
Takashi Anan,Tadashige Sonoda,Yuji Asada, and SusumuTakayasu
Department of Dermatology, Oita Medical University, Oita, Japan
(Background) Protease nexin-1 (PN1) is a potent inhibitor of serine protease including thrombin,
urokinase-type plasminogen activator (u-PA) and trypsin. Its mRNA is expressed speci¢cally by the
dermal papilla during anagen. However, biological roles of PN1 in hair growth are still unclear.We
hypothesized that PN1 controls signal transduction by thrombin and u-PA through their receptors,
like in the platelet, vasculature and brain. In this study, we examined the expression of mRNA by
RT-PCR for protease-activated receptors (PAR-1, 2 and 3) and u-PA receptor (u-PAR) in human
scalp hair follicles which were dissected into upper and lower connective tissue sheath (UCTS and
LCTS), dermal papilla (DP), and upper and lower epithelial compartments (UEC and LEC). PAR-1
and 3 are receptors for thrombin, and PAR-2 for trypsin and mast cell tryptase. (Result) The expres-
sion of mRNA of PAR-1was detected in almost all mesenchymal compartments, namely in UCTS,
LCTS and DP. PAR-3 was detected in UCTS or LCTS of some individuals. Neither PAR-1 nor PAR-
3 was expressed in epithelial compartments. PAR-2 expression was not detected in any compartments
of hair follicles. U-PARwas expressed in almost all compartments. These results suggest the possible
role of PN1, which might inhibit thrombin and u-PA at their receptor level, although physiological
roles of thrombin and urokinase in hair follicle are unknown.
080
Endothelins Induce the Regression of Anagen Hair Follicle via Endothelin Recep-
tors
N. Tsuji, A. Ohuchi, S. Moriwaki, and Y. Takema
Biological Science Laboratories, Kao Corp.,Tochigi, Japan
It has been reported that the several peptide or cytokines (EGF,TGFb etc.) suppress hair growth in vivo.
We have found the interesting phenomenon that subcutaneous injection of endothelins induces mor-
phological transition of hair follicle at an anagen phase into a catagen-like appearance in guinea pig. In
this study, we examined the mechanism of hair regression induced by endothelins in in vivo and in
vitro study. Histological examination revealed that the catagen-like morphological change of anagen
hair follicles caused one day after subcutaneous injection of endothelins (0.3 mg/50 ml) into the dorsal
skin of guinea pig, and anagen hair follicles were completely disappeared associated with depilation
four days after endothelin injection. The depilation by endothelin-1was signi¢cantly inhibited by the
simultaneous injection of endothelin receptor antagonist, PD142893 (10 mg). The topical application of
endothelin-1 (0.02% in polyethylene glycol) signi¢cantly inhibited hair regrowth of C3H mice. In
order to examine whether endothelins would directly act on hair follicle, the isolated human hair
follicles were maintained in serum-free Williams E medium with or without endothelin-1. The rate
of elongation and DNA synthesis of hair follicle was signi¢cantly suppressed by the addition of en-
dothelin-1 at a dose of 100 ng/ml. And the hair follicles incubated with endothelin-1 changed mor-
phologically to a club hair-like structure. These results strongly suggested that endothelins would
directly induce the regression of growing hair follicles via endothelin receptors on follicular cells.
081
Combined E¡ect of Substance P and Calcitonin Gene Related Peptide on the Hair
Growth
Hyung Jin Ahn,Young Hee Kim, In-Bum Sohn, andWon-Soo Lee
Department of Dermatology,Yonsei UniversityWonju College of Medicine,Wonju, Korea
Peripheral nervous system has important roles in the hair follicle growth and hair cycle change which
are mediated by neuropeptides. Substance P(SP), one of the most important neuropeptides, stimulates
mouse hair growth by increasing anagen stage of hair cycle. It is postulated that calcitonin gene related
peptide (CGRP) may also exert some role in the hair growth of C57BL/6 mouse model. So, we hy-
pothesize that combined use of SP and CGRP may exert positive e¡ects in terms of hair growth than
SP alone.
We studied the e¡ect of SP and CGRP on human hair growth using organ culture model in which
isolated hair follicles were grown in vitro.We devided the culture plates into four groups, i.e., control
group, SP group, CGRP group, and combined group. The results were evaluated by measuring linear
hair ¢ber growth and hair follicle morphology on light and electron microscopy and by measuring
radioisotope uptake of[methyl-3H] thymidine and [U-14C] leucine of hair follicle.
We found that SP prolonged the anagen phase of hair cycle and that combined use of SP and
CGRP potentiated the e¡ect of SP on this.
From the results, we can conclude that combined use of SP and CGRP exert positive e¡ect in the
human hair growth in vitro than SP alone.
082
Balding Scalp Dermal Papilla Cells Secrete a Soluble Factor(s) Which Delays the
Onset of Anagen in Mice in vivo
K. Hamada1 and V. A. Randall2
1Basic Research Laboratory, Kanebo Ltd., Kanagawa, Japan and 2Dept. of Biomedical Sciences, University of
Bradford,WestYorkshire, UK
Androgens are required for scalp hair follicle miniaturisation in androgenetic alopecia, but their me-
chanism of action is unclear. The mesenchyme-derived dermal papilla is probably the key tissue in
androgenic regulation. Cultured dermal papilla cells secrete soluble factors which stimulate the
growth of other follicular cells. Our earlier studies demonstrated that media conditioned by balding
dermal papilla cells had less stimulatory capacity for either human or rat cultured dermal papilla cells
than normal scalp cell media. This study was designed to determine whether balding or normal scalp
cell media a¡ected mouse hair growth in vivo. Conditioned media from dermal papilla cells derived
from normal, balding and clinically normal androgenetic alopecia scalp follicles (24 h in serum-free
medium) were injected subcutaneously into the shaved backs of C3H/HeN mice (n¼ 5 or 6; injec-
tions days 1, 3, 4, 6). After 65 days, hair growth was assessed visually, by histology and by quantitating
hair cycle markers.
Normal cell media had no e¡ect, but hair growth was delayed in mice treated with balding or
clinically normal balding cell conditioned media compared to both control serum-free media and
normal cell media. Histological examination con¢rmed the anagen and telogen de¢nition by observa-
tion and revealed no pathological changes in follicles from conditioned media treated mice. Analysis
of cell proliferation (g-glutamyl transpeptidase) and angiogenesis (alkaline phosphatase) markers con-
¢rmed that hair growth was present in 4/6 control mice and 4/5 treated with normal cell media, but
only 1/6 treated with balding and 2/5 with clinically normal balding cell media.
Thus, androgenetic alopecia dermal papilla cells from both balding and almost normal follicles
clinically appear to be secreting soluble factor(s) into their media which can delay the onset of anagen
in mice in vivo. Such factors were not present in normal scalp cell media as this had no e¡ect on mouse
hair growth in vivo. This inhibitory factor(s) appears to act across species. Such anagen-delaying or
telogen-prolonging paracrine factors may well be important in the processes of androgenetic alopecia.
083
Expression of Angiotensin Type 1 Receptor in the Hair Follicle and the Hair Folli-
cle-associated Tumors
Hikaru Takeda, and Shigeo Kondo
Department of Dermatology,Yamagata University School of Medicine,Yamagata, Japan
Angiotensin receptors are the speci¢c receptors of angiotensin II of the rennin-angiotensin system.
The existence and distribution of the receptors in the hair follicle have not been clari¢ed.We immu-
nohistochemically studied the expression of the receptors in the human hair follicle using normal
scalp skin from a 24-year-old Japanese man. The experiments demonstrated the expression of angio-
tensin type 1 receptor (AT1) in the inner root sheath and the outer root sheath except for the basal
layer. The expression pattern suggests the role of AT1 in association with keratinization. Based on the
results, we studied the expression of AT1 in the hair follicle-associated tumors such as epidermal cyst
and basal cell carcinoma. The cases were selected from the ¢les of the Yamagata University Hospital,
Japan between 1995^1999. The results revealed the distinct staining patterns of these tumors, respec-
tively. These observations suggest that studying AT1 expression may be useful in understanding the
pathophysiology of the hair follicle and the associated tumors.
084
Intracellular Signalling of Phytoestrogens in Relation to VEGF receptors Expres-
sion by Hair Follicle cells
S. Lachgar, M. Charveron, M.E. Balana, and Y. Gall
Pierre Fabre Research Institute, FaculteŁ de MeŁ decine Rangueil,Toulouse, France
Many studies indicate the impact of phytoestrogens (PHO) in normal physiology of humans and ani-
mals. They have demonstrated to possess numerous biological properties such as inhibition of tyrosine
kinase activity. The mechanisms by which these PHO exert their e¡ect are multifactorial and tissue-
speci¢c. The impact of PHO on hair growth was less extensively investigated. Published reports in-
dicate that treatment of mouse keratinocytes with selective PKC inhibitors stimulates their prolifera-
tion and in vivo stimulates murine hair growth (Yokoo et al, 1999). These data led us to study ¢rst the
e¡ect of PHO on PKC and then after to test the hypothesis that the vascular responses of hair follicle
cells in vitro are linked to the e¡ects of PHO on PKC activity and expression.We evaluated byWes-
tern-blot analysis the e¡ect of two total plant extracts: soya and pueraria in comparison with two free
forms (genistein, daidzein) and two conjugated forms (daidzin, puerarin) on the expression of PKC a
and d isoforms.We also evaluated their e¡ect on PKC activity in cultured human hair follicle dermal
papilla cells (DPC). In parallel, we evaluated by Western-blot and RT-PCR the e¡ect of PHO on
VEGF receptors (£t-1 and Flk-1) expression on DPC. The direct e¡ect of PHO on hair growth was
assessed on cultured human isolated hair follicles.
Our results showed a dose-dependent inhibition of PKC a and d expression in the presence of
PHO and speci¢c inhibitors of PKC isoforms. PKC activity was also seen to be markedly decreased
in the presence of genistein, daidzein and soya extracts (42% inhibition for 1 mM genistein and 44%
for soya extract at 1 mg/ml). The PKC activity was less reduced in the presence of pueraria extract at 1
mg/ml (10% inhibition). The inhibition induced by genistein is similar to that of a PKC inhibitor:
Calphostin C (45% inhibition). However, we observed an increase of VEGF receptors gene and pro-
tein expression in the presence of PHO. Speci¢c inhibitors of PKC isoforms also promoted Flt-1 ex-
pression by DPC. An improvement of hair follicle growth is observed in the presence of PHO.
Our results showed that Flt-1 and KDR expression within hair DPC is mainly mediated through
the PKC pathway. This signalization is modi¢ed in the presence of PHO and chemical protein kinase
inhibitors: an overexpression of VEGF receptors is observed in DPC. It will be of interest to examine
the functional impact and signi¢cance of protein kinase C modulation on the established vasculature
of the hair follicle.
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Integrin Blockers Stimulate Hair Growth in Microdissected Human Anagen VI
Follicles but not in Murine Skin Organ Culture.
Sven Mˇller-R˛ver1, Eva MJ Peters1, Ingrid Moll1, Michael P. Philpott2, and Ralf Paus1
1Dept. of Dermatology, University Hospital Eppendorf, University of Hamburg, Hamburg, Germany; 2Dept. of
Dermatology, Queen Mary andWest¢eld College, London, UK
Integrins have been shown to play major roles during hair follicle morphogenesis. Therefore, the use
of modulators of integrin binding may be a promising strategy for hair growth manipulation.
Here, we have investigated the spatiotemporal distribution of the integrin chains a1, a2, a3, a4, a5,
a6, and b1 during murine hair follicle morphogenesis and hair follicle cycling in C57BL/6J mice, and
have analysed the e¡ect of functional integrin blockers such as anti-b1 integrin antibodies, RGD pep-
tides or disintegrins (echistatin, £avoridin, kistrin) on neonatal hair follicle morphogenesis in murine
skin organ culture or adult human hair growth in vitro (microdissected anagen VI scalp hair follicles).
During murine hair follicle morphogenesis, the beta-1 integrin chain is broadly expressed throughout
skin, including in basal layer epidermal keratinocytes, developing hair buds and outer root sheath
(ORS) as well as in ¢broblasts of the dermal papilla (DP) and the perifollicular connective tissue
sheath (CTS). a1 and a3 IR was found on sebocytes as well as on ORS and basal layer epidermal
keratinocytes. a2 IRwas mainly found on the CTS during catagen. a4 IRwas found on nerve ¢bres
and endothelial cells as well as on the most proximal hair matrix. a5 IRwas detected, throughout the
hair cycle, on DP and CTS ¢broblasts, while a6 IRwas found on all epidermal and distal ORS ker-
atinocytes. Inhibitors of integrin binding such as RGD peptides or disintegrins did not alter signi¢-
cantly the velocity of hair follicle morphogenesis in murine skin organ culture of neonatal mouse skin
biopsies (P1). In contrast, the functional inhibition of integrin binding promoted human hair growth
in vitro: Microdissected human anagen VI hair follicles displayed signi¢cantly more hair shaft elonga-
tion compared to vehicle controls after administration of anti-b1 integrin antibodies (po0.005), RGD
peptides (po0.02) or the disintegrin echistatin (po0.05). These results suggest that integrin signalling
is an intriguing novel target for pharmaceutical hair growth modulation.
086
Study of the E¡ects of Thyroid Hormone on Hair Cycle and Hair Growth
Yang Shuxia, Ma Shengqing, and Qin Jian
First Hospital of Beijing University, Beijing, China
To study the e¡ects of thyroid hormone on hair cycle and hair growth C57BL6 mice of 6^8 weeks old
with hair of telogen were selected, and were fed with di¡erent dosage of L-thyroxine sodium (T4).
Anagen was induced by depilation as control.We also cultured the follicles and dermal papilla cells of
human scalp hair.We observed the growth and the synthesis of protein and DNA of triiodothyranine
(T3)-treated follicles by inverted microscope, 3H-leucine incorporation and 3H-thymidine incorpora-
tion. Cultured dermal papilla cells were treated with various concentration of T3. The DNA and in-
sulin-like growth factor I (IGF-I) synthesis were measured by 3H-incorporation and ELISA
respectively. The results showed that anagen of C57BL6 mice can be induced byT4. The duration of
anagen induced byT4 was the same as that of control. The T3-treated follicles, compared with con-
trol, transformed into catagen prematurely. T3 also inhibited the protein and DNA synthesis of the
follicles. The DNA and IGF-I synthesis of the cultured dermal papilla cells was stimulated byT3 100
nM. This study suggested that T4 can induce telogen hair of C57BL6 mice transforming into anagen,
and the reason might be that T3 can stimulate dermal papilla cells growth, and increase the IGF-I
synthesis. However,T3 can shorten the anagen duration of cultured hair follicles, and inhibit protein
and DNA synthesis at the same time.
087
E¡ect of Minoxidil on Proliferation and Apoptosis in Human Dermal Papilla Cells
Jun-Kyu Oh, Ji-Hyun Han, Kyu-Han Kim, Jin-Ho Chung, Kwang-Hyun Cho, and Hee-Chul Eun
Department of Dermatology, Seoul national university, Seoul, Korea
Minoxidil promotes hair growth and prolongs the duration of anagen phase, but the exact mechanism
of these e¡ects has not been known. Recently, it was reported that testosterone and dihydrotestoster-
one inhibited proliferation and induced apoptosis in dermal papilla cell and this might be another
pathomechanism of androgenetic alopecia. In this study we investigate whether minoxidil promotes
proliferation and inhibits apoptosis in cultured human dermal papilla cell.
We used MTT assay to evaluate the in£uence of minoxidil on proliferative activity of dermal pa-
pilla cells at 0, 108, 107, and 106 M after 5 days, and also estimated the phosphorylation of extra-
celluar signal-regulated kinase (ERK) by immunoblotting at 0, 107, and 106 M after 1, 24, and 48
hours. To evaluate the in£uence of minoxidil on apoptosis, the expression of bcl-2 and bax was de-
tected by immunoblotting at 0, 107, and 106 M after 24 and 48 hours.
In MTTassay proliferative activity of DPCwas increased as a concentration-dependent manner and
phosphorylation of ERKwas also increased with minoxidil, which shows that the proliferative e¡ect
of minoxidil is induced by phosphorylation of ERK. The expression of bcl-2 was increased and the
expression of bax was decreased with minoxidil after 24 hours, which shows antiapoptotic e¡ect of
minoxidil occurs through bcl-2/bax pathway.
This study shows that minoxidil has proliferative and antiapoptotic e¡ects on dermal papilla cells,
and this may be one of the mechanism by which minoxidil acts on hair growth.
088
E¡ect on Hair Growth of HEM-13/HDC(A Mixture of 8 Herbal Extracts) in Hu-
man and C3H Mice
EY Choi1,YJ Park2, BI Ro3, and MH Chung1
1Dept. of Pharmacology, Seoul National University, College of Medicine, Seoul, Korea, 2Handock Cosmetics Co.
Ltd. Seoul, Korea and 3Dept. of Dermatology, Chung Ang University, College of Medicine, Seoul, Korea
In Korean folk medicine, several herbs have been known to improve blood £ow and been used for
wound and in£ammation, which are: Angelicae Radix, Cnidii Rhizoma, Salviae Miltiorhizae Radix, Persicae
Semen, Sinomeni Caulis et Rhizoma,Viticis Fructus, Zanthoxylum piperitum and Carthami Flos. Based upon
their pharmacological actions, we assume that these herbs may also stimulate hair growth and thus,
tested their e¡ect using the mixture of their ethanol extracts (HEM-13/HDC). Clinical study: 150
subjects of male pattern alopecia were treated with HEM-13/HDC twice a day for 6 months and sub-
jective and objective clinical symptoms were assessed. Objective symptom was assessed by photo-
graphic method. Over 85% of the subjects showed improvement of clinical symptoms and increase
of hair growth. Animal study: 36 C3H mice whose hair in the lower half of the back was removed
were grouped into 3 (n¼12 in each group); vehicle (30% ethanol), HEM-13/HDC and minoxidil
(30% in ethanol) were applied for the hairless part on the back once a day for 3 weeks. Hair growth
was assessed by photographic method. In both the HEM-13/HDC and minoxidil groups, the hair
grew into the normal state in 3 weeks but in the vehicle group, hair grew only to 1/3 the state of
HEM-13/HDC group. In the animal study, it is as e¡ective as or more e¡ective than minoxidil. Any
skin reactions were not observed in clinical and animal studies.We concluded that HEM-13/HDC has
a hair growth stimulating e¡ect.
089
The E¡ect of Sophora Root Extract on the Anagen Elongation and Isolation of Ac-
tive Compounds
T. Takahashi, C. Hamada, A. Ishino, K. Kobayashi,T. Kimura, K. Komatsu and M. Tajima
Shiseido Basic Research Center,Yokohama, Japan
Androgenetic alopecia is characterized by the gradual miniaturization of hair follicles (vellus hair)
resulting from the decrease in the duration of anagen phase. Thus, the anagen elongation is thought
to be the most e¡ective for the improvement of androgenetic alopecia. In the course of screening plant
extracts for anagen elongation activity, the extract of dried roots of Sophora Flavescens Aiton (SRE),
which is well-known as a Chinese traditional medicine, was found to possess potent anagen elonga-
tion activity using human hair follicle organ culture. When anagen hair follicles were cultured in
Williams E medium in the presence of SRE, hair shaft elongation was signi¢cantly accelerated com-
pared with those cultured in the absence of SRE. In anagen hair follicles, the proliferating cells are
distributed in epithelial cells, such as hair matrix cells and outer root sheath cells (ORSC). The elon-
gation of anagen phase was estimated by growth stimulation of hair follicle epithelial cells.We used a
serum-free culture system of human ORSC to estimate the e¡ect of anagen elongation.When human
ORSC was cultured in the presence of SRE, one ppb of dry residue was su⁄cient for the growth
stimulation of ORSC. These results suggest that SRE is e¡ective for anagen elongation because of
the stimulation of the proliferation of hair follicle epithelial cells. In order to isolate active compound
for anagen elongation, SRE was fractionated by solvent extraction and subsequent silica gel chroma-
tography. The hydrophobic fraction showed activity for ORSC growth stimulation. Further puri¢ca-
tion showed two independent active compounds.When their structures were elucidated using NMR
and FAB-MS method, these were two pterocarpan derivatives, medicarpin and maakiain, and exhib-
ited signi¢cant acceleration of ORSC proliferation.
090
The E¡ect of Taurine and its Derivatives on the Hair Follicle Cell
T. Magara, C. Hamada,T. Takahashi, A. Ishino and M. Tajima
Shiseido Basic Research Center,Yokohama, Japan
Taurine is the most abundant sulfur amino acid in mammals, and may have important functions in
several tissues and organ. It was demonstrated in the adult mice that a high density of taurine was
found external root sheaths just below the insertion of the sebaceous glands by radioautography (1).
However, no report has been known about the function of taurine on hair follicle. We investigate
whether taurine and its derivatives have an e¡ect on the proliferation of the outer root sheath cells
(ORS) and dermal papilla cells (DP).
The cell line of human ORS and DP was established by infection of a recombinant adenovirus
vector containing T antigen. The ORS was cultured in the serum free medium on Type I collagen
coated dish with taurine, N-methyltaurine and beta-alanine. Addition of taurine, N-methyltaurine
and beta-alanine show the signi¢cant increase on the proliferation of ORS, but not on that of DP.
These results suggest that distribution of taurine around hair follicle may a¡ect the cell growth.
The proliferation by taurine and beta-alanine indicate the mechanism on that glycine receptor is acti-
vated and that then the proliferation of epithelial cells may be due to the opening of the ion channel.
(1) Watanabe H et al (1995), Cell Mol Biol (Noisy-le-grand);41:49^55.
140 ABSTRACTS JID SYMPOSIUM PROCEEDINGS
091
A Reliable Method to Select Human Hair Follicle for Organ Culture
Jun-Kyu Oh, So-Hyun Park, Kyu-Han Kim, Jin-Ho Chung, Kwang-Hyun Cho, Hee-Chul Eun
Department of Dermatology, Seoul National University, Seoul, Korea
Among several in vitro models for hair growth studies, organ culture of hair follicle has been the most
popular mothod principally to investigate growth factors thought to be involved in hair growth con-
trol mechanisms and to test viability of hair follicle which have had various ischemic or traumatic
injuries. In such experiments, changes in hair growth are commonly used as the measure of activity
and viability. But Robinson et al showed that the behavior of murine vibrissa follicles in organ culture
is determined by the point in the hair growth cycle at which they are taken. In case of human hair,
there have been no reliable methods to select hair follicles on speci¢c hair cycle stage, so it has been
di⁄cult to evaluate the result of an experiment using hair follicle organ culture method. In this study
we investigate a new method which can be used in humans to select hair follicles for organ culture.
In three volunteers, hairs in 2 0.5 cm area of occipital scalp was cut and bleached by an agent
containing H2O2. After 2 weeks biopsy was done in the bleached area and all hair follicles were mi-
crodissected. The growth of each hair during 2 weeks was measured and anagen terminal hair follicles
were further divided into 3 groups by hair growth rate. Hair follicle organ culture was done in 3
groups and length of hair was measured on alternate days. The growth rate of hairs were compared
among 3 groups.
In result the growth rate of hair during organ culture was related to the hair growth rate in vivo, and
it showed signi¢cant di¡erence among 3 groups.
Using this method, the result of an experiment using follicle organ culture method would be more
reliable, and in conventional follicle organ culture the su⁄cient number of hair follicles are required
to minimize this inherent error.
092
Ectopic Expression of c-Myc in Murine Skin A¡ects the Hair Growth Cycle and
Induces Sebaceous Gland Enlargement
J.J. Bull1, S. Mˇller-R˛ver2, C.M.T. Chronnell1, I.A. McKay1, S. Pelengaris3 and M.P. Philpott1
1Centre for Cutaneous Research, St Bartholomew’s and the Royal London School of Medicine and Dentistry, Queen
Mary College, University of London UK; 2University Hospital Eppendorf, University of Hamburg, Germany;
3Biological Sciences, University ofWarwick, Coventry, UK
The mammalian hair follicle is a highly dynamic skin appendage that undergoes repeated cycles of
growth and regression involving closely co-ordinated cell proliferation, di¡erentiation and apoptosis.
The transcription factor c-Myc has been strongly implicated in these processes in many tissues.
c-Myc overexpression in transgenic mice has been shown to stimulate hyperproliferation and dis-
rupt terminal di¡erentiation of suprabasal keratinocytes in the epidermis (Pelengaris et al, 1999) and
promote human keratinocyte stem cell di¡erentiation in vitro (Gandarillas et al 1997). Recently we have
reported that in human hair follicles, c-Myc expression in the outer root sheath is restricted to the
putative stem cell compartment and have suggested that c-Myc may be involved in regulating cell fate
within this region.
In this study we have investigated the e¡ects of c-Myc overexpression on the hair cycle and hair
phenotype of transgenic mice, in which c-Myc activity can be reversibly induced by expression of c-
Myc-ERt (Pelengaris et al, 1999). Topical application of 4-hydroxytamoxifen (4OHT) was used to
induce c-Myc-ERt activity in dorsal skin of transgenic mice.Wild-type and transgenic mice were
treated with 4OHT twice weekly for 7 weeks. The hair growth cycle stage of transgenic and wild-
type mouse skin was then characterised. Alkaline phosphatase and oil red O staining were used to
distinguish the dermal papilla and sebaceous gland respectively.
In 4OHT treated c-Myc-ERt transgenic mice, normal synchronised hair cycling was deregulated,
with hair follicles at various stages of the cycle. In contrast, all hair follicles were in telogen in wild-
type mice. Moreover, sebaceous glands were enlarged in 4OHT-treated c-Myc-ERt transgenic mice.
These data suggest c-Myc a¡ects hair follicle cycling and sebaceous gland growth.
093
Mesenchymal cell dynamics during the murine hair growth cycle
D.J. Tobin1, M. Magerl1, A. Gunin2, R. Paus2
1Dept. of Biomedical Sciences, University of Bradford, Bradford, England and 2Dept. of Dermatology, University
Hospital Eppendorf, Hamburg, Germany
Dramatic changes are seen in both the HF epithelium and mesenchyme during the hair growth cycle.
However, the relative contributions of the HF ¢broblast sub-populations, i.e. the dermal papilla (DP)
and the connective tissue sheath (CTS), to this process remain unclear. Here, we studied changes in
total HF length, total DP size, and DP and CTS mitotic indices during the C57BL/6 hair growth
cycle. Proliferation and apoptosis were also examined by immunohistochemistry (Ki67, PCNA,
BrdU), mitotic index after cholchicine injection, and by light and electron microscopic analysis. Early
induced anagen was associated with a very rapid increase of total DP size beginning at day 3 (anagen
II;500 mm2) and reaching a maximum at day 12 (anagenVI;7200 mm2). This 14-fold increase occurred
with only a 2-fold increase in DP cell number; indicating the major contribution of extracellular
matrix production to DP size. DP enlargement occurred signi¢cantly earlier than a corresponding
increase in total HF length. This increase occurred initially via greater numbers of DP cells and before
evidence of intra-DP cell proliferation, yet coincided with mitosis in the CTS. This suggests that CTS
¢broblasts proliferate and thereafter migrate into the DP. DP and CTS organization and cellular activ-
ity was also modulated during the hair cycle. Telogen DP, consisting of tightly-packed inactive cells,
displayed heterochromatic nuclei and limited cytoplasm. Anagen onset correlated with increasing
numbers of randomly distributed cells of variable activity, but with increasing nuclear euchromatism.
While DP mitosis was rare (anagen I-IV), most cells were highly active by anagen IV, aligning per-
pendicular to the hair growth direction. The DP was fully extended, with ¢broblasts oriented parallel
to the growth axis, in anagen VI. DP extracellular matrix and cytoplasmic volume were reduced in
early catagen, with a corresponding increase in nuclear heterochromatism. Late catagen/telogen DP
contained fewer cells with increasingly pleomorphic nuclei. Since the reduction in DP volume and
cell number in catagen/telogen occurred without apoptosis, ¢broblasts likely migrate out of the late
anagen DP back into the proximal CTS.
This study suggests that HF mesenchymal cells exhibit a greater proliferative and migratory capa-
city than previously thought and suggests dynamic exchange of HF ¢broblast sup-populations during
the hair growth cycle.
094
Patterns of Insulin-Like Growth Factor Expression During Murine Hair Follicle
Development and Cycling
Y-C. Liu, J.J. Bull, S. Muller-Rover, M.P. Philpott
Centre for Cutaneous Research, St Bartholomew’s and the Royal London School of Medicine and Dentistry, QMW
College. University of London, UK
The insulin-like growth factors (IGF-I and IGF-II) are polypeptide growth factors that exhibit close
homologies to insulin and possess potent anabolic and mitogenic e¡ects both in vivo and in vitro. The
biological e¡ects of both IGF-I and IGF-II are mediated via the IGF-I receptor (IGF-IR), which can
also be activated in vitro by supra-physiological levels of insulin.
We have previously reported that cultured human hair follicles maintained in the absence of IGF-I
show premature entry into catagen. Immunohistochemistry of human skin has shown that IGF-IR is
expressed in the dermal papilla (DP) and matrix but not in the highly proliferative germinative
epithelium. Moreover, IGF-IR expression appears to be regulated in a hair cycle dependant manner
(Rudman et al 1997 JID). These data suggest that IGF-I may play an important role in regulation of the
hair growth cycle. To investigate this in more detail we have studied by immunohistochemistry the
patterns of expression of IGF-I, IGF-IR, IGF-II, IGF-II receptor (Mannose-6-phosphate receptor), In-
sulin receptor (IR) in murine hair follicles and during the murine hair growth cycle.
Our key ¢ndings were that IGF-I immunoreactivity (IR) was weakly expressed in 0^5 day old skin
and that a similar pattern of IGF-IR expression was also observed. In 12 day old mice (anagen), IGF-
IR and IGF-I IRwere detected in both the interfollicular epidermis and dermis as well as in the hair
follicle epithelium (germinative epithelium, matrix and ORS) and the dermal papilla (DP) and con-
nective tissue sheath (CTS). IR expression mirrored that of IGF-IR. Strong IGF-IIR IRwas detected
on the sebaceous gland. In 18 day old mice (catagen) marked downregulation of IGF-IRwas detected
in the receding epithelial strand, whilst the DP and permanent portion of the ORS were positive. In
24 day old mice (telogen) little IGF-I R or IGF-I IR were detected on the hair follicle epithelium.
However, the DP remained positive for both IGF-I and IGF-IR. The marked downregulation seen
for IGF-I and IGF-I Rwas also observed for the IR.
This data supports our previous data and demonstrates marked changes in the patterns of IGF-I
expression during the murine cycle. However, our data suggests that di¡erences in the patterns of
expression exist between murine and human hair follicles and that this may re£ect di¡erences in hair
cycle control, cytokine function or possible cytokine redundancy between murine and human folli-
cles.
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Expression of Insulin-Like Growth Factors in the Hair Cycle of Rats
P. I. Hynd and N. M. Penno
Dept. of Animal Science, Adelaide University, Roseworthy Campus, Roseworthy, South Australia, Australia
The insulin-like growth factors (IGF) are thought to play a role in the regulation of hair growth, but
presentation of IGF to their receptors depends on binding proteins (IGFBP-1to -6) in tissues.We re-
port here the sites of expression of mRNA for the six IGFBP throughout the rat hair cycle.
In situ hybridisation to DIG-labelled mRNA probes for the six rat IGFBP was used to identify the
sites of expression throughout the hair cycle in skin from the back of rats from days 3 to 35 after birth.
Histone mRNA expression was used as a positive control and sense probes used as negative controls.
The positive histone control identi¢ed strong and speci¢c labelling of the mitotic region of the
follicle bulbs as expected. Sense probes were largely colour-free. IGFBP- Telogen (21d) Anagen 1 (3^
5d) Catagen (20d) Anagen 2 (19d) 1 ORS nd nd nd 2 DP condensate ORS, BC, DPC, E KZ ORS,
BC, DPC, E 3 DP condensate nd DPC nd 4 DP condensate DPCells (few) nd nd 5 DP condensate
¢bre tip, I BC (few) nd 6 nd nd nd nd (ORS outer root sheath; DP dermal papilla; BC bulb cells; KZ
keratinising zone; E epidermis; I infundibulum; nd not detected)
Spatial di¡erences within the hair follicle, and changes in the expression of the IGFBP in the hair
cycle, lend credence to the possibility that the IGFBP may regulate the action of IGF and alter follicle
activity. In contrast to Batch et al. (1996) we did not detect IGFBP-3 and -5 in the dermal papilla of
anagen follicles, although these binding proteins were detected in the dermal papilla condensate of
inactive follicles. Further work is required to clarify these discrepancies and to elucidate the role of
the IGF axis in the regulation of hair follicles.
Batch, J. A., Mercuri, F. A. AndWerther, G. A. (1996). J. Invest. Dermatol. 106:471^475.
096
Standardized Macroscopic Quanti¢cation of Murine Hair Follicle Regression
(Catagen) in vivo by Dotmetric Planimetry
Murat nalan and Ralf Paus
Department of Dermatology, University Hospital Eppendorf, University of Hamburg, Hamburg, Germany
The murine hair cycle is an instructive model for identifying catagen-manipulatory agents, and the
analysis of catagen-associated changes in back skin pigmentation of C57BL/6 mice has been a particu-
larly attractive study system. However, standardized, sensitive, accurate and quantitative techniques for
assessing these skin color changes as indicator of catagen development in vivo remain to be developed.
Here we present ‘‘dotmetric planimetry’’ (DMP) as a very simple, new assay system that meets these
requirements. To correlate distinct hair cycle stages with the catagen-associated back skin color
changes, telogen C57BL/6 mice were anagen-induced by depilation. Spontaneous catagen develop-
ment was then assessed by photodocumenting the skin color changes, and by planimetric measure-
ment of the percentage of the catagen area, using a transparency and a uniform dot pattern (¼ dot
matrix). Dots were counted and related to the total dot-count of the entire back skin area. On day 18
after depilation, i.e. when back skin displays three di¡erent colorgrades (black-grey-pink) and when
almost all anagen follicles have entered into catagen, the mice were sacri¢ced, and color-classi¢ed
biopsies were subjected to quantitative histomorphometry. On day 18 after depilation, the skin classi-
¢ed as pink occupied 17-27%, grey skin 31^44% and black skin 37^45% of the back skin. By histo-
morphometry, pink skin corresponded predominantly to catagen stages VIþVII (97%), grey skin to
catagen stages III^V (76%), and black skin samples to catagen IIþ III (88%). DMP allows one to easily
correlate the macroscopic skin color with the underlying hair cycle stage, and enables one to record
and quantify the e¡ects of any test agent on the wave-like, polarized catagen development from neck
to tail in murine back skin ^ during ongoing in vivo-experimentation, and without the need for his-
tology. DMP may also be used for analyzing a wide range of patterned skin phenomena, including
androgenetic alopecia and alopecia areata.
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Expression of ErbB Protooncogene Family Members in Human Hair Follicle
Epithelium Correlates with the Catagen Inductive Capacities of Heregulin b1
EMJ Peters, F L˛hr, C Kuwert, I Moll, R Paus
Department of Dermatology, University Hospital Eppendorf, University of Hamburg, Hamburg, Germany
Activation of growth and di¡erentiation cascades by growth factors such as EGF, and heregulin play
important roles in hair growth control. Their cognate subtype I receptor tyrosine kinases erbB-2,
erbB-3, and erbB-4 are known to play a major role in epithelial growth control, with erbB-2 enhan-
cing signalling through erbB-3 and erbB-4, which promotes epithelial proliferation. However, in the
absence of erbB-2, erbB-3 and erbB-4 appear to promote di¡erentiation. Since, EGF and erbB-2
transgenic mice display distinct hair growth abnormalities, we have further explored the role of the
erbB protooncogene family in hair biology.We employed immunohistochemistry to detect erbB-2,
erbB-3, and erbB-4 in human scalp skin samples. In anagen hair follicles, we found predominant
staining for all investigated receptors in the proximal outer root sheath and the sebaceous gland, but
never in the dermal papilla. ErbBs were also immunoreactive in cells of the keratogeneous zone. Ad-
ditional ErbB-2 immunoreactivity was seen in matrix cells, while erbB-4 was detected distal of the
keratinogeneous zone. Telogen hair follicles exhibited only very weak epithelial staining for all three
markers. Epidermal expression was high for erbB-2, erbB-3, and erbB-4 in the basal layer but weak in
suprabasal layers for erbB-2. In addition, cultured human anagen hair follicles (Philpott model) were
treated with heregulin b1, a high a⁄nity ligand for erbB-3 and erbB-4. Treatment of human anagen
VI scalp hair follicles with 0,5 mg/ml heregulin b1 resulted in inhibition hair shaft elongation (more
than 35 % compared to untreated controls), and premature induction of a catagen-like stage in the
majority of the cultured hair follicles. These data suggest a role for erbB-3 and erbB-4- mediated
signaling as a stimulus for trichocyte di¡erentiation processes, e.g., in the regressing outer root sheath
during catagen. Therefore, erbB-signaling is an attractive new target for therapeutic control in human
hair growth. ErbB-3 or erbB-4 agonists may lead to development of new pharmaceutical tools to
manipulate hair growth, e.g., hirsutism.
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The Shedding Phase of the Mouse Hair Growth Cycle, Exogen, is Coupled to Ana-
gen and Generates a Unique Hair Shaft Base
Y. Milner1, J. Sudnik, M. Filippi, M. Kashgarian2, and K. Stenn
1Skin BiologyTRC, Johnson & Johnson, Skillman, NJ, Myers Skin Biochemistry Laboratory, Department of
Biological Chemistry, Life Sciences Institute,The Hebrew University, Jerusalem, Israel, 2Department of Pathology,
Yale University School of Medicine, New Haven, CT
The normal hair follicle undergoes phases of growth (anagen), regression (catagen), and rest (telogen).
It has long been recognized that at some time at the end of the cycle the hair shaft sheds. This shed-
ding phase, recently termed ‘‘exogen’’, has been given little attention and thus is poorly understood. It
was the purpose of this study to characterize the exogen phase in the mouse. Using the C57Bl/6 strain
we developed a method for collecting (‘‘vacomb’’) and quantifying shed hair (spectrophotometry)
from newborn and adult mice.We found that the base of shed hairs di¡er from the base of telogen
hairs (by their elongated shape, nibbled contour, and poorly preserved cytologic detail) and that this
di¡erence is demonstrable by light and electron microscopies. During spontaneous and induced hair
cycles, although there is a basal amount of hair shedding in all phases of the cycle, the greatest amount
of shedding occurs during mid to late anagen. The hair shafts that are shed in any phase show chie£y
exogen morphology. As seen by metabolic labeling the hair shafts that shed are formed, for the most
part, during the previous cycle. These studies present a method for collecting and quantifying shed
hair, and document, for the ¢rst time, that exogen occurs predominately during anagen and that its
shaft base is unique. Collectively, these ¢ndings underscore the existence and distinctiveness of the
exogen phase of the hair cycle.
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Prolonged Telogen Stage by Footshock Stress in Mice
E. Aoki1, K. Kaneko1,T. Shibasaki2, S. Kawana1
1Dept. of Dermatology, Nippon Medical School,Tokyo, Japan and 2Dept. of Physiology, Nippon Medical School,
Tokyo, Japan
It has been determined that some stress in£uences skin conditions, for example allergic dermatitis and
transepidermal water loss. However, the relation between stress and hair growth has not been proved.
In this study, we evaluate the in£uence of footshock stress on the hair cycle in mice. Female C57BL/6
mice, at 7^8 weeks of age were used. After depilation of back skin to synchronize hair cycle, each
mouse received electric footshocks for an hour daily for 6 weeks and we observed the haircycle stage
macroscopically and histologically. The term of ¢rst anagen stage in the stressed mice was the same as
in normal control mice, but the beginning of the second anagen stage was delayed in the stressed mice
compared to control mice. That is the telogen stage was prolonged in stress mice.We conclude that
hair cycle delay prolongs telogen stage in mice by stress.
100
Epithelial-Mesenchymal Interaction During Hair Follicle Development
M. Inamatsu1,3, S. Oomizu1, H. Kuwamoto1,T. Endo1, K. Toyoshima2, and K. Yoshizato1,3
1HiroshimaTissue Regeneration Project, Hiroshima Prefecture Collaboration of Regional Entities for the
Advancement ofTechnological Excellence, JST, Hiroshima, Japan, 2Bioart Laboratory, Hiroshima, Japan and 3Dept.
of Biol. Sci., Grad. School of Sci., Hiroshima Univ., Hiroshima, Japan
During embryonic development, hair germs are formed by a series of interactions between epidermal
cells and the underlying mesenchymal cells. Pelage hair germs begin to be formed from 15 day post-
coitus (dpc) in rats.
We implanted rat embryonic skin at varied hair developmental stage onto the back of nude mice.
No hair formation was observed from 14 dpc skin which had not formed hair germs in vivo. Hairs
were induced from the implants of any stage of the embryonic skin after 15 dpc. These results indi-
cated that crucial events responsible for hair development occurred between 14 dpc and 15 dpc.We
asked whether the competence of 15 dpc skin to develop hair bud resides in the epidermis, the me-
senchyme, or both. To address this question we developed a hair-induction assay model composed of
dissociated epidermal and mesenchymal cells isolated from rat embryos at various embryonic stages.
Epidermal and mesenchymal cells from di¡erent stages were combined and grafted on the back of
nude mice to induce hairs. The result of this experiment is presented.
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Hair Follicle Development in Organotypic Culture
M. Inamatsu1,3, M. Yamao2, S. Oomizu1, and K. Yoshizato1,3
1HiroshimaTissue Regeneration Project, Hiroshima Prefecture Collaboration of Regional Entities for the
Advancement ofTechnological Excellence, JST, Hiroshima, Japan, 2Bioart Laboratory, Hiroshima, Japan, and 3Dept.
of Biol. Sci., Grad. School of Sci., Hiroshima Univ., Hiroshima, Japan
The dermal papilla (DP) plays a crucial role for the development of hair follicles through interacting
with epidermal cells. In vitro model study is one of the approaches to identify principles associated
with this interaction. In this study, we developed an organotypic culture as a skin model wherein
the early phase of hair development can be reproduced.
The skin was constructed by culturing keratinocytes of rat sole on the ¢broblast-populated collagen
gel. Freshly isolated DPs of rat vibrissae were inserted beneath the epidemal layer and the model was
cultured at the air-liquid interface. At day 7 of culture, the epidermis adjacent to the DPs thickened
and enclosed the DPs. On the other hand, no morphological change was observed in organotypic
cultures inserted with aggregates of rat skin ¢broblasts as the negative controls. It seems that intact
DP interacted with keratinocytes and induced an initial morphological change of hair bulb formation
under the culture condition. A similar change was seen in the model inserted with aggregates of DP
cells.
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Characterization of vibrissa germinative cells: transition of cell types
Aki Osada, Koji Kobayashi
Department of Biology, Graduate School of Science andTechnology, Chiba University
Follicular stem cells have long been believed to locate at the hair bulb. It was recently demonstrated,
however, that most stem cells segregate at the bulges of mouse pelages and rat vibrissae or at the mid
portion of human scalp hair follicles. A few stem cells, however, do locate at the follicular bulb. On
the other hand, germinative cells, small cell masses attached to the stalks of dermal papillae that are
able to di¡erentiate into the hair shaft and inner root sheath, form follicular bulb-like structures when
co-cultured with dermal papilla cells. We studied the growth characteristics of germinative cells to
determine the cell types in the vibrissa germinative tissue. Germinative tissues, attaching to dermal
papillae, were cultured on 3T3 feeder layers. The cultured keratinocytes were harvested and trans-
ferred, equally and for two passages, onto lined dermal papilla cells and/or 3T3 feeder layers. The
resulting germinative cells were classi¢ed into three types. Type 1 cells grow very well on either feeder
layer, whereas Type 3 cells scarcely grow on either feeder layer. Type 2 cells are very conspicuous and
are reversible. They grow well on 3T3 but growth is suppressed on lined dermal papilla cell feeder
layers. The Type 2 cells that grow well on 3T3 feeder layers, however, are suppressed when transferred
onto lined dermal papilla cells and the Type 2 cells that are suppressed on lined dermal papilla cells
begin to grow again on 3T3. These characterized cell groups changed their appearance depending on
hair cycle stages. Next, we isolated these germinative cells and succeeded to obtain Type 1 and Type 2
cloned cells. The transition of one cell type to another in vitro and the cell types that these germinative
cell types correspond to in vivo is discussed.
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In vitro Development of Hair Follicles Reorganized from Single-Cell Suspension of
Embryonic Mouse Upper Lips
T. Matsuzaki, M. Imai, A.Wada, M. Iida, and S. Ihara
Department of Biological Science, Faculty of Life and Environmental Science, Shimane University, Matsue,
Shimane, Japan
It is known that hair follicles are able to be reconstructed in vitro from dissociated vibrissal hair germs
of embryonic rats by rotation culture followed by £otation culture (two-step culture method). We
applied this method to mice in order to take advantages of using a lot of genetically modi¢ed mice.
Upper lips were collected from E13 or 14 of C57BL/6 mice, and treated with trypsin for 12 min. In
some experiments, collagenase digestion preceded the trypsin treatment. Dissociated cells were cul-
tured in rotating dishes and then resultant cell-aggregates were cultured by £oating on the surface of
a medium. Gene-transfer e⁄ciency was examined by adding retrovirus vectors carrying a lac-Z gene
into rotation culture. In other experiments, we mixed upper lip cells of GFP-transgenic mice into
rotation culture to chase cell-lineage during follicle development. Lac-Z gene transcripts were de-
tected by X-gal staining, and GFP-positive cells were detected under £uorescent microscope after
proper ¢xation.
Hair follicles were formed in the aggregates and di¡erentiated normally in 7 days of cultivation.
Incidence of hair formation was related to duration of tryptic digestion, i.e., longer treatment resulted
in poor aggregation of cells and in failure of hair formation. Lac-Z retrovirus vectors were integrated
into dissociated cells very e⁄ciently. Addition of Lac-Z retrovirus vectors or GFP-transgenic cells did
not cause any abnormality or retardation of development. Thus both techniques seem to be applied to
the two-step culture. However, cell dissociation procedure was thought not enough, because X-gal-
positive cells were frequently found in dermal tissues but less in epithelial ones, and GFP-positive
keratinocytes did not mix well with GFP-negative ones. Collagenase treatment was very e¡ective to
increase the number of single cells without prolonged tryptic digestion. The cells isolated by collage-
nase/trypsin digestion formed hair follicles in which GFP-positive keratinocytes were randomly dis-
tributed in epithelial tissues reorganized through the two-step culture.
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Formation of epidermis/hair follicles by inoculating cell suspension directly onto a
dorsal skin defect in nude mice
Teruhiko Makino, Masaaki Morohashi, Nam-ho Huh
Department of Biochemistry and Department of Dermatology, Faculty of Medicine,Toyama Medical and
Pharmaceutical University,Toyama, Japan
Potentiality of histogenesis is of the most reliable markers for characterization of cells. To assess the
histogenic capacity of cells of di¡erent origin, we inoculated cell suspension directly onto a skin defect
made at the dorsal part of nude mice using a silicon apparatus.When the epidermal keratinocytes and
the dermal ¢broblasts including dermal papilla cells prepared from 17.5-day-old embryos were inocu-
lated in a 1:1 mixture (B510E6 cells each), fully di¡erentiated epidermal tissues and hair follicles
were formed in 3 weeks. Sebaceous glands were also observed. In mouse embryos at the gestational
day 17.5, the epidermis is matured to form the horny layer, but the hair follicles are still developing
without hair shafts and sebaceous glands. Thus the inoculated cells apparently segregated each other
and followed the original program to complete the skin development. Similar tissues were formed
when the both type of cells were inoculated after being cultured separately for 3 days. Cells derived
from a transgenic mouse expressing the green-£uorescent protein gene (provided by Prof. M. Okabe,
Osaka University) gave rise to £uorescent skin tissues, con¢rming the origin of the tissue. Human
foreskin keratinocytes could form epidermal tissue when inoculated with human dermal ¢broblasts.
The cells in granular layer expressed human type-pro¢laggrin. However, no hair follicles were
formed. These results indicate that the present system is most suitable to assess the histogenic capacity
of cells, particularly to form hair follicles.
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Proliferation and Transdi¡erentiation of Infundibulum Keratinocytes in Associa-
tion with The Bulge of Vibrissa Follicles
M. Iida, A.Wada, S. Ihara, and T. Matsuzaki
Department of Biological Science, Faculty of Life and Environmental Science, Shimane University, Matsue,
Shimane, Japan
We studied habitat of the stem cells of mouse vibrissa follicles by detecting the location of the cells
which could reproduced hair bulbs in amputated follicular fragments.We used C57BL/6-derived GFP
transgenic mice (GFP-TG) in which almost all types of cells express green £uorescent protein under
the control of beta actin promoter.Vibrissa follicles of GFP-TG mice were cut into four pieces along a
longitudinal axis, which were named fragment I, II, III, and IV in order of proximity to the hair bulb.
All fragments except fragment I were stu¡ed with an intact vibrissal papilla of non-transgenic C57BL/
6 mice (NTG) and were transplanted under the kidney capsule of other NTG. In the second experi-
ment, fragment II or III from NTG was grafted as above but with fragment IV from GFP-TG in close
association. In both experiments, transplanted fragments were observed under a £uorescent micro-
scope and were subjected to histological examination after 1 month of grafting.
Hair bulbs were reproduced in fragments II and III, but not in IV. Incidence of hair formation was
higher in the grafts of fragment III (65%) than II (35%). Hairs reproduced in fragment III were thicker
and longer than those in fragment II. Thus follicular stem-like amplifying cells (SLAC) may reside
much in fragment III, less in II, and not in IV. The dermal sheath cells (DSC) also seem to take part
in a hair reproduction process because that frequency of hair formation increased when the intact
papillae were stu¡ed in the fragments in contact with DSC. In the second experiment, we detected
hairs with GFP in the grafts of both fragments II and III, suggesting that fragment IV-derived kerati-
nocytes could change their cell fate to follicular SLAC when they were associated with proper circum-
stance for SLAC. Incidence of hair formation and £uorescent intensity of the hairs were superior in
fragment III to II.
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Hair-Inducing Ability of Cultured Rat Dermal Papilla Cells
Koh-ei Toyoshima1, Hitoshi Kuwamoto2,Yoso Sueyoshi1, Mutsumi Inamatsu2, and Katsutoshi
Yoshizato2,3
1Bioart Laboratory, 2HiroshimaTissue Regeneration Project, Hiroshima Prefecture Collaboration of Regional Entities
forAdvancement ofTechnological Excellence, JST, 3Dept. of Biological Science, Graduate School of Science,
Hiroshima University
The dermal papilla (DP) is a messenchymal component of the hair follicle and can induce ectopic hair
follicles when it is implanted into the afollicular skin. Inamatsu et al. established serial cultivation of rat
DP cells by maintaining them with the conditioned medium of kerationocytes and FGF2 (J. Invest.
Dermatol., 111(5), 767^75, 1998). These cells sustained their hair follicle-inductive ability during the
culture for more than 70 passages. However we could not observe the growth of hair shaft by trans-
plantation of DP cells in rat sole skins. Combinations of cultured DP cells and epidermal cells freshly
prepared from newborns of rat were grafted onto the back of nude mice to test the hair-inducing
ability of cultured DP cells. The DP cells obtained from primary cultures induced the growth of dense
hairs at the grafted sites, but macroscopical hair growth out of the skin was not seen for DP cells at
passage number 21 and 51, although we con¢rmed microscopically the induction of hair follicles and
hair shafts in the intracutaneous regions for these passaged DP cells. Our results showed that cultured
DP cells progressively lost the hair growth-inducing potential during serial cultivation, but retained
hair follicle-inducing ability.
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Follicular Slow Cycling Stem Cells are Directed to Cell Death by Plucking, Fol-
lowed by Regeneration in the Reconstructed Bulge Region
M. Ito, and K. Kizawa
Basic Research Laboratory, Kanebo Ltd., Odawara, Japan
Hair follicle stem cells reside in the bulge region that marks the lowest end of the permanent portion
of the follicle. The bulge region is considered to be an excellent compartment for protection of folli-
cular stem cells. However, after plucking clubs for anagen induction, we previously found that most
cells in the bulge region experienced massive cell death1. To clarify whether follicular stem cells, de-
¢ned by their slow cycling nature, are directed to cell death by plucking, we determined the precise
location of slow cycling stem cells in plucked follicles.
Neonatal mice were injected subcutaneously with 5-bromo-2-deoxyuridine (BrdU) (50 mg/g body
weight) twice daily for 3 days from the third day after birth. Consistent with other reports, in 8 to 10-
week old mice slowly cycling stem cells that retain BrdU label were found to reside in the bulge area.
After plucking telogen follicle clubs, the sections were subjected to a TUNEL reaction as well as im-
munohistochemistry for BrdU.We found that most of the follicular epithelial cells labeled with BrdU
were positive for TUNEL staining at 4.5 hours after plucking, showing that follicular stem cells were
directed to cell death. Nevertheless, the disrupted bulge regions were restored by 48 hours after pluck-
ing, and hair follicle regeneration was accomplished without delay.
To know whether the repopulated bulge cells acquired a slow cycling nature, we attempted to
characterize the label retaining property of the reconstructed bulge region. Eight-week-old mice re-
ceived an intraperitoneal injection with BrdU during bulge reconstruction. Most of the epidermal
cells, including repopulated bulge cells, were labeled with BrdU within 3 days. By 22 days after
plucking, BrdU labels were exclusively retained in the bulge area of the telogen follicles. These results
indicated that slow cycling cells are repopulated and form the functional stem cell compartment.
We concluded that plucking is a useful means of inducing experimental cell death in follicular stem
cells. Furthermore, subsequent reconstruction of the bulge region involves the renewal of follicular
slow cycling stem cells.
1. M Ito, K Kizawa J Invest Dermatol 114:854, 2000 (abstr.)
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Micrografts of Human Scalp onto Nude Mice:Technical Improvement of a Human
Hair Growth Model in vivo
D.Van Neste, MB. de Brouwer,T. Leroy, G. Shaker
Skinterface sprl,Tournai, Belgium and HairTechnologys, Brussels, Belgium
Several sources of evidence support the use of human scalp grafts onto nude mice as a model for the
study of human hair growth ex vivo. Grafted hair follicles showed slowing down of the linear growth
rate to 2/3 of the initial value and reduction of the expected life span of the hair follicles (up to 8
months) even though some follicles may engage into a second cycle of hair production. Testosterone
conditioning of such mice bearing samples from a¡ected scalp sites (androgenetic alopecia) has been
proposed for assessing the e⁄cacy of compounds having anti-androgen activity. At this stage however,
information on the % of success of graft take (in terms of grafts and in terms of follicular units) is
lacking.
In this study we performed micrografts (1 to 3 follicular units - una¡ected androgen non sensitive
donor site), aiming to document an eventual increase of the success rate usually obtained with the
conventional punch grafts (10 to 15 follicles from a¡ected scalp sites). These ‘‘micro’’ samples were im-
planted in mice and then monitored for hair growth during 7 months. Quantitative data were ob-
tained from phototrichograms performed every month.
The analysis of the phototrichograms showed 58.33% productive micrografts compared to the
31.1% ratio obtained from punch grafts. The number of productive follicular units in micrografts
reaches 47.22 % of the initially active follicles while only 10.5% follicles remained active with the
punch graft method.
Our results suggest that the improved grafting method inspired from cosmetic scalp surgery pro-
tocols must be further investigated as a clinically relevant experimental model.
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The Human Hair Follicle Contains Two Distinct K19 Positive Compartments in the
Outer Root Sheath: A Unifying Hypothesis for Stem Cell Reservoir?
Stephane Commo, Olivier Gaillard and Bruno A. Bernard
Hair Biology Group, L’OreŁ al, Clichy, France
Up to now, the localisation of stem cells in human anagen hair follicle relied on three complementary
approaches, namely detection of slow cycling cells, detection of high colony forming cells and di¡er-
ential immunohistochemical staining. These techniques, however, gave con£icting results since stem
cells were localised either as long label retaining cells in the so-called bulge area, or as high colony
forming cells in the lower third of the follicle. In the present study we investigated the expression of
cytokeratin 19 a marker for putative stem cell-containing epithelial compartments, in order to charac-
terise stem cell distribution in human hair follicle throughout the hair cycle.We found that anagen
human hair follicle contained two distinct reservoirs for stem cells, located in the upper and lower
thirds of the follicle. These two reservoirs fuse during catagen-telogen transition phase and individua-
lise again in the newly forming anagen hair follicle.
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Treatment of Alopecia Areata with Mycophenolatmofetil
D. Sobczak, H. Rheinen
Dep. of Dermatology, University of Freiburg, Germany
After androgenetic alopecia, alopecia areata is the most common kind of hair loss. Characteristically
there arise some circular sites on the capillitium, mostly without any clinical signs of in£ammation,
cicatrization or atrophy. The hair loss can increase until total baldness of the scalp, eyelids and body.
Because of their psychosocial stigmatization, the medical attendance and therapy of patients who su¡er
from distinct forms of alopecia areata is di⁄cult to challange.
The aim of this study was to determine the e¡ect, e⁄ciency, tolerance, side e¡ects and toxicity of
Mycophenolatmofetil on patients who su¡er from alopecia areata. It was a monocentral, open, not
controlled and prospective study.
We treated 20 patients with distinct forms of alopecia areata (hair loss of more than 70% of the
capillitium, alopecia totalis or alopecia universalis) with Mycophenolatmofetil (Cell Cepts) over a
space of 6 months. The daily oral dosage of Mycophenolatmofetil was 2g, split in two rations, in
combination with 10 mg Prednisolon (Decortin Hs) per day. Before this study, the patients had un-
successfully been treated with local steroids and DCP. Patients with a acute gastrointestinal ulceration,
leucocyteso2500/ml, plateletso50000/ml, malignancies, infections, pregnant or nursing women could
not be included.
The results of the study were that 3 of the 20 patients (15%) dropped out because of side e¡ects, in
5 of the 20 (25%) patients there was no improvement of the alopecia, 5 patients (25%) got partial
improvement of hair growth and in 7 of the 20 patients (35%) the hair growth improved considerably
under this medical treatment.
We conclude that because of the proven good tolerance of Mycophenolatmofetil and the selective
e¡ects of the substance it could be a valuable alternative in treatment of distinct forms of alopecia
areata.
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Neurological Abnormalities in Alopecia Areata
M. Toyoda, M. Nakamura,T. Makino, and M. Morohashi
Dept. of Dermatology,Toyama Medical and Pharmaceutical University,Toyama, Japan
Much clinical evidence suggests that the nervous system can in£uence the course of alopecia areata
(AA). Although it is probable that components of the nervous system are involved at various stages
in the pathogenesis of AA, there has been little substantial evidence of speci¢c participation of neuro-
genic factors in that disease process. To examine neurological abnormalities in the lesional skin as well
as in the peripheral blood from patients with AA, we examined characteristic expression of neuropep-
tides and those degrading enzymes in the lesional skin, and plasma levels of neuropeptides and nerve
growth factor in AA. In addition, correlation of these neurological factors with the histopathology
such as mast cells and with the immunophysiology such as cytokine pro¢les in AA was statistically
evaluated. Imunohistochemical studies of the central hair loss areas of patients with AA revealed that
rich innervation by substance P (SP)-containing nerve ¢bers in a¡ected hair follicles, strong expres-
sion of neutral endopeptidase in hair follicles and lack of immunoreactivity for angiotensin-convert-
ing enzyme in perifollicular vascular endothelia. Further, intense expression of endothelial-leukocyte
adhesion molecule-1 (ELAM-1) on vessels and many degranulating mast cells were observed adjacent
to a¡ected hair follicles in AA. Plasma levels of both SP and nerve growth factor were signi¢cantly
higher in patients with multiple patchy type of AA than in controls as well as in another types of AA
including alopecia totalis or universalis. In multiple patchy type of AA, signi¢cant correlation was
observed between plasma levels of SP and serum levels of nerve growth factor, interleukin (IL)-1,
IL-4, IL-6, interferon-gamma and soluble ELAM-1, and between plasma levels of nerve growth fac-
tor and the number of mast cells, serum levels of SP, IL-4, IL-10, soluble ELAM-1 and soluble vascu-
lar cell adhesion molecule. These data represent the ¢rst reported evidence of multiple aspects of
neurological abnormalities in AA and suggest the involvement of neurogenic factors in the pathogen-
esis of AA, probably through an interaction with in£ammatory cells, proin£ammatory cytokines and
cell adhesion molecules.
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Use of Minoxidil Topical Solution in the Treatment of Alopecia Areata in Patients
Under 18 Years of Age
R.J. Trancik1, J.R. Spindler1, R.V. Cuddihy1, P. Doren2
1Pharmacia Consumer Healthcare, Peapack, NJ, USA and 2TKL Research Inc., Paramus, NJ
Although the use of minoxidil topical solution (MTS) in the treatment of alopecia areata (AA) in
patients under 18 years of age has been a common practice amongst physicians for several years, the
prevalence of use in this population has not been well established. The objective of this study was to
estimate the prevalence of use of MTS in treating AA patients under the age of 18 years.This survey of
clinicians was conducted with a written questionnaire and supported by face-to-face interviews with
respondents who claimed to have prescribed MTS for the treatment of AA in patients less than 18
years of age. Data from a total of 18 clinicians who treated 173 patients with AA between the ages of
1 and 17 years were collected and analyzed. Forty-eight percent were 1 to 10 years of age and 52% were
11 to 17 years of age at initiation of treatment. The mean duration of MTS treatment was 22.9 and 20.6
months, in males and females, respectively. The majority of patients (over 90%) were being treated
with other medications in combination with MTS. Some patients (20% of the males, 18% of the
females, and 19% overall) showed complete hair regrowth in the treated scalp areas. A few patients
showed no change in their hair loss (15% overall) or a worsening of their hair loss (4% overall).
Fifty-six percent of males and 58% of females are currently still undergoing treatment with MTS.
Thirteen percent of patients treated with MTS alone reported an adverse reaction (itching).Very few
patients (1% overall) were discontinued from treatment due to an adverse reaction. The results of this
survey show that there is a population of male and female patients under 18 years of age who are being
treated o¡-label with MTS. The results further suggest that MTS use in this population of patients has
been e¡ective, safe, and well-tolerated.
Key words: topical minoxidil, alopecia areata, adolescents
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A Clinical Study of Alopecia in Children (1995^2000)
YJ Kim,YS Chong, BI Ro
Dept. of Dermatology, College of Medicine, Chung Ang University, Seoul, Korea
To evaluate the clinical characteristics and psychosocial dynamics of children with alopecia, Ahn and
Ro had reported alopecia in children from January, 1991 to March, 1995 in the First Tricontinental
Meeting of Hair Research Societies in Brussels. This study was performed from April, 1995 to De-
cember, 2000. Among 854 new alopecia OPD patients 161 (19.0%) were children under 15 year old
with alopecia (A. areata: 118, A. totalis: 32, A. universalis: 10 and trichotillomania: 2).
Results were as follows: 1) The average age of alopecia in children was 7.8 years, and 55.9% were
primary school students. 2) The most common type of alopecia in children was alopecia areata
(73.3%). 3) The previous episodes of alopecia were observed in 12.4%, and family history was ob-
served in 6.8%. 4) Atopic dermatitis was the most common associated disease (23.0%). 5) The eldest
sibling or the children with stressful condition due to school task and extracuricular works had high
morbidity (45.3%, 29.1%, respectively). 6) On the neuropsychiatric consultation, psychiatrically pro-
blematic cases were observed in 51.7%, and neurotic children and adjustment disorders were the most
common problems among them.
These results suggest that alopecia in children was predominantly developed in primary school stu-
dents, the eldest sibling, children with atopic dermatitis or de¢cient parent^child relationship. Psycho-
logic stress is an important factor in the development of the disease or may contribute as an
aggravating factor.
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A Clinical Study of Alopecia Areata (1996^2000)
DS Chang,WJ Tak, BI Ro
Dept. of Dermatology, College of Medicine, Chung Ang University, Seoul, Korea
To evaluate the clinical manifestations and the e¡ects of treatment we performed clinical study of 532
patients with alopecia areata (including A. totalis: 28 cases, A. universalis: 41 cases) who had visited the
Dept. of Dermatology, College of Medicine, Chung Ang University during the 4 years from March,
1996 to February, 2000.
Results were as follows; 1) There was 290 male and 242 female patients being most prevalent in the
third decade (32.5%) and the average was 26.8 years and 96 cases (18.0%) showed alopecia areata in
children. 2) The most common site of predilection was the occipital region in both male and female,
which were 167 cases (57.6%), 89 cases (36.8%) respectively. 3) Previous episodes of alopecia areata were
observed in 153 cases (28.8%), and family history was observed in 48 cases (9.0%). 4) Associated dis-
eases with alopecia areata were seborrheic dermatitis (174 cases), atopic dermatitis (16 cases), hepatitis
(11 cases) urticaria (10 cases), diabetes mellitus (8 cases), etc in 301 cases (56.6%). 5) The e¡ect of treat-
ment modalities (DPCP, intralesional triamcinolone injection, and PUVA) revealed no di¡erence
based on increases in the size and number of bald areas.
Based on our ¢ndings, alopecia areata prominently developed in the third decade, and alopecia
areata in children, pervious history and severity of alopecia areata were increased. And therapeutic
modalities on alopecia areata revealed no di¡erence.
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Successful Treatment of Alopecia Totalis/Universalis by General PUVA Therapy
Combined with Systemic and Topical Corticosteroids
M Yamashita, RTsuboi, K Takamori1, H Ogawa
1Dept. of Dermatology, Juntendo University School of Medicine, Urayasu Hospital1,Tokyo, Japan
Alopecia totalis/universalis (AT/AU) patients 15 years old or older, who visited Juntendo University
Hospital from 1994 to 1998, were enrolled in this study. AT patients (108 cases) and AU patients (175
cases) were treated with one of four di¡erent regimens for more than six months, and the rate of
e⁄cacy, recurrence and adverse e¡ects of each modality were compared. Group 1 (N¼ 58) was treated
with topical immunotherapy using SADBE; group 2 (N¼ 85), with topical corticosteroids; group 3
(N¼104), with systemic and topical corticosteroids; group 4 (N¼ 36), with oral 8-methoxypsoralen
and general UVA irradiation combined with systemic and topical corticosteroids. The therapeutic ef-
fects were quantitatively compared by scoring the degree of hair regrowth. The results indicated the
following percentage ¢gures for moderate and marked improvement in each group: group 1, 41.4%
(15.5%); group 2, 37.6% (23.5%); group 3, 57.7% (43.3%); group 4, 72.2% (61.1%). Meanwhile, the
recurrence rate was 66.6% for group 1, 30.0% for group 2, 35.6% for group 3 and 13.6% for group 4.
The e⁄cacy rate of groups 3 and 4 was superior to that of groups 1 and 2. Group 1 showed a low rate
of marked improvement and a high recurrence rate, while group 4 showed a high rate of marked
improvement and a low recurrence rate. Adverse e¡ects caused by the application of topical and sys-
temic corticosteroids were frequently observed in groups 2 to 4, but were improved after tapering the
dose of corticosteroids. Among the four treatments tested, general PUVA therapy, combined with
systemic and topical corticosteroids, is the best treatment both in terms of e⁄cacy and recurrence rate,
and is recommended as an excellent treatment for adult alopecia totalis/ universalis.
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Interleukin-1 Variants in Alopecia Areata: Association Analysis of Disease Severity
and Therapeutic Response to Diphenylcyclopropenone
RTazi-Ahnini1,2, AJG McDonagh2, A Cox1, AG Messenger2, GW Du¡1, MJ Cork1,2
1Division of Genomic Medicine, 2Department of Dermatology, Royal Hallamshire Hospital, University of She⁄eld,
UK
Alopecia areata (AA) is a reversible hair loss disorder with a major genetic component. It is charac-
terised by focal in£ammatory lesions with perifollicular T-cell in¢ltrates, re£ecting the role of local
cytokine production in the pathogenesis. IL-1a and IL-1b are important inhibitors of hair growth in
vitro and their e¡ect is opposed by the interleukin-1 receptor antagonist. IL-1 cluster genes are there-
fore candidate genes in AA. To investigate the role of the IL-1 system in AA, we examined three
biallelic polymorphisms (IL1Aþ 4845, IL1Bþ 3954 & IL1B-511) in 165 patients and 1145 matched con-
trols.
In contrast with a previous report (1), we found no signi¢cant association of IL1B-511 or
IL1Bþ 3954 genotypes with disease in the overall dataset, or on strati¢cation by disease severity or
age at onset. Moreover, the power of the earlier study was low, around 41%, while our study has
approximately 90% power to detect such an e¡ect. However, there was an association of marginal
signi¢cance with IL1Aþ 4845 and AA in the overall dataset [odds ratio 1.39, (95% CI 1.00, 1.93)]. This
was due mainly to the contribution from mild cases of AA (patchy disease), suggesting that IL-1a
may have a particular role in the pathogenesis of this subgroup.
Diphenylcyclopropenone (DPCP) is used for topical immunotherapy in AA but it is an inconve-
nient treatment with a low success rate. A test with predictive value for e⁄cacy would be valuable
when considering DPCP therapy. The IL1Aþ 4845, IL1B-511 & IL1Bþ 3954 genotypes were analysed
in relation to therapeutic response in a subgroup of 60 patients treated with DPCP for at least 6
months. None of the IL1A or IL1B genotypes had predictive value for DPCP response. However, the
possibility of an association of IL1A or IL1B genotypes with DPCP response can only be con¢dently
excluded by studying a larger series of patients receiving this treatment.
1. Galbraith GM, et al. 1999. Hum Hered 1999;49:85^9.
117
Intravenous Repeated Pulse Methylprednisolone Therapy for Severe Alopecia
Areata: An Open Study of 32 Patients
P. Reygagne, Ph Assouly, C Jouanique, B Matard, H Bachelez, L Dubertret
Sabouraud center and dermatology service (Pr Dubertret), Hopital Saint Louis, Paris, France
Background: Alopecia areata (AA) is probably an autoimmune disease. Available therapies include
topical, intralesional, or systemic corticosteroids. Systemic pulse methylprednisolone therapy has been
reported to be well tolerated and e¡ective in patients with rapidly progressing AAwith ongoing hair
loss of less than 12 months duration.
Objective: In order to research an improvement of those results, we performed a prospective open
study to determine the e⁄cacy of monthly repeated intravenous pulse of methylprednisolone.
Methods: 500 mg of methylprednisolone were administered 3 successive days every month for 3
months. 3 optional series of pulses were proposed to the partial responders after 3 months. 32 patients
received 3 series of pulses between Dec. 1999 and Dec. 2000. All had an active or very active AAwith
a bald or a hair loss area exceeding 30% of the scalp for less than 1 year (3 months for most of them).
They were 8 men and 24 women. Average age was 30 years (9^60 years).
Results: No major side e¡ects were observed. At 3 months of follow up, 15 patients had a 80 to 100%
regrowth (47%), 5 a partial regrowth (15%), 7 a stabilisation (22%), and only 5 an aggravation (16%).
Results for 16 more patients and for 6 months of follow-up are pending. As during previous studies,
patients with plurifocal AA showed the best regrowth. Several factors will be discussed concerning
the response rate: age, type of AA, and delay from the onset to the treatment.
Conclusion: Monthly repeated series of intravenous pulses of methylprednisolone over 3 months
seem to be well tolerated and more e¡ective than a single series in patients with acute extensive AA.
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E⁄cacy of Narrow-Band UVB in the Treatment of Alopecia Areata
Chantal Bolducn, Lori Hobbsnn, Jerry Shapironn, David McLeannn, Harvey Luinn
nUniversity of Montreal, Montreal, Quebec, nnUniversity of British Columbia,Vancouver, British Columbia
Alopecia areata has been shown to be responsive to systemic PUVA therapy, presumably via its im-
munomodulatory e¡ects. NB-UVB has previously been demonstrated to be e¡ective for a number of
other PUVA-responsive disorders including psoriasis, parapsoriasis and vitiligo. The aim of this pilot
study was to determine the e⁄cacy of narrow-band UVB (NB-UVB) light therapy for extensive
alopecia areata.
This was a bilateral left-right controlled study where only half of the scalp was exposed to NB-
UVB while the other half of the scalp and the rest of the body were covered with protective garments.
This study involved patients with extensive alopecia areata (440%) who underwent thrice weekly
NB-UVB treatments over six months. The initial NB-UVB treatment dose was 70% of the MED
as determined by baseline phototesting. Successive treatment £uences were gradually increased by
10% as tolerated. Hair loss was graded semiquantitatively and photographs are taken at baseline and
again every 4 weeks throughout the study.
Seven patients have been enrolled in this pilot study. Two patients showed regrowth on the treated
side only. One patient showed regrowth on the treated side initially, but subsequently showed re-
growth on both treated and non-treated sides. The other four patients did not experience regrowh,
but these patients had long-standing alopecia. Treatment has been well-tolerated and no patient ex-
perienced any phototoxicity. Our results did not reach statistical signi¢cance, and this may be related
to the study sample size. Nevertheless based on our initial results to date as well as the tolerability of
the treatment, additional studies appear to be justi¢ed.
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Prognostic Factors In The Treatment Outcome Of Severe Alopecia AreataWith To-
pical Diphenylcyclopropenone
A. Sivayathorn, S. Suwanwalaikorn, S. Thongserm, B. Tangtong
Department of Dermatology, Siriraj Hospital, Mahidol University, Bangkok,Thailand
Topical immunotherapy with diphenylcyclopropenone (DPCP) is an e¡ective treatment for extensive
forms of alopecia areata (AA). However it requires prolonged period of treatment and causes potential
uncomfortable side e¡ects. Previous studies of prognostic factors for the outcome of this treatment
have been reported with variable results.
The purpose of this study is to identify prognostic factors, which facilitate selection of patients for
topical DPCP treatment.
Retrospective analysis of data of 41 patients (32 females, 9 males) with severe AA treated with to-
pical DPCP at our hair clinic was performed. There were 19 patients with severe multiple patchyAA
(MAA; 30^90% hair loss), 2 alopecia totalis (AT), 18 alopecia universalis (AU) and 2 di¡use type of
AA. Ten factors were evaluated as potential prognostic factors. These include type of AA at the initial
time of treatment, sex, age at onset, age at the initial treatment with DPCP, duration of the disease
before treatment, history of recurrence, loss of body hair and eyebrow, presence of nail changes, per-
sonal and family history of autoimmune diseases. Statistical analysis was performed by Chi-square
tests.
Twenty-four (58.53%) of forty-one patients exhibited a good response (490% hair growth). Fac-
tors that appeared to be signi¢cantly prognostic for treatment outcomes are: type of AA at the initial
time of treatment (MAA; response rate 19/19), AU and di¡use AA (response rate 4/16; pr0.001), loss of
body hair or eyebrow (response rate 8/20 vs 12/20 for those without; pr0.019) and age at onset
(28.8714.9 yrs. in response group vs 20.279.9 yrs. in non-response group; pr0.045).
MAA and older age of onset appeared to favor prognostic outcomes whereas AU and di¡use AA,
loss of body hair or eyebrow and younger age of onset appeared to associate with unfavorable prog-
nostic outcomes. Such prognostic factors are useful in screening and informing candidates for DPCP
immunotherapy.
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E⁄cacy of Imiquimod in the Treatment of Alopecia Areata
Chantal Bolducn, Harvey Luinn, David McLeannn, Jerry Shapironn
nUniversity of Montreal, Montreal, QueŁ bec,
nnUniversity of British Columbia,Vancouver, British Columbia
Alopecia areata (AA) is a relatively common, non-scarring type of hair loss. The pathophysiology of
alopecia areata is still unclear, but an autoimmune mechanism is the most widely accepted theory.
Based on current available data, AA appears to exhibit a TH1 cytokine pro¢le. IL-1 has been found
to be associated with alopecia areata, and is a potent inhibitor of hair growth in vitro. Furthermore IL-1
appears to induce histologic changes similar to those seen in alopecia areata. Imiquimod (Aldara) is a
topical immune response modi¢er that stimulates the secretion of di¡erent cytokines, most of which
are associated with a TH1 response. Although AA is potentially associated with IL-1 and a TH1 cyto-
kine pro¢le, imiquimod, which most likely enhances TH1 response, has been used anecdotally for
alopecia areata with some success. The aim of this pilot study was to assess the potential e⁄cacy of
imiquimod in the treatment of alopecia areata.
The study had a prospective, open-label, left-right half-head controlled design. Only half the scalp
was treated 3 times a week for 4 months, while the other side was left untreated. Hair loss was graded
semiquantitatively and photographs were taken at baseline and serially every 4 weeks throughout the
study. The treatment was very well tolerated. Six patients with extensive AA (40^99%) were included
in the study. One patient experienced bilateral regrowth. One patient worsened on both treated and
non treated sides. His condition was active when he entered the study and his course was most likely
unrelated to imiquimod. The other four patients did not grow hair and kept a similar score from
baseline to the end. In conclusion, this pilot study shows that imiquimod applied 3 times/week is
unlikely to have e⁄cacy in severe AA.
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A Case of Severe Dermographism to Diphenylcyclopropenone Therapy for Alope-
cia Universalis
N. Skrebova,Y. Nameda, H. Takiwaki, S. Arase
Dept. of Dermatology,The University ofTokushima School of Medicine,Tokushima, Japan
Most side e¡ects associated with topical sensitizers in the treatment of alopecia areata do not require
suspension or termination of therapy. Here we report a case of a 19-year-old Japanese man with an 11-
year history of alopecia universalis. 3 weeks after initial sensitization with diphenylcyclopropenone
(DPCP) 1% eth. on his left forearm, a trial was made on the scalp with a 0.003% DPCP solution,
open patch tests on the back having established a minimum erythema dose of 0.005%. After the 1st
application of 0.003% DPCP solution to the whole scalp, the patient developed acute contact derma-
titis at the test site, together with widespread severe dermographism and pressure-induced urticaria at
the site of stimulus. Topical immunotherapy with DPCP was discontinued. The scalp contact derma-
titis receded in 2 weeks after the usage of the topical corticosteroid. For 3, 5 months the severity of the
urticarial reaction and the e⁄cacy of treatment were assessed by means of the dermographism test and
the pressure test before and after treatment with oral H1 antihistamines. The course of these side e¡ects
in our patient suggests that a Type I-associated severe urticarial reaction persisting for a long period
can be provoked by topical immunotherapy. Therefore, precautions must currently be taken in the
therapeutic use of potent sensitizers such as DPCP.
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Stereological Analysis of Activated Eccrine Glands in Alopecia Areata Using the
Silastic Mold Technique
K. Lockhart, M. Ericson, N. Beheshti, and M. Hordinsky
Department of Dermatology, University of Minnesota Academic Health Center, Minneapolis, Minnesota, USA
Eccrine gland function has been hypothesized to be abnormal in patients with alopecia areata. In this
study, eccrine gland function was studied in six patients with extensive scalp alopecia areata (490%
hair loss) and six age- and sex-matched controls. Eccrine glands were stimulated by iontophoresis
using 1% pilocarpine at 2 mA direct current for 5 minutes on the scalp, above the left ear, and at a
site on the dorsum of the left hand. Sweat droplet impressions were collected in silicone (Silastic)
molds at 0, 15, and 30 minutes after stimulation and evaluated by stereology. Stereology is an accepted,
unbiased method for collecting information about number, length, surface area, and volume of speci-
mens. Though eccrine gland analysis by the Silastic mold technique is considered to be more sensitive
than evaporimetry, especially when combined with computerized image analysis, interpreting the Si-
lastic molds can vary because of mold thickness, pooling of droplets, or interference of other cuta-
neous appendages. Therefore, the techniques used in this study were evaluated for reproducibility.We
studied eccrine gland function in three control subjects on three di¡erent days with visits occurring 1
to 2 weeks apart. Reproducibility of the stereology technique was assessed by blinding the observer to
subject, status (patient or control), and time period.We found no di¡erence in eccrine gland function,
between patients and controls, on the hand (p¼ 0.221) or the scalp (p¼ 0.669). Stereology proved to
be highly reliable for analysis of the molds (R¼ 0.974, N¼18), but eccrine gland stimulation and
collection showed a 35.7% variability.While the pilocarpine stimulation/Silastic mold technique was
not reproducible on a week-to-week basis, stereology proved to be a consistent tool for unbiased ana-
lysis of the Silastic molds. Future studies should be directed towards testing of alopecia areata patients
and controls for several days to obtain an average estimate of eccrine gland function with the pilocar-
pine stimulation/Silastic mold technique and stereology.
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Histopathology of Alopecia Areata and Male Androgenetic Alopecia in Horizontal
Sections of Scalp Biopsies
HJ Lee1, JH Lee1, SJ Ha1, JC Kim2, HO Kim1, JW Kim1
1Dept. of Dermatology, College of Medicine,The Catholic University of Korea, Seoul1, and Dept. of Immunology,
Kyungpook Nationa 2University School of Medicine,Taegu, Korea
The advantages of horizontal, over vertical, sectioning of scalp biopsies allow morphometric analysis
of follicular structures. In this study, we performed the morphometric analysis of alopecia areata and
androgenetic alopecia using the horizontal sectioning method. Paird, 4-mm punch biopises were ta-
ken from the margin of alopecic patch from 21 alopecia areata patients or the frontal lesion of 13
androgenetic alopcia patients, and from clinically normal occipital scalp of all subjects. The histo-
pathological features were consistent with the known descriptions, but the data on follicular counts
showed striking di¡erences compared to that of Caucasians. In alopecia areata, numbers of vellus hairs
and follicular stelae was increased signi¢cantly (po0.05). Terminal telogen hairs were signi¢cantly in-
creased (po0.05) with decrease in terminal anagen hairs. In androgenetic alopecia, numbers of vellus
hairs and follicular stelae was increased signi¢cantly (po0.05) in the lesion compared with the normal
occipital scalp. Slight increase of terminal telogen hairs was observed without statistical signi¢cance.
Our results suggest that horizontal sectioning of scalp biopsies is a useful diagnostic method but dif-
ferences in follicular counts should be considered in interpreting the morphometric data in Koreans.
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E¡ects of Finasteride on Apoptosis and Regulation of the Human Hair Cycle
Marty E. Saway1, Ulrike Blume-Peytavi2, Diane L. Mullins3, Bernard P. Nusbaum4, DavidWhiting5,
DonaldW. Nicholson6, George Lotocki7, Robert W. Keane7
1ARATEC, Ocala, FL; 2FreieUniversitat, Berlin, Germany; 3Asheville, North Carolina; 4Miami, FL; 5Baylor
Hair Research Center, Dallas,TX; 6Merck-Frosst, Kirkland, Quebec, Canada; 7University of Miami, Department
of Physiology and Biophysics, Miami, FL, USA
A number of studies have provided evidence that apoptosis is a central element in the regulation of
hair follicle regression. In androgenetic alopecia (AGA) the exact location and control of key players in
the apoptotic pathways remains obscure. In the present study, we used a panel of antibodies and in-
vestigated the spatial and cellular pattern of expression of caspases and Inhibitors of Apoptosis (IAPs)
such as XIAP and FLIP, in men with normal scalp and in men with AGA before and after 6 months
treatment with 1mg oral ¢nasteride treatment. Constitutive expression of caspases-1, -3, -8 and -9 and
XIAP was detected predominately within the isthmic and infundibular hair follicle area, basilar layer
of the epidermis, and eccrine and sebaceous glands. AGA a¡ected tissues showed an increase in caspase
(-1, -3, -6, -9) immunoreactivity with a concomitant decrease in XIAP staining. After 6 months of
¢nasteride treatment both caspases and XIAP were similar to levels exhibited by normal subjects.
Immunoblot analysis was performed to determine antibody speci¢city and cellular expression of cas-
pases. Puri¢ed populations of keratinocytes, melanocytes, dermal papilla, dermal ¢broblasts derived
from human hair follicles were cultured in vitro and treated with 0.5 mm staurosporin. Time-course
experiments revealed that processing of caspase-3 is a principal event during apoptosis of these hair
cell types. These data suggest that alterations in levels of caspases and IAPs regulate hair follicle home-
ostasis. Moreover, ¢nasteride appears to in£uence caspase and XIAP expression in hair follicle cells
thus signaling anagen, active growth in the hair cycle.
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Perception of Men with Androgenetic Alopecia byWomen and Nonbalding Men
HJ Lee1, SJ Ha1, D Kim2, HO Kim1, JW Kim1
Dept. of Dermatology1and Biostatistics 2, College of Medicine,The Catholic University of Korea, Seoul, Korea
Male pattern hair loss has signi¢cant negative psychosocial e¡ects. It has been asserted that the negative
e¡ect of AGA is often trivialized by those not a¡ected by it, and most studies concerning the percep-
tion of balding have focused on the e¡ects on the patients. In this study, we assessed the perception of
balding men by others. A questionnaire on the perception of balding men was answered in 90 non-
balding and 30 balding men and 130 women. Balding men were perceived as being older and less
attractive in over 90% of the total subjects. However, a perception of being less con¢dent, duller,
and less potent was reported by less than half of the subjects. A perception of looking less attractive
was signi¢cantly more common in women than nonbalding men (po0.05). A perception of less con-
¢dence was signi¢cantly more common in balding men than nonbalding men (po0.05). The percep-
tion of men with AGA by others was similar to the psychosocial e¡ects reported by the patients
themselves. This suggests that AGA can signi¢cantly in£uence social interactions.
126
Investigation of the Systemic Bioavailability of 5% Minoxidil Topical Solution in
Young Males with EarlyAndrogenetic Alopecia
R.J. Trancik1, J.R. Spindler1, J.J. Ferry1, R.V. Cuddihy1, R.D. Gilbert2, M. Casser2
1Pharmacia Consumer Healthcare, Peapack, NJ, USA and 2TKL Research Inc., Paramus, NJ
There are no pharmacokinetic data on minoxidil topical solution (MTS) in adolescents with androge-
netic alopecia (AGA). The objective of this investigation was to establish the steady-state percutaneous
absorption and systemic bioavailability characteristics of 5% MTS in young male subjects (age 17 years
and younger) with earlyAGA.This study was designed as a single-arm, single-center, open-label clin-
ical investigation. Thirteen male subjects, age 17 or younger, with evidence of thinning hair at the
frontal or vertex area of the scalp, self-administered 5% MTS 1.0 mL twice daily for a total of 11 doses
to the balding area of the scalp. Serum and urine minoxidil levels were measured. AUC estimation
and Cmax calculations were performed. Thirteen subjects who met entry criteria completed the study
and were evaluable for analysis. Steady-state levels of minoxidil were achieved rapidly in these sub-
jects. Mean Cmax was 1.58 ng/mL and mean AUC (0-24) was 25.4 ng-hr/mL. Mean total minoxidil
excretion over the initial 12 hours after the application of the last dose was 537 mcg. There were no
reports of scalp irritation with the use of 5% MTS. Fourteen adverse events were reported including
abnormal liver function test ¢ndings. One subject had 2 adverse events (increased total bilirubin and
increased ALT) that the investigator attributed to the study medication; none were serious. No one
discontinued study participation because of an adverse event. Based on the results of this study, and
in comparison to previous studies in older male subjects, it appears that younger subjects (o18 years
of age) are not at risk for increased absorption of minoxidil when 5% MTS is applied BID for multi-
ple days.
Key words: topical minoxidil, adolescents, bioavailability
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Incidence of Androgenetic Alopecia in Males 15 to 17 Years of Age
R.J. Trancik1, J.R. Spindler1, S. Rose1, R.V. Cuddihy1, S.J. Hellebusch2
1Pharmacia Consumer Healthcare, Peapack, NJ, USA and 2Q2 Marketing Research, Inc., Cincinnati, OH
The incidence of androgenetic alopecia (AGA) among males 15 to 17 years of age has not been well
established. The objective of this study was to determine the incidence of AGA among a large sample
of 15- to 17-year-old males. Males who were 15 to 17 years of age (inclusive) were independently
screened, recruited, and then interviewed by 10 board certi¢ed dermatologists at their respective re-
search facility. Each participant ¢lled out a self-administered questionnaire and underwent a scalp ex-
amination by the dermatologist. A modi¢ed version of the Hamilton-Norwood Scale was used to
evaluate each subject. Five hundred and seventy-six adolescents agreed to participate; 496 (86%) actu-
ally responded and were enrolled. Dermatologists found that among those subjects who participated
in the survey, 16% exhibited signs of AGA. Additionally, dermatologists judged that 14% of the re-
spondents exhibited early signs of AGA. About one third of the respondents have a history of thin-
ning hair or baldness on their mother’s side of the family while over one half have a history of
thinning hair or baldness on their father’s side of the family.Very few respondents examined had evi-
dence of other underlying scalp conditions or disorders. This study provides a reasonable estimate of
the incidence of AGA in males 15 to 17 years of age. The true incidence of AGA among males in this
age range is estimated to be within the range of the two rates determined in this study: 16% (modi¢ed
Hamilton-Norwood Scale) to 14% (dermatologist-reported early signs of AGA).
Key words: topical minoxidil, androgenetic alopecia, adolescents
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Stabilization of Hair Loss with Use of Minoxidil Topical Solution
J. Rundegren1 and R.J. Trancik2
1Pharmacia Consumer Healthcare, Helsingborg, Sweden and 2Peapack, NJ, USA
A post-marketing surveillance study in over 11,000 minoxidil topical solution (MTS) 2% users with
androgenetic alopecia demonstrated that 4 out of 5 subjects experienced a slowing or stopping of hair
loss with MTS (Rogaine/Regaine). Although subjects’opinion of treatment results were considered to
be important, further corroboration of these results was conducted and other data have been generated
to support stabilization of hair loss. A recent analysis of hair count data in four multicenter studies
evaluating both MTS 2% and 5% (two studies in females and two in males) has substantiated that
hair loss can be stabilized with MTS use. The hair count stabilization data, based on a calculation of
increased or unchanged number of non-vellus hairs compared to baseline, showed that for males the
stabilization (percent of subjects) was 90% and 77% for MTS 2% users, and 96% and 75% for MTS
5% users. For females, the percentages were 87% and 88% for MTS 2% users, and 85% and 89% for
MTS 5% users. In addition, using hair count data in subjects treated with MTS 2% and 3% for up to
5 years (Olsen et al [JAAD 1990;22:643^46]), it was estimated that hair loss stabilized in 4 out of 5
(80%) subjects. An evaluation of global photography, carried out by two blinded dermatology experts
for a registration trial of MTS 5% in men, further supports stabilization of hair loss. One expert eval-
uated hair loss stabilization to be 94% in both MTS 2% and 5% MTS groups. The second expert
reported stabilization in 85% of the subjects using MTS 2%, and 83% using MTS 5%. In conclusion,
multiple studies support the ability of MTS to stabilize hair loss in 4 out of 5 users.
Key words: topical minoxidil, androgenetic alopecia, hair loss stabilization
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Clinician Survey Evaluating Minoxidil Topical Solution in the Treatment of Andro-
genetic Alopecia in Patients Under 18 Years of Age
R.J. Trancik1, J.R. Spindler1, R.V. Cuddihy1, P. Doren2
1Pharmacia Consumer Healthcare, Peapack, NJ, USA and 2TKL Research Inc., Paramus, NJ
The use of minoxidil topical solution (MTS) for the treatment of androgenetic alopecia (AGA) in
patients less than 18 years of age has not been previously characterized. The objective of this study
was to estimate the prevalence of use of MTS among patients under 18 years of age for the treatment
of AGA.This survey of clinicians was conducted with a written questionnaire and supported by face-
to-face interviews with respondents who claimed to have prescribed MTS for the treatment of AGA
in patients less than 18 years of age. Data were collected from 84 clinicians who had treated a total of
448 patients between the ages of 10 and 18 years. The majority of the patients were male (76%); 24%
were female. The mean ages of the patients at initiation of MTS treatment for their hair loss were 15.8
and 15.2 years, in males and females, respectively. In the males, 38% had frontal hair loss, 21% had
vertex hair loss, and 40% had both frontal and vertex involvement. The mean duration of MTS treat-
ment was 17.4 and 19.2 months, in males and females, respectively. Sixty-seven percent of males and
63% of females are currently still undergoing treatment for AGAwith MTS. For patients whom the
response to treatment was known, 55% of males and 51% of females showed an improvement in scalp
coverage or reduced hair loss; 40% of males and 44% of females showed no change. Overall, only 5%
of the patients had worsening of their hair loss.Very few patients (6% overall) reported adverse reac-
tions that were related to MTS treatment (mostly itching or mild irritation). This study shows that
there is a population of patients (ie, less than 18 years of age) who are being treated o¡-label with
MTS. Furthermore, the results suggest that MTS use in patients less than 18 years of age has been
e¡ective, safe, and well-tolerated.
Key words: topical minoxidil, androgenetic alopecia, adolescents
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Irreversibility of Hair Follicle Changes After 30 Months of Androgenetic Alopecia
Konstantinova N, Korotkii NG, Sharova N, Barhunova E, Gaevski D
Nioxin Research Inc, Atlanta, USA; Moscow Medical University
We studied horizontal and vertical biopsy from 15 caucasian 24^41 year old males diagnosed with
bitemporal recession Androgenetic Alopecia (AA) for 1.5^18 years (average 7.4 years). All 15 biopsies
were stained with H&E,Van Gieson and with other collagen speci¢c stainings.
1. Eleven pts with AA longer than 3 years had perifollicular ¢brosis - collagen ¢bers were compact
and formed a small scar-like formation around each anagen hair follicle (HF). Two patients - 33 year
old with 18 month AA and 23 year old with 20 month AA did not have these hair follicle changes.
Two 26-year-old patients with 30 and 36 month AA respectively were found to have some not so
severe collagen ¢ber changes. 2. Infundibulum of HF dilatated 124-192 mm and most of them covered
with keratinazed plug lacking normal hair shaft growth. 3. Decreased number of hair follicles 1.75^
2.45 per sq. mm from 3.5^5 per sq. mm in control group. 4. None of anagen HF was situated in
subcutaneous fat.
We showed a correlation between length of the AA and severity/thickness of perifollicular ¢brosis.
The result of this study is that any treatment of AA is recommendedto start earlier than 30 months
from ¢rst signs of AA. This should prevent irreversible collagen changes associated with ‘‘¢brotic in-
capsulation’’ of most anagen HF in involved areas, which usually leads to loss of normal blood supply,
innervation, and subsequent miniaturization and prevention of hair from normal cycling.
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E¡ect on Hair Growth of HEM-13/HDC Hair Tonic (Herbal Extract Mixtures) in
Androgenetic Alopecia as Measured by Phototrichogram
BJ Shin, SWAhn,WJ Tak, BI Ro
Dept. of Dermatology, College of Medicine, Chung Ang University, Seoul, Korea
We studied to investigate the clinical improvement of herbal extract mixtures in the patients with
androgenetic alopecia. Total 76 patients (treatment group: 62, placebo group: 14, male: 63, female: 13)
with androgenetic alopecia received topical application of HEM- 13/HDC hair tonic or placebo for 6
months and then all of them received topical application of HEM-13/HDC hair tonic for 3 months.
The e⁄cacy was evaluated by hair counts, patient self-assessment, global photographic assessment
and phototrichogram of the bald area in a circle of 1cm in diameter. Hair count and image analysis
was performed before treatment, at 3, 6, 9 month after treatment respectively to compare the hair shaft
diameter and hair density.
At baseline, mean total hair counts in the tested area were 63.4 in the treatment group and 64.7 in
the placebo group. At month 6, patients in the placebo had a decrease (mean7SE) in hair counts of
1.370.4 hairs. At month 9, patients in the treatment had an improvement (mean7SE) in hair counts
of 3.570.7 hairs respectively (po0.05), and had a signi¢cant increase in hair diameter (po0.05).
These data support that HEM-13/HDC hair tonic results in favorable e¡ects on hair growth of
patients with androgentic alopecia.
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A Clinical Study of Androgenetic Alopecia (1999^2000)
YS Chong,YJ Kim, BI Ro
Dept. of Dermatology, College of Medicine, Chung Ang University, Seoul, Korea
The purpose of this study is to evaluate the family history, clinical and endocrine status of patients
with androgenetic alopecia. 736 patients with androgenetic alopecia who had visited Dept. of Derma-
tology, Chung Ang University during the 2 years from January, 1999 to December, 2000 were exam-
ined.
Results were as follows: 1) Male patients (571) are more common than female patients (165). They
are mostly in the twenties (male patients: 325; 56.9%, female patients: 45; 27.3%). 2) In the 571 male
patients, Hamiton-Norwood type IIIv is predominant (99 patients: 17.3%). In the 165 female patients
Ludwig type I is predominant (103 patients: 62.4%). 3) 340 patients (59.5%) among 571 male patients
and 51 patients (30.9%) among 165 female patients have family history. 4) The most common accom-
panying disorder is seborrheic dermatitis (male patients: 349; 62.2%, female patients: 94; 57.0%). 5)
Serum testosterone levels are increased in 78 male patients (13.7%) and 23 female patients (13.9%).
These results suggest that those who want to treat androgenetic alopecia at earlier ages are gradually
increasing. And it seems to believe that the age, genetic factors, localized e¡ects of androgens on the
scalp and the density and/or functional activity of androgen receptors may in£uence the pathogenesis
of androgenetic alopecia.
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The Change of Hair Density and Hair Diameter with Aging and Androgenetic
Alopecia in Japanese Male
A. Ishino,T. Takahashi, J. Suzuki and M. Tajima
Shiseido Basic Research Center,Yokohama, Japan
Androgenetic alopecia (AGA) is the most common type of baldness with vellus hairs and completely
atrophic follicles. The duration of hair cycle of vellus hair is less than that of terminal hair.The balding
process is usually gradual the miniaturization of hair follicle (vellus hair) and successive hair shading.
Giacometti reported that the density of hair decrease with age. The contributions of population of
miniaturized or lost hairs on the AGA progressing are still unclear. We investigate the hair density
and diameter in Japanese male with or without AGA to discuss the relationships between these data
and over all hair appearance.
The subjects between 15 and 61 years old with (n¼ 258) or without (n¼123) AGA were studied.
The subjects with AGA classi¢ed in classes III-vertex, IV,V orVI on the Norwood ^ Hamilton classi-
¢cation. The inspected alopecia scores were evaluated by comparing with the prevalidated reference
scale from 1 (slightly bald) to 10 (bald). The vertical hairs in areas of 55 mm were cut with scissors
to record the images. The number of cutting hairs counted and the density of hair were calculated on
the images. The hair diameter were calculated as the pixel numbers on magni¢ed images.
The hair density distributed from 136 to 312 cm2 and slightly decreased with age after 40 years in
non-bald subjects. The average of density on bald subjects is not signi¢cantly di¡erent from that on
non-bald subjects. The distribution of hair diameter indicated that the remarkable peak were observed
at 90 mm in 10’s^40’s of non-bald subjects. In non-bald 50’s, the peak were slightly shifted to thinner.
In AGA, the peak at 80^90 mm were disappeared, but the ratio of vellus hair increased with the alo-
pecia scores. It is concluded that the appearance of hair loss on the AGA progressing at least until the
class VI on Norwood classi¢cation results from the miniaturization of hair follicle, but not from the
hair shading.We therefore believe that the prolongation of anagen duration is important to improve
AGA.
134
The Hair-Growing Activity of Procyanidin Oligomers
T Takahashi1, A Kamimura1, S Honda2, M Kagoura3, M Ohtsuyama3, M Morohashi3
1Tsukuba Research Laboratories, Kyowa Hakko Kogyo Co.,Tsukuba, Ibaraki, JP; 2Biochemicals Division, Kyowa
Hakko Kogyo Co., Chiyoda,Tokyo, JP; 3Department of Dermatology,Toyama Medical and Pharmaceutical
University, Sugitani,Toyama, JP
Procyanidins are a family of condensed tannins we have identi¢ed in apples, which act as a hair-grow-
ing factor in the murine model both in vitro and in vivo.We have previously reported that the growth-
promoting e¡ect on murine hair epithelial cells attributable to procyanidin B-2, one species of pro-
cyanidin oligomer, reaches about 300% relative to controls; and have also shown that procyanidin B-2
possesses intensive anagen-inducing activity in the C3H in vivo mouse model. This presentation de-
scribes our investigations during a 12-month clinical trial of highly puri¢ed procyanidin oligomers
isolated from unripe apples, chie£y comprising procyanidin B-2, procyanidin B-1, and procyanidin
C-1. The clinical trial was performed in a total of 21 subjects showing male pattern baldness on the
head. The test agent (about 1.8 ml per dose) was applied to the subjects’a¡ected scalp area twice a day,
giving a daily dose of 16 mg of procyanidin oligomers. During the 12 months of twice-daily applica-
tion of the agent, the hair-growing e¡ects were evaluated according to the following parameters: the
macrophotographically recorded change in the number of hairs in the designated scalp area, the
changes in the diameter of hairs clipped from the designated scalp area, and the changes in the photo-
graphically recorded global view of the subjects’ heads. No side e¡ects were observed in any subjects.
After 12 months of use, 71% of the subjects showed an increased number of hairs in the designated
scalp area relative to pre-trial measurements. The numbers of total hairs in the designated scalp area
after the 12-month trial were signi¢cantly greater than the measured values at the start of the trial
(paired t-test, po0.005).We also observed a clear trend towards increased number of nonvellus hairs
(440 mm) in the designated scalp area after the 12-month trial compared to the values measured at the
start of the test. A number of the subjects showed cosmetically satisfactory changes. Procyanidin ther-
apy shows promise as a potential cure for male pattern baldness.
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Treatment of Androgenetic Alopecia with Combination Therapy of Oral Finaster-
ide,Topical Minoxidil, and Tretinoin
Gwang Seong Choi, Sung Joo Lee
Department of Dermatology, Inha University, Inchon, Korea
Finasteride is an e¡ective oral medication in the treatment of androgenetic alopecia (AGA). Minoxidil
has a direct e¡ect on hair growth by stimulating dermal papillae or follicular hair matrix cells. Simul-
taneous administration of topical minoxidil with tretinoin may enhance the response of AGA to min-
oxidil.
We treated 41 AGA patients from 23 to 43 years of age (grade III and VI, according to the Nor-
wood-Hamilton classi¢cation scale) with combination therapy. The results were evaluated by patient
self assessment and investigator assessment by comparision of clinical photography. Every 3 months,
clinical evaluation and adverse events were assessed. At month 12, of the 41 patient enrolled, e¡ective
results, including excellent results and good results, were observed in 27 (65.9%) patients. Progressed
hair loss compared to baseline were 2 (4.9%) patients. Adverse e¡ects including sexual dysfunctions
and skin irritation were observed in 2 (4.9%) and 6 (14.6%) patients, respectively. The results between
self assessment and investigator assessment showed similarity.
The combination therapy of oral ¢nasteride 1 mg/day, topical 3% minoxidil, and 0.025% tretinoin
improved AGA more e⁄ciently comparing to monotherapy.We recommended combination therapy
in those patients with AGAwho desire medical therapy.
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Androgenetic Alopecia and its Relationship with Testicular Cancer
MP Birch, JCR Bowlingn, AG Messenger
nDepartments of Dermatology, Royal Hallamshire Hospital, She⁄eld &The Middlesex Hospital, London, UK
During recruitment for a clinical trial of a treatment for androgenetic alopecia in young men two out
of 30 men wishing to enrol in the trial gave a history of testicular cancer.We therefore carried out an
observational study to examine the association between male androgenetic alopecia and testicular can-
cer in more detail.
We examined 144 patients with a diagnosis of testicular cancer attending an oncology clinic. They
were classi¢ed by: histological diagnosis (68 teratoma, 73 seminoma, 2 mixed seminoma/teratoma and
1 leydig cell), age, treatment received, and hair status (Norwood-Hamilton Scale). Hair status was as-
sessed by two observers and compared with a database of 558 healthy males drawn from the local
population and in whom hair status had been evaluated by the same observers. Hair loss was classi¢ed
as nil (Norwood Hamilton grades I and II), mild (grades IIv, III, IIIa, IIIv), moderate (grades IV andV)
and severe (grades VI and VII).
There was a signi¢cant increase in mild hair loss in men with seminoma (52%) compared with
controls (25%) whether adjusted (po0.01, con¢dence interval 1.97^7.44; Mantel-Haenszel test) or un-
adjusted (po0.01, CI 1.57^5.74) for age. There was a signi¢cant increase in mild hair loss in men with
teratoma (38%) compared with controls (25%) when adjusted (po0.01, CI 1.23^4.88) for age, how-
ever this was not signi¢cant when unadjusted for age (p¼ 0.25, CI 0.76^2.52).
The causes of testicular cancer are unknown but genetic factors, cryptorchidism, exposure to ma-
ternal hormones in utero and exposure to other environmental hormones have all been implicated.
Our results indicate that balding tends to occur earlier in men predisposed to seminoma suggesting
that similar genetic or environmental factors underlie both conditions.
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Early Detection of Decreased Hair Numbers and Hair Miniaturisation in Androge-
netic Alopecia in Man
T. Leroy and D.Van Neste
Skinterface sprl,Tournai, Belgium and HairTechnologys, Brussels, Belgium
In male androgenetic alopecia (AGA), global changes of scalp hair observed on many years are the
result of discrete structural and/or functional modi¢cations at the level of individual hair follicles.
The aim of this study was to evaluate correlation between hair density, % of thin hair and clinical
staging.
5 controls (C) and 21 untreated male subjects with AGA (16^51years) were examined and classi¢ed
according to a modi¢ed Norwood-Hamilton scale (9 stage I^II; 9 stage III and 3 stageV). Scalp photo-
graphs (primary enlargement  3) were taken in all subjects on 3 anatomical sites (¢xed coordinates
on the left and right side of the top of the head and one occipital). Hair counts were obtained from
two di¡erent photographic procedures i.e., before and after contrast enhancement (CE). Percentages of
thin hair (o40 mm) were obtained after microscopic measures on clipped hair.
We observed more scalp hairs after contrast enhancement (po0.0001). Signi¢cant di¡erences of
extra hair (n/cm2) were detected speci¢cally between groups (p¼ 0.0002) on top of head (Cþ 29;
AGAþ 60) as opposed to the occipital site (Cþ 29; AGA þ 33). On the top of the head, we observed
a decrease of hair density with both photographic methods (controls4I^II¼ III4V; po0.05) and an
increase of thin hair (I^II¼ IIIoV; po0.0001) in correlation with the Hamilton severity score while
no changes were recorded in the occipital site.
The extra 60 hairs observed after CE in AGA (top of head) re£ects probably a mixed population of
thin and less coloured hair already engaged in the ‘‘miniaturisation process’’ usually undetected without
CE. The density changes occur at an early stage of AGAwhile the top of the head is not yet clinically
a¡ected (severity grades I^III). The more drastic decreases of density in the more severely a¡ected pa-
tients (V) are consistent with hair thinning and the clinical observation of an expanding wave of
follicular hypotrophy.
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Androgenetic Alopecia in Adolescence
Wilma Bergfeld, Fabiane Mulinari^Brenner
Department of Dermatology,The Cleveland Clinic Foundation, Cleveland, Ohio, USA
Androgenetic alopecia (AGA) is an autosomal dominant condition with variable penetrance that af-
fects about 50% of men and women. AGA is androgen mediated with puberty onset (early teens or
twenties) in both sexes and frequently being fully expressed by the forties. Early identi¢cation of this
condition leads to better treatment results.
A review of patients under 18 years old with clinical diagnosis of AGAwas performed. These pa-
tients were seen from 1997 to 2000 on the Department of Dermatology ^ The Cleveland Clinic Foun-
dation. Clinical presentation, family history of AGA, laboratory tests and scalp biopsies were
reviewed. Twenty-one patients (4 female and 17 male) were in the young cohort. Age range was 13^
17 years (mean 15.4 years). Frontal, vertex or both areas were a¡ected. Family history of AGA was
present in 18 patients. Androgen excess signs such as acne (7 patients), hirsutism (4 patients) and sebor-
rheic dermatitis (7 patients) were also associated with alopecia. Hormone levels suggested androgen
excess only in 6 patients (2 female and 4 male) of 16 tested. Scalp biopsies were performed in 3 patients
and con¢rmed the presence of hair follicle miniaturization.
AGA may start early in adolescence, especially when the patient has family history of AGA. It can
be associated with other signs of androgen excess, however laboratory tests are not always helpful.
AGA should be remembered as a cause of hair loss in adolescence.
148 ABSTRACTS JID SYMPOSIUM PROCEEDINGS
139
Quantifying Progression or Reversal of Follicular Miniaturization in Androgenetic
Alopecia by Image Analysis
David A.Whiting and Douglas Can¢eld
Baylor Hair Research andTreatment Center
Follicular counts in horizontal sections of serial scalp biopsies are tedious but do measure the progres-
sion of hair loss or regrowth in androgenetic alopecia. Digital imaging should provide precise, repro-
ducible information more easily. A method of image analysis was developed to count and size hairs. A
Nikon D1 digital camera attached to an Olympus BX 40 microscope was linked to a Dell Dimension
XPS T500 desktop computer. Data from the imaging program was handled by automated computer
analysis.
In the US Phase III ¢nasteride study, 26 men aged 18^41 years with androgenetic alopecia had 4
mm punch biopsies of vertex alopecia at baseline and 12 months, and 12 were re-biopsied at 60
months. All 64 biopsies were evaluated by a dermatopathologist, blinded to time and treatment, ¢rst
with direct microscopic follicular counts; later the entire 4 mm cross-section of each biopsy was re-
photographed digitally, using a 2 magni¢cation objective. All terminal and vellus hairs visible in
the papillary dermis were marked by the investigator. A technician then mapped each cross-sectional
hair shaft area for automated image analysis. Total hairs in each section were counted, and hair widths
subdivided into vellus-like hairs and small, intermediate and large terminal hairs.
Both image analysis and traditional follicular counts showed a signi¢cant increase in terminal hairs
with ¢nasteride but not placebo at 12 months. At 60 months, on image analysis, mean hair width
increased by 11.11% in 11 ¢nasteride patients and decreased by 18.08% in the 1 placebo patient. Image
analysis of hair widths in all patients at baseline showed 50.5% vellus-like hairs, 35.7% small terminal
hairs, but only 11.8% medium and 2.0% large terminal hairs, suggesting that miniaturization is abrupt
rather than gradual.
In summary, this method of histologic image analysis is reliable, reproducible, capable of providing
precise hair width data, and simpler and quicker than regular follicular counts.
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HistologyAnd Hormonal Activity In Senescent Thinning In Males
Price V.H.,
Dept. of Dermatology, University of California, San Francisco; Sawaya M.E., ARATEC Clinics & University of
Miami, Miami, Florida; Headington J.T., Dept. of Dermatology & Pathology, Ann Arbor, MI; Kibarian M.K.,
Dept. of Dermatology, GeorgeWashington University,Washington, D.C.
Senescent thinning of the scalp hair, or thinning that occurs after age 60, is poorly understood, and it
is unclear whether this is a distinct entity or part of the continuum of androgenetic alopecia (AGA). In
a previous study, young males age 18 to 30 with AGA had higher levels of 5a-reductase type 1 and 2,
more androgen receptors, and lower levels of cytochrome P-450 aromatase in hair follicles in the
frontal region of the scalp than in the occipital region. This study in males age 60 years and older
was designed to determine whether the histology and hormonal ¢ndings in older males with hair
thinning are similar to AGA in young males.
Males who experienced the ¢rst onset of scalp hair thinning after age 60 were compared to age-
matched males (controls) without a history of hair thinning. Four scalp biopsies, two from the frontal
and two from the occipital scalp, were obtained for horizontal sectioning and biochemical assay.
Histologic ¢ndings were primarily follicular downsizing. Follicular drop out was not detected
using elastic tissue staining, and there was no signi¢cant di¡erence in number of follicles in frontal
compared to occipital scalp. Senescent thinning was indistinguishable from androgenetic alopecia in
older males. In£ammatory changes were not a signi¢cant feature.
Biochemical analysis for androgen receptors, 5a-reductase type 1 and 2, and aromatase, in scalp
biopsies from older males showed nearly a two fold decrease in levels compared to levels in young
males with AGA. In males over 60, androgen receptor and aromatase levels were low and comparable
in scalp with and without thinning in both frontal and occipital regions. The 5a-reductase type 1 and
2 levels were only slightly higher in males with thinning hair in both frontal and occipital regions,
but the di¡erences were not signi¢cant.
Histologic and hormonal ¢ndings suggest that senescent thinning is a di¡use process that is histo-
logically similar to AGA, but hormonally di¡erent and may not be entirely androgen dependent.We
hypothesize that senescent alopecia is distinct from AGA.
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A Case of Postmenopausal Frontal Fibrosing Alopecia
HJ Lee, SJ Ha, HO Kim, JW Kim
Department of Dermatology, College of Medicine,The Catholic University of Korea, Seoul, Korea
Postmenopausal frontal ¢brosing alopecia is a recently described, rare scarring alopecia. The disease is
characterized by progressive frontal recession in postmenopausal women with clinical features of a
¢brosing alpecia. The histologic ¢ndings are indistinguishable from those seen in lichen planopilaris.
Postmenopausal frontal ¢brosing alopecia has been reported mostly in white women and is especially
rare in Asian women.We describe a typical case of postmenopausal frontal ¢brosing alpecia in a Kor-
ean woman. A 60-year-old woman presented with progressive scarring alopecia of frontotemporal
hairlines. Histologic examination showed perifollicular ¢brosis and in£ammatory in¢ltrates around
the infundibular and isthmus portion. Postmenopausal frontal ¢brosing alopecia may be more com-
mon than it is reported, and careful examination is needed in elderly female patients with frontal
recession.
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Segmented Heterochromia In Scalp Hair
Kyeong HanYoon1, Daehwan Kim1, Sungbin Im1, Seong Hyang Shon2,Won Soo Lee3
1Department of Dermatology and 2Laboratory, Ajou University School of Medicine, Suwon, Korea, and the
3Department of Dermatology,Wonju University Medical College,Wonju, Korea
Segmented heterochromia of scalp hair is a pigmentary disorder of hair characterized by alternating
dark and light segments on each hair shaft. It is known to be associated with iron de¢ciency anemia,
but little is known about its pathogenesis.
An 11-year-old boy who had black scalp hairs presented scalp hairs showing alternating dark and
light segments on their shafts con¢ned to his vertex for about 1 year. He had had iron de¢ciency
anemia for 6 years. There was no remarkable family history of illness.
On examination black hairs and hairs with alternating segments were intermingled on the vertex.
There was no di¡erence of thickness, length, or straightness between the both groups of hairs.
His hemoglobin was 9.1 g/dl; hematocrit, 28.9%; mean corpuscular volume, 60.7 £; mean corpus-
cular hemoglobin, 19.2 pg; mean corpuscular hemoglobin concentration, 31.6 g/dl; serum ferritin, 2 g/
l; serum iron, 11 g/dl; and, total iron binding capacity, 561 g/dl. His liver function tests and urinalysis
were normal.
Under light microscope, dark segments of the hairs were densely packed with black pigmented
granules while black or brown pigmented granules were loosely arranged in light segments. Fonta-
na-Masson and GP-100 stain revealed no di¡erence in the number of melanocytes and melanin pig-
ments between normal and pathologic hair follicles in biopsy specimens of scalp. In transmission
electron microscopy, the amount of cortical melanosomes was getting decreased along the hair shaft
from the dark segment to the light segment. In dark segments, dense ellipsoidal melanosomes were
noted while loosely packed round melanosomes were found in the light segments.
There is little signi¢cant ¢ndings related with the pathogenesis of segmented heterochromia, we
suggest a possibility that eumelanosomes can be replaced by pheomelanosomes or there may be a
transient retardation of melanogenesis in human melanocytes under certain conditions.
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A New Case Of MultipleWarty Dyskeratomas Of The Scalp: E¡ectiveness Of Aci-
tretine
B. Matard, P. Reygagne
Sabouraud Center, Saint Louis Hospital, Paris, France
Multiple warty dyskeratoma(WD) is clinically and histologically a very characteristic disease which is
very rare and little known.We report here a new case where acitretine has been e¡ective.
Case report: A 60- year-old man without any personal nor familial medical history presented with
about thirty hyper keratotic cutaneous nodules, with central plugs for some of them, scattered on the
scalp, mostly on the right parietal area. These lesions were appeared when he was about 40 and were
asymptomatic. The rest of clinical examination was normal. Histologically, a characteristic aspect with
dyskeratosis and acantholysis was seen. 20 mg/24h of acitretine during one month had caused the dis-
appearance of about 90% of the lesions. This result was maintained for the four following month with
a dose of 10 mg/24h. Since then, the patient has not been seen.
Comments: DV is a rare epidermal benign tumor most often isolated, usually seen in middle aged
and elderly adult. Multiple forms are exceptional (1) (less than 10 cases in the medical literature). It
seem to a¡ect especially the hair follicle as it is suggested by the frequent localisation on the scalp in
the multiple and isolated form. Clinically, it is typically a nodular £esh colored lesion, itchy or asymp-
tomatic, composed of a raised margin and a crateriform center ¢lled with keratotic plug. Histologi-
cally there is characteristic focal acantholysis and dyskeratosis. Although the cause of WD is
unknown, a link with Darier disease could exist as it is suggested by the histological aspect and the
case report of a multiple WD associated with a Darier disease in a father and his daughter (2). The
treatment of isolated form is surgical excision. In the multiple form, Acitretine was e¡ective at a low
dose in our patient (10 mg/24h) and 40 mg/24h in a Vakilzadeh’s patient (2).
References:
1.T.W.GRIFFITHS et al: Multiple warty dyskeratomas of the scalp. Clinical and Experimental Der-
matology 1997; 22: 189^191
2.F.VAKILZADEH et al: Dyskeratomatosis verruciformis: an unusual manifestation of Darier dis-
ease. Eur J Dermatol 1995; 5: 358^60
144
Impaired Hair Growth And Structural Defects In Patients With Laron Syndrome
(Primary IGF-I De¢ciency)
R. Lurie1, D. Ben-Amitai1, Z. Laron2
Dermatology Unit Hair Clinic1, Endocr. Diabetes Res. Unit2, Schneider children’s Med. Ctr.,Tel Aviv University,
Israel.
Control of hair growth through IGF-I involves speci¢c binding proteins (BPs),Which control IGF-I
transport, e¥ux from the circulation and association with IGF-IR. The regulation of hair follicle
growth through IGF-I is due, to the interaction of circulating and locally produced IGF-I on the hair
follicles. Human hair growth in vitro showed that IGF-I maintain hair follicle in anagen (growing
stage) and enter catagen (regression stage) if IGF-I is absent. Transgenic mice overexpressing IGF-I in
the skin shown signi¢cantly increased vibrissa elongation. Laron syndrome (LS) primary growth hor-
mone (GH) resistance has no GH signal transmission, and thus, no generation of circulating IGF-I is a
unique model to study the e¡ect of IGF-I on human hair.
Patients with LS are born with sparse hair, which grows slowly, resulting in large temporal reces-
sion throughout childhood and adult age. In adults the hair texture varies, and the patients develop
alopecia of variable size, more pronounced in males. It is of note that despite decrease in the elastica of
the dermis, early thinning and wrinkling of the skin, signs of early aging, graying of the hair delayed
and reduce.We have investigated by light and scanning electron microscopy (SEM) the hair of 6 un-
treated adults LS patients (2M, 4F, aged 21^48 years), 5 IGF-I treated children with LS (4M, 1F, aged 8^
13 years).
The hair have been plucked by rubber-protected forceps from the frontolateral and Alopecia area of
the scalp. The hair showed dysplastic and broken hair shaft and SEM revealed longitudinal grooves,
torsion, and irregularities and impression of the hair shaft, as seen in pili torti, trichorrhexis nodosa
pseudomonilethrix. This is the ¢rst report of hair structural defects in man caused by IGF-I de¢ciency
and bears on the role of IGF-I hair growth and development.
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Hydroxychloroquine Sulfate’s Ine¡ectiveness in the Treatment of Lichen Plano-pi-
laris and Idiopathic Pseudopelade
C. Jouanique, P. Reygagne, P. Assouly, B. Matard, E. Marechal, H. Bachelez and L. Dubertret
Center Sabouraud, Saint-Louis Hospital, Paris, France.
Regardless of its etiology, the treatment of pseudopelade is di⁄cult. Previously we have tried using
acitretine or thalidomide, without success. Antimalarials are commonly used to treat lichen planus
and chronic discoid lupus erythematosus.
Nine patients with progressive pseudopelade were included. The average age was 54,9 years (range
35 to 73). There were 6 women and 3 men. In 4 cases diagnosis was lichen plano-pilaris, in 4 cases
idiopathic pseudopelade and in one case it remained uncertain between lupus and lichen. Hydroxy-
chloroquine sulfate was administered at 400 mg daily for six months. Patients were examinated every
two months, including each time: a clinical examination, a standardised global photography (using
Can¢eld’s method) and hair count around a previously small shaven area with a central tattoo (using
macrophotography).
The standard photographies and the hair count using macrophotographies were the two principal
criteria used in evaluating the treatment’s e⁄ciency. Using the standard photographies three cases were
considered as stabilised and six as worsened. None were improved. After six month’s treatment the
hair count using the macrophotographies showed an average hair loss of 21% (range 4,5% to
53,3%). Tolerance was good.
This was a small open study with only 9 patients. Based on subjective evaluation using standard
photographies only 3 patients were considered as stabilized, while others were noted as aggravated.
However, in these 3 apparently stabilized patients, the hair counts revealed respective hair losses of
15,4%, 4,5% and 4,8%. The ¢rst case was an idiopathic pseudopelade and the other two were
lichen plano-pilaris. Although there was no control group in this study, hydroxychloroquine sulfate
does not seem e⁄cient in controlling the progression of lichen plano-pilaris of the scalp.
Key words: lichen plano-pilaris; pseudopelade of Brocq; hydroxychloroquine sulfate
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Six Cases of Permanent Triangular Alopecia
SW. Park, JW. Kim, SW. Hwang, HY.Wang, HS. Sung
Dept. of Dermatology, In-Je University School of Medicine, Pusan, Korea
What we propose to term permanent triangular alopecia, ¢rst described by Sabouraud in 1905, is
usually called congenital triangular alopecia or (congenital) temporal triangular alopecia. This is a
kind of non-cicatricial alopecia that shows permanent alopecia without any change in the size of the
scalp, especially the fronto-temporal suture and temporal areas. The shape of the alopecia is not always
triangular, and sometimes it is Lancet-shaped or oval. This symptom is usually present at birth or just
after, but several cases at around 6 years old and one at 27 have been reported. It is characterized by the
fact that changes in shape or size does not occur over the lifetime of the patient. Since the lesion is
clinically similar to alopecia areata, the possibility of unnecessary treatment caused by misdiagnosis is
high. The only successful treatment is surgical excision or hair transplantation.
Six patients (F/4, F/21, M/8, M/26, M/28, M/48) have been observed for the last 3 years. In the
females it occurred bilaterally in the fronto-temporal suture area, and in males it occurred unilaterally
in the occipital area of the 8-year-old boy and fronto-temporal suture area of the 3 men. The 8-year-
old boy’s alopecia occurred when he was one year old and other 5 cases were observed at birth. His-
topathologic examination of 5 cases including the 8-year old boy revealed normal epidermis, vellus-
like hair follicles and indeterminate follicles instead of mature follicles in the dermis.
As the vast majority of lesions appear during the ¢rst 6 years of life and the lesions can also occur
in the occipital region or any other scalp region, the authors suggest that the term permanent trian-
gular alopecia is much more reasonable than that of congenital triangular alopecia or (congenital)
temporal triangular alopecia.
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Di¡use Non-Scarring Alopecia And Syringoma
Chull-Wan Ihm, Ki-Bong Ko
Chonbuk National University Hospital, Department of Dermatology, Chonju, South Korea
Cases showing both alopecia and syringoma or eccrine sweat duct proliferation have rarely been re-
ported but discussions seem to continue if the sweat duct proliferation is true syringoma or not and if
the sweat duct proliferation would be the etiology of the alopecia or the result of ¢brosis after in£am-
mation causing the alopecia.We report a case whose di¡use alopecia was thought to be due to syrin-
goma of the scalp. A 43-year old woman developed di¡use hair thinning on her temporal and frontal
scalp with papular eruptions on the face and the posterior auricular areas for the past 5 years. Both of
the papular eruptions and hair thinning developed together and gradually progressed. On the poster-
ior auricular areas the papular eruptions stopped about 2cm before the auricles and changed to smooth
£at skin. Biopsies from the temporal scalp, the smooth area adjoining the auricle, the papules on the
posterior auricular area and on the forehead all showed syringomatous in¢ltration.With above ¢nd-
ings we concluded that syringoma could develop without papular skin lesions and could cause non-
scarring di¡use hair thinning.
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Acquired Localized Heterochromia of Scalp Hair
Sewon Lee,Won-Soo Lee
Department of Dermatology,Yonsei UniversityWonju College of Medicine,Wonju, Korea
Heterochromia of hair is the presence of more than one distinct color of hair in the same person.
Rarely, a circumscribed patch of hair of di¡erent colors occurs in several clinical settings. The condi-
tion generally has a genetic basis, although the mode of inheritance is not known.
A 17-year-old Korean boy had had localized circumscribed patch of yellowish brown hair on the
frontal and vertex scalp for 4 months. His scalp hair was straight, abundant, and normal in growth.
But the proximal part of each a¡ected hair near scalp surface was black and the hair color gradually
changed peculiarly into yellowish brown color when it grows distally. Other parts of scalp hair and
body hair were normal and black. The patient had never had a permanent wave or treated his hair
with dyes or bleaching agents. The condition was not associated with past medical history or family
history, and there was no history of exposure to special drugs or other chemicals. Routine laboratory
tests and speci¢c tests for metabolic disorders were negative or within normal limits. Studies using a
transmission electron microscope revealed di¡erent shapes and numbers of melanosomes compared
with normal eumelanosomes seen in regular mongoloid black hair.
We report herein a boy with peculiar localized heterochromia of scalp hair of unknown etiology
without familial background.
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Alopecia Areata And Uveitis
J. J. Stene, Fl. Neczyporenko, M. Song
Department of Dermatology, CHU St. Pierre, ULB, Brussel, Belgium
We report the case of a 38-year-old-woman treated for 3 years by contact immunotherapy with di-
phencyprone (DCP) for severe alopecia areata (AA). In June 2000, alopecia was still evolutive in some
areas: the concentration of DCP was increased from 2.3% to 2.5%; 30 hours after the application, the
patient presented a papulovesicular eruption of the frontal region, headaches and a decrease of the
visual acuity. Ophtlamic examination showed a bilateral uveitis, iris atrophy and discret lesions of
the choroid. Investigations by PCR from aqueous humor were negative for HSV, HZV and CMV.
Biological investigations showed normal thyroid function but presence of auto-antibodies. Comple-
ment was in normal range; there were no circulating immune complexes and no antinuclear antibo-
dies.Viral serologies showed the absence of recent infection for HSV, HZV, CMV, EBVor hepatitis C.
30 mg of Prednisolone were given and uveitis progressively disappeared in 3 weeks.
There were few possibilities that uveitis could be a direct consequence of the treatment: contact
immunotherapy with DCP has been used for many years and such a side e¡ect has never been re-
ported. However, we could suggest that immunological process induced by DCP, revealed a genetic
predisposition for uveitis. E¡ectively, AA and uveitis can be associated in the rareVogt-Koyanagi-Har-
ada syndrome which can, beyond ocular and dermatological manifestations, associate meningo-ence-
phalitic and auditory involvement.
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Hair Counts from Scalp Biopsy Specimens in Asians
HJ Lee1, SJ Ha1, JH Lee1, JW Kim1, HO Kim1, DAWhiting2
1Dept. of Dermatology, College of Medicine,The Catholic University of Korea, Seoul, Korea and the 2Baylor Hair
Research andTreatment Center, Dallas,Texas, USA
Di¡erences in hair density have been described according to the ethnic background in white Cauca-
sians and African-Americans. Asians have fewer hairs than Caucasians. We performed this study to
assess the normal values of hair counts in Koreans. Horizontal sections of 4mm punch biopsy speci-
mens from clinically normal occipital scalps were examined at various levels from the papillary dermis
to the subcutis, and follicular counts of terminal/vellus hairs and anagen/telogen hairs were obtained.
A total of 35 subjects with clinically normal occipital scalps (13 androgenetic alopecia patients, 20 pat-
chy alopecia areata patients, and 2 healthy volunteers) were included. The numbers of total hairs,
terminal and vellus hairs, and terminal anagen hairs were signi¢cantly lower (Po0.05) in Koreans
compared with the published data of white Caucasians and African-Americans. Percent ratios of term-
inal anagen and telogen hairs were similar to Caucasians and African-Americans. Follicular density
was signi¢cantly lower (Po0.05) in Koreans than in Caucasians and African-Americans. In Koreans,
females had a signi¢cantly higher number of terminal hairs than males (Po0.05). Hair density is sig-
ni¢cantly lower in Koreans than in white Caucasians or African-Americans. Slight sexual di¡erence
exists in follicular counts in Koreans. Our data could be used as a guideline for determining normalcy
in interpreting horizontal sections of scalp biopsies from Asians.
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Computer Assisted Histomorphometric Evaluation of Scalp Biopsy
D. Shum, M. Martinka, O. Bernaldo, H. Lui, J. Shapiro
Division of Dermatology, the University of British Columbia, British Columbia, Canada.
A major challenge in the histopathologic examination of scalp biopsies is to adequately visualize and
evaluate as many of the hair follicles present in the tissue.While routine vertical sections are easier to
process and exhibit familiar histological landscape, oblique orientation of the follicular structures pre-
cludes any means of quanti¢cation even if multiple serial vertical sections are available. To improve on
the diagnostic yield of conventional vertical sections, the use of transverse sections of a scalp punch has
been suggested. An obvious disadvantage of transverse sectioning is that a very limited crosssection of
each follicle is shown in each microscopic section. Numerous sections are needed to demonstrate the
follicles in their entirety and to determine follicular growth activity.
In the management of patients with alopecia, accurate morphometric analysis of hair growth is
required. Recent advances in PC-based computing have enabled e⁄cient processing of large number
of images and this technology is well suited for the study of transverse sections of scalp biopsies. To
ensure complete coverage of all the follicular structures, scalp biopsies from 12 patients with non-in-
£ammatory, non-scarring alopecia have been serially sectioned in 0.05 to 0.1 mm interval, resulting in
30 to 70 sections in average for each case. Three dimensional reconstruction imaging softwares are
then used to evaluate and quantify the follicular structures, and the results are analysed. In addition,
a computer generated 3 dimensional model of each biopsy tissue core is generated, allowing easy vi-
sualisation of all hair structures.
Our data suggest that the anatomy of follicular structures and scalp hairs, including density and
diameter, is more variable than previously reported. Up to 60 hairs have been counted in a 4.0mm
punch and our 3D models demonstrate the occasional merging of follicular infundibulae and exis-
tence of dystrophic follicular units. Patients with nonscarring, non-in£ammatory alopecia may su¡er
from overlap of diseases, which can only be revealed by detailed histomorphometric studies.We be-
lieve computer assisted analysis of the scalp biopsy is the best means to further quantify variations of
human scalp hair and to diagnose, as well as manage patients with hair disorders.
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Quantitative Evaluations for Scalp Hair Growth by Using A Digital Camera and
Computer Image Analysis
T. Arai,T. Takahashi, and M. Tajima
Shiseido Basic Research Center,Yokohama, Japan
Quantitative evaluations for hair growth are necessary to assess the e¡ects of hair growth ingredients.
Several methods, for example, photo-trichogram, hair counting, and visual observation or computer
image analysis of the photographs of scalp, have been known. The photo-trichogram and the hair
counting do not exactly correspond to global hair image because of the measurements in partial area
on scalp. In the visual observation or computer image analysis of photographs, that are correspond to
global hair image, it is important to obtain the photographs on the identical conditions including
volunteer preparation, lighting, camera settings, ¢lm, development, and so on. For example, the dark
development causes to evaluate narrower area of thin hair than the accurate area. However, it is di⁄-
cult to obtain the photographs on the identical conditions in development of ¢lm in an analog cam-
era. To accomplish the identical conditions on photographs, we attempted to use a digital camera of
high resolution, 2.74-Mpixel in 23.715.6 mm-sizeCCD. The top views of volunteer head with a color
standard paper were photographed on the identical conditions in hair preparation, lighting, and cam-
era settings. The computer images transferred from the camera were recti¢ed color distortion on the
hue, the value and the chroma of color standard paper. The range of hue, value, and chroma in scalp
skin color without hair were de¢ned. The area with scalp skin color on head was calculated as pixel
numbers. By using this method of quantitative evaluations for scalp hair photograph, we evaluated the
e⁄cacy of hair growth by a lotion containing the extract of dried roots of Sophora Flavescens Aiton in
the double-blind clinical test.
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Phototrichogram Analysis of Japanese Female Subjects Complaining of Chronic
Di¡use Hair Loss
RUeki, RTsuboi,Y Inaba1, H Ogawa
Dept. of Dermatology, and Epidemiology and Environmental Health1, Juntendo University School of Medicine,
Tokyo, Japan
Idiopathic chronic di¡use alopecia in middle-aged women is roughly divided into female androge-
netic alopecia and chronic telogen e¥uvium. But the appropriate classi¢cation has not been clearly
established, and the characteristics of each alopecia subgroup, especially of the mild form, are not fully
understood. The hair growth pattern in chronic di¡use alopecia was divided into sub-groups by using
non-invasive quantitative methods after determining the key parameters of hair growth. One hundred
one Japanese female subjects complaining of di¡use hair loss over several years and ¢fty-eight healthy
Japanese female volunteers were studied. Phototrichogramwas performed at 0 and 48 h after the clip-
ping of the hairs of the parietal region. The diameter of the excised hairs was measured separately.
Multiple regression analysis indicated that hair density, hair diameter, short hair ratio and hair growth
rate, but not anagen hair ratio, were important, in the order given, for grading the severity of female
di¡use alopecia. From the result of cluster analysis, hair growth patterns of the subjects complaining
of di¡use hair loss were divided into six abnormal groups (N¼ 60), two borderline groups (N¼ 21)
and one normal group (N¼ 20). The normal control subjects, as judged by macroscopic observation,
included two borderline and one abnormal subject, with respect to hair growth patterns. The photo-
trichogram, combined with measurement of hair diameter, is an accurate tool for assessing hair
growth patterns in chronic di¡use alopecia, especially for detecting the slight changes in the early
phase. Among the various parameters mentioned, hair density is the most important parameter for
assessing clinical hair loss in female subjects.
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Guidelines And Techniques For The Accurate Classi¢cation Of Chemotherapy In-
duced Hair Follicle Dystrophy
Bori Handjiski, Sven Mˇller-R˛ver, Eva M. J. Peters, Gerd Lindner, Ralf Paus
Dept. of Dermatology, University Hospital Eppendorf, University of Hamburg, Germany
In order to recognise even subtle forms of hair follicle dystrophy after pharmacological manipulation,
it is critically important to be able to identify and accurately classify the distinct stages of the follicular
response to damage and the corresponding degree of hair follicle dystrophy.We, therefore, have devel-
oped a set of simple and pragmatic classi¢cation criteria for chemotherapy-induced hair follicle dys-
trophy, using the C57BL/6J mouse model of cyclophosphamide-induced alopecia (Am J Pathol
144:719^34, 1994).We suggest to divide murine hair follicle dystrophy into six distinct stages: healthy
anagen VI (HA), light dystrophic anagen VI (LDA), moderately dystrophic anagen VI (MDA), severe
dystrophic anagenVI (SDA), dystrophic catagen (DC), and dystrophic telogen (DT). The basic classi-
¢cation criteria include: the structure and pigmentation of the hair shaft (continuous shaft and normal
pigmentation during HA and LDA; broken shaft and disrupted pigmentation during SDA, DC and
DT), the location and volume of ectopic melanin granules, the location, volume and shape of the
dermal papilla (large and oval during HA and LDA; swollen during SDA; round and compacted dur-
ing DC and DT) as well as abnormal widening of the hair canal (DC, DT). In addition, the following
immunohistochemical markers aid in dystrophy classi¢cation: the number of TUNELþ keratino-
cytes in the bulb as a marker for the level of dystrophy-associated apoptosis (HA: no; LDA43;
MDA45, DC410), the immunoreactivity for neural cell-adhesion molecule (NCAM) and alkaline
phosphatase activity as a marker for the level of damage to the DP, as well as a broadly increased
immunoreactivity for ICE (caspase-1), Bax, Fas/Apo-1, p53, p55TNFR, p75NTR and a decrease of bcl-
2 immunoreactivity. These staging parameters not only o¡er a useful tool in murine models of che-
motherapy-induced alopecia, but also when screening drug-treated mice for even discrete forms of
hair follicle dystrophy in a highly standardised, reproducible, easily applicable, and quanti¢able man-
ner.
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Ultrastructural Characteristics of Trichilemmal Cysts
M. Nakamura, M. Toyoda, M. Kagoura, S. Higaki, and M. Morohashi
Dept. of Dermatology,Toyama Medical and Pharmaceutical University,Toyama, Japan
The name of trichilemmal cyst (TC), one of the skin tumors with di¡erentiation toward hair struc-
tures, was designated on the basis of its keratinization pattern, which is analogous to that in the outer
root sheath of the hair. Although the histological features of TC have been well documented, only
few ultrastructural studies of TC have previously been performed. We examined two cases of TC,
which occurred on the scalps of 2 Japanese women mainly at the electron microscopic level. Histolo-
gically, the tumors were intradermal cysts lined by a squamous epithelium composed of pale kerati-
nocytes that increase in height as they mature and that transform abruptly into a solid eosinophilic-
staining keratin without forming a granular layer. The ultrastructural characteristics of TC included an
abrupt transition from nucleate to anucleate cells, a few, oval and small-sized keratohyaline granules
mixing with increasing numbers of tono¢brils from the peripheral layer towards the center, the ag-
gregation of spherical vesicular particles, especially along the boundary zone between the keratinizing
cells and the keratinized cells, desmosomal structures in keratinized cells, and interdigitation of keratin
in the uppermost keratinizing cells. The keratinization pattern of TC was unique in that typical soft or
hard keratinization processes did not occur. Although the origin of spherical particles is unclear at
present, our observation suggested that the spherical particles may be derived from the plasma mem-
brane of the uppermost keratinizing cells and may contribute to the formation of lipid droplets, a
feature characteristic of keratin inTC.Trichilemmal keratinization is observed in the trichilemmal sacs
which surround the lower ends of catagen or telogen hairs as well as in the outer root sheaths in the
follicular isthmus of anagen hairs. Comparison of the ultrastructure of these two known types of
trichilemmal keratinization with the keratinization pattern of TC in our patients indicates that TC
may di¡erentiate into or originate from the proliferation of the outer root sheath in the follicular
isthmus of anagen hairs.
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Anagen E¥uvium In Chronic Renal Failure
S. Suwanwalaikorn1, A. Sivayathorn1, M. Chiba2, K.Vareesangthip3, J. Manonukul4, R. Tsuboi5, H.
Ogawa5
1Department of Dermatology, 3Medicine, and 4Pathology, Faculty of Medicine Siriraj Hospital, Mahidol University,
Bangkok,Thailand 5Department of Dermatology, 2Epidemiology & Environmental Health, Juntendo University
School of Medicine,Tokyo, Japan
Anagen e¥uvium is the sudden loss of dystrophic anagen hair within several days of a metabolic
insult. It is most commonly occurs after chemotherapy, radiation therapy or poisoning with thallium
salt or arsenic.
We report a group of 18 cases (5M, 13F) who presented with sudden onset of di¡use hair loss oc-
curring within a few days, involving as many as 80^90% of the scalp hairs. Eleven cases were pre-
viously diagnosed as having chronic renal failure. The rest were discovered to have chronic renal
failure during investigation for the cause of alopecia. There was no history of exposure to chemother-
apy or radiation. All patients were clinically well without any signs and symptoms of neurological,
gastrointestinal or dermatological abnormalities. Spontaneous hair re-growth without any treatment
occurred in all patients.
Positive laboratory investigations include elevation of serum BUN and creatinine, proteinurea and
mild anemia. Light microscopy of both pulled and plucked hairs revealed a tapered proximal end
characteristic of dystrophic anagen. Scalp biopsies revealed most follicles in the catagen stage with
no in£ammation. Hair’s quantitative analysis for electrolytes and trace elements by Proton Irradiating
X-ray Emission (PIXE) revealed signi¢cantly increased in potassium content (396.57228 mg/g vs
188787 mg/g) and decreased in iron content (22.6714.8 mg/g vs 42719 mg/g) compared to normal
controls. There were no thallium deposit in the hair and blood.
To our knowledge, this is the ¢rst report of anagen e¥uvium as being the consequence of chronic
renal failure. Although, the true mechanism involved in this entity remains obscure, it can be corre-
lated with intoxication on the basis of the current knowledge and this clinical presentation should
alert clinician as another manifestation of chronic renal failure.
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Examining the Etiology Telogen E¥uvium in Pre- and Postmenopausal Women:
A Chart Review Study
Janet L. Roberts
Oregon Health Sciences University, Portland, OR, USA
Telogen e¥uvium is caused by premature cycling of anagen hairs into the telogen phase, usually in
response to a physiologic insult. This chart review retrospective study was performed in a dermatol-
ogy practice specializing in hair disorders to establish the most common cause of telogen e¥uvium in
both premenopausal and postmenopausal women. One hundred and ¢fty three women who were
diagnosed with telogen e¥uvium from 1995^1998 were studied. All women diagnosed with female
pattern hair loss or other confounding factors were excluded as were those women who did not return
for follow up. Resolution of the telogen e¥uvium was required for inclusion in the analysis. Seventy
two percent (n¼ 75) of women in the premenopausal group were found to have iron de¢ciency as the
cause of telogen e¥uvium. Iron de¢ciency is de¢ned as having a ferritin level of under 40 ng/ml or
iron percent saturation under 20%. Forty nine percent (N¼ 24) of women in the postmenopausal
group were found to have drug-induced telogen e¥uvium while 29% (N¼14) had iron de¢ciency.
Iron de¢ciency is the most common cause of telogen e¥uvium in premenopausal women. Although
medications are the most common cause of telogen e¥uvium in postmenopausal women, iron de¢-
ciency should be ruled out.
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Trichotillomania: A Review of 28 Biopsies
Wilma Bergfeld, Colleen Embi, Fabiane Mulinari-Brenner, Karen McCarron
Departments of Dermatology and Pathology,The Cleveland Clinic Foundation, Cleveland, Ohio - USA
Trichotillomania (TM) is a chronic disorder in which patients traumatically remove their own hair in
a bizarre pattern. TM can mimic other diseases and it is frequently not clinically suspected as patients
typically do not disclose their actions.
We reviewed 28 scalp biopsies on 26 patients with clinical diagnosis of TM. The biopsies were
vertically sectioned and examined with H&E. Additional sections were used in all cases as well as
special stains which included PAS, elastic, colloidal iron, Giemsa, melanin, and iron. The clinical
charts were reviewed in all cases.
Twenty-six patients (24 female, 2 male) were in the cohort, 2 patients had 2 sets of biopsies. Age
range was 13^78 years (mean 42 years). The histologic ¢ndings included: follicular plugging (96%),
decreased total numbers of follicles (93%), reversed anagen: telogen ratio (86%), decreased numbers of
sebaceous glands (68%), increased vellus hairs (57%), melanoderma, the presence of pigment contain-
ing macrophages in the dermis (68%), ¢brous tracts (64%), trichomalacia (57%), pigmented casts
(36%), hair granulomas (18%), and dermal in£ammation (43%).
This review contains an older mean age group than previously reported. Trichomalacia and pig-
mented casts are considered to be infrequent but speci¢c histologic signs for TM. This study reveals
a higher percentage of trichomalacia, but fewer pigmented casts when compared with previous stu-
dies. Melanoderma, a non-speci¢c sign, has not been previously reported in TM and it was found in
over 60% of our cases. Scalp biopsies are valuable in the diagnosis of TM.
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The Incidence of Depleted Iron Stores in North American Females Presenting
with Hair Loss
C. Haycox
Virginia Mason Medical Center, Sequim,WA, USA and Dept. of Medicine (Dermatology) University of
Washington, Seattle,WA, USA.
Iron de¢ciency is recognized as a cause of di¡use, non-patterned alopecia, but may also co-exist in
other causes of hair loss. A retrospective study of 53 North American females presenting to a specialty
hair disorders clinic, complaining of either increased shedding or progressive thinning, was performed
to determine the incidence of depleted iron stores, re£ected by low serum ferritin, in these women.
The women were 42 þ / 15 years of age and complained of thinning or shedding for a duration
of 3.3 þ/ 4.15 years. A diagnosis of androgenetic alopecia (AGA) was made in 55% (29/53) and the
remaining 45% (24/53) had a di¡use, non-patterned alopecia (DA). Of the women with AGA, 76%
(22/29) also had depleted iron stores re£ected by ferritin less than 50. Of the women with DA, 83%
(20/24) had ferritin less than 50. Of the women with ferritin, less than 50 only 11% (5/42) had abnor-
mally low peripheral iron studies: either abnormal serum iron, total iron binding capacity, or percent
saturation. 17% (7/42) of these women with ferritin under 50 had an associated ¢ngernail dystrophy
such a thin, brittle, slow-growing nails with or without distal onychoschizia, 10% (4/42) had some
history of anemia, and only 5% (2/42) were strict dietary vegetarians.
In this study of North American women presenting with hair loss the majority had depleted iron
stores, even those in whom another clear reason for hair thinning, such as AGAwas readily identi¢-
able. However, only a minority of women had abnormal peripheral iron studies, or other clinical clues
of iron de¢ciency such as a history of anemia, vegetarianism or nail dystrophy. Since aggressive iron
replacement therapy can correct the associated hair growth abnormality, this study suggests that it is
vital to look for depleted iron stores in all women presenting with increased shedding or progressive
thinning, regardless of co-existent diagnoses such as AGA.
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Inhibition of Ornithine Decarboxylase: E¡ects on the Hair Follicle Cytoskeleton
and Epidermis of Patients with Pseudofolliculitis Barbae (PFB)
M. Ericson, C. Boeck and M. Hordinsky
Dept. of Dermatology, University of Minnesota Academic Health Center, Minneapolis, Minnesota, USA
The purpose of this study was to obtain information on the mechanism of action of e£ornithine hy-
drochloride cream 13.9%, an irreversible inhibitor of the enzyme ornithine decarboxylase, in the treat-
ment of Grade 3 PFB in adult males of African-American descent.We hypothesized b.i.d. application
of the cream for 16 weeks to the beard region of 10 men with PFB would alter epidermal thickness,
the hair ¢ber, and hair follicle structure through disruption of actin bundles.
Photographs and 4-mm skin biopsies were obtained from PFB lesions at Treatment Days 2 and 114.
At the end of the treatment course, clinical severity of PFB improved in the majority of patients.
Formalin-¢xed biopsy samples were stained with hematoxylin and eosin and Ki67 antibody, a marker
for cell proliferation. Zamboni’s-¢xed biopsy samples were processed and stained for laser scanning
confocal microscopic (LSCM) analysis.
In post-treatment samples; (1) the number of miniaturized follicles increased and the number of
large curved follicles decreased, (2) epidermal thickness remained the same in all samples, (3) epider-
mal di¡erentiation appeared more organized, and (4) Ki-67 staining revealed a decrease in epidermal
staining in all but 2 patients. LSCM analysis revealed changes in actin ¢lament architecture in the
keratogenous zone of the outer root sheath of anagen beard hair follicles. Actin ¢lament bundles also
appeared very disorganized and parallel orientation was lost.
We conclude that e£ornithine hydrochloride cream 13.9% may be an e¡ective drug in the manage-
ment of PFB and possibly other skin diseases characterized by abnormal cell proliferation. Our data
also suggest that e£ornithine hydrochloride cream 13.9% disrupts the actin cytoskeleton of the actively
growing beard hair follicle. Disruption of this sca¡olding could lead to subsequent loss of follicle
integrity and alteration of growth characteristics of the beard hair follicle.
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E¡ect of Intense Pulsed Light on Hair Cycle. Clinical and Histological Aspects
G Moreno-Arias1, C Castelo-Branco2, J Ferrando1
Depts. of 1Dermatology and 2Gynecology, Hospital Cl|¤ nic, University of Barcelona, Spain.
The aim of this prospective, randomized, controlled clinical assay was to evaluate the clinical and
histological response to intense pulsed light (IPL) in 49 females with hormonal or idiopathic facial
hirsutism (chin/sideburns) and dark/coarse hair. Age ranged between 13 and 62 years while skin
phototype was II-IV (Fitzpatrick’s scale). The treatment was an intense pulsed light source (Epi-
Lightt, ESC Medical Systems, Israel) with 695^755 nm, 10 45 nm spot, 3.5^3.8 ms pulse length,
triple mode, £uence of 40^43 J/cm2 at 8-week intervals. A total of 4 to 8 sessions were administered.
Clinical pictures, trichogram per area unit and terminal hair digitalized photo-count were per-
formed before each treatment session in both control and study areas. Two biopsies were performed
to each patient, one at the beginning of the study in the control area, and the second one after any of
the treatment sessions in the study area. Conventional optical microscopy, androgenic hormonal pro-
¢le and a gynecological (CCB) evaluation were performed.We observed a decrease in terminal hair
count with an increase in the proportion of vellus-like hair. Delayed hair regrowth and minimal side
e¡ects were also evidenced. Trichograms showed a decrease in the anagen/telogen ratio with dys-
trophic broken hairs. Histological ¢ndings disclosed: architectural changes in the follicular unit, peri-
follicular vacuolization, focal damage to sebaceous gland and ostium dilatation. Intracellular edema,
apoptosis, intra and extra-cellular melanin debris, perifollicular in£ammatory in¢ltrate and ¢brosis,
and neocolagenogenesis were also observed.
These results allow us to con¢rm IPL epilation as a safe and e¡ective treatment method for hirsut-
ism.
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Infrequent B-Catenin Gene Mutations In Pilomatricomas In Koreans
HJ Lee1, SJ Ha1, JS Kim1, EJ Seo2, HO Kim1, and JW Kim1
1Dept. of Dermatology and 2Clinical Pathology, College of Medicine,The Catholic University of Korea, Seoul,
Korea
b-catenin mutations were reported to play a causal role in the development of pilomatricomas. In a
recent study, 75% of pilomatricomas had b-catenin mutations.We investigated the causal role of b-
catenin gene mutations in pilomatricomas of Koreans. This study included 10 formalin-¢xed, para⁄n-
embedded pilomatricomas in Koreans. Basophilic nucleated tumor cells were microdissected and, as
normal controls, in¢ltrating in£ammatory lymphocytes were microdissected from the same histologic
specimens. Sequencing analysis of exon 3 of the b-catenin gene was performed. Dinucleotide repeat
markers D5S409 and D5S299 were used for PCR-based microsatellite analysis of APC gene. Immu-
nostaining for b-catenin and Lef-1 was performed by the avidin-biotin-peroxidase method. Sequen-
cing analysis found no mutations in CTNNB1 in 9 samples of pilomatricomas. Only one case had a
missense mutation of b-catenin gene at codon 37 from TCT (Ser) to TAT (Tyr). All pilomatricomas
revealed intense expression of nuclear Lef-1 and nuclear and cytoplasmic b-catenin. LOH was ob-
served in 3 out of 5, and in 2 out of 4 informative samples from microsatellite markers D5S299 and
D5S409 analysis, respectively. The immunohistochemical results suggest the abnormalities in Wnt-
wingless pathway resulting in stabilization or constitutive expression of b-catenin. The absence of
CTNNB1mutations suggests apc inactivation, or involvements of other components of the wnt-sinal-
ing pathway.
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Mutation In The Type II Hair Keratin In The PatientsWith Inherited Hair Disorder
Monilethrix
Woo-Young Sim, Dong-Ju Ha, and Sung-Soo Kimn
Department of Dermatology, nDepartment of Molecular Biology, College of Medicine, Kyung Hee University,
Seoul, Korea
Monilethrix is a rare autosomal dominant hair disorder characterized by increased hair fragility, kera-
tosis pilaris, and unique beaded morphology. Recently pathogenic mutations in the helix termination
and helix initiation motif of two type II human hair cortex keratin (hHb1, hHb6) genes have been
identi¢ed in monilethrix patients.
A 24-year-old Korean woman presented with progressive hair loss and emergence of short brittle
hair which started at low occipital area from the age of 4 months. Physical examination revealed ker-
atosis pilaris on both thighs. Family history showed 12 clinically a¡ected individuals in three genera-
tions, which exhibited inheritance pattern of autosomal dominant. On light microscopy, the regular,
dark beads were seen alternating with the pale constriction of the internodes.
We have studied hair keratin genes with DNA extracted from the peripheral blood lymphocytes of
clinically a¡ected individuals (the patient and her mother) and clinically non-a¡ected individuals (two
sisters of the patient). PCRwas used to amplifying genomic DNA fragments containing the coding
sequences for a-helical 1A, 1B, 2A, and 2B subdomains of the type II hair cortex keratins hHb1 and
hHb6. The PCR products were subcloned into pGEM T vector by standard subcloning technique.
The subcloned DNA was puri¢ed from each E. coli colonies and used for DNA sequencing. DNA
sequence was determined by the dideoxy-chain termination method using a T7 sequenase version
2.0 kit (USB, Cleveland, OH). By examining the rod domains of hHb1 and hHb6, we have identi¢ed
novel point mutation in exon 4 of hHb6 in the patient and her mother. The mutation a¡ected the
second base of codon 220 (G to A transition), leading to histidine substitution of arginine residue.
The sequence of the 1A and 2B helical regions of hHb1 and hHb6 were normal.
We report a novel mutation of hHb6 R220H in a family with monilethrix.
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A Family Case Of Alopecia Universalis Congenita Is Not Linked To Hairless Gene
Y. Takahashi, O. Mori, M. Morita, and T. Hashimoto
Dept. of Dermatology, Kurume University School of Medicine, Fukuoka, Japan
Inherited forms of hair loss without associated skin or internal abnormalities are rare diseases. Two
autosomal recessive types of this condition have been described: alopecia universalis congenita and
atrichia with papular lesions. The two diseases have been shown to result from a mutation in the hu-
man hairless gene.
We report a Japanese family of alopecia universalis congenita with autosomal dominant mode of
inheritance, in which a 28-year-old father and his two sons were a¡ected. No associated ectodermal
defects were noted. In mutation analysis for the father, no mutation was identi¢ed in hairless gene.
These results suggest that there may be another gene responsible for alopecia universalis congenita.
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Pili Annulati: Exclusion From Candidate Areas
Jack Green1,3, David de Berker2, Elizabeth Fitzpatrick3, Susan Forrest3, and Rod Sinclair1
1Department of Dermatology, St.Vincent’s Hospital, Melbourne, Australia; 2Bristol Royal In¢rmary, Bristol,
England; 3Murdoch Childrens Research Institute, Melbourne, Australia
The purpose of this study was to investigate whether pili annulati is linked to keratin loci on chromo-
some 12 and 17 and the hairless/Marie Unna locus on chromosome 8p21.
Twenty-¢ve individuals from two families after being examined and having hair taken for micro-
scopy to establish phenotype had genomic DNA extracted. Microsatellite markers in the above areas
were examined using gP33 labelled forward primers.
Nine of eighteen individuals from one family and three of seven individuals from a second family
had pili annulati.
Linkage analysis of markers D17S855 and D17S1818 at y¼ 0.05 gave LOD scores of ^0.43 and 3.86;
markers D12S90 and D12S361 gave LOD scores of ^1.20 and ^2.57; and markers D8S560 and D8S298
gave LOD scores of ^3.11 and ^2.16.
Assuming no locus heterogeneity in these families these results suggest that a genetic susceptibility
locus is unlikely to be present in these candidate areas.
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High E⁄cacy Gene Therapy of Growing Hair Shafts
N Saito1,2, M Zhao1, L Li1, E Baranov1, M Yang1,Y Ohta2, K Katsuoka2, and RM Ho¡man1
1Anti Cancer, Inc., San Diego, CA 92111; 2Department of Dermatology, Kitasato University School of Medicine,
Sagamihara, Japan
A novel gene therapy technology of hair follicles has been developed which results for the ¢rst time in
e⁄cient genetic and phenotype alteration of the hair shaft. Mouse anagen skin fragments in histocul-
ture were transduced at high e⁄ciency by adenoviral-green £uorescent protein (GFP) with subsequent
grafting of the skin fragments to nude mice. The histocultured skin fragments were treated with col-
lagenase which made the hair follicles accessible to adenoviral-GFP enabling high-e⁄ciency transduc-
tion. On day-1 after gene transduction, GFP was expressed in 80% of hair follicles in the collagenase-
treated histocultured skin. GFP was visualized in the hair bulbs and dermal papillae in the histocul-
tured skin.Without collagenase treatment, GFP expression was negligible. The extent of GFP expres-
sion in the hair follicle depended on adenoviral titer and duration of adenoviral treatment. High GFP
expression was maintained for at least 18 days in histoculture. After transplantation of the GFP-trans-
duced skin to nude mice, GFP was readily visualized in as many as 75% of hair follicles including
large numbers of GFP£uorescent growing hair shafts. Thus, transgene expression was maintained in
vivo in hair follicles to the extent that growing hair shafts were transformed as demonstrated by their
speci¢c GFP £uorescence. RT-PCR con¢rmed GFP-gene transfer and expression in the hair follicle in
histoculture as well as after grafting for at least 2 weeks. These experiments thus demonstrate that hair
follicle gene targeting ex vivo enable for the ¢rst time high e⁄ciency gene transduction which results
in extensive hair shaft alteration in vivo. This novel technology indicates the possibility of e⁄cient
clinical genetic modi¢cation of the hair shaft such as during the hair transplant process.
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E¡ect of Coapplication of Capsaicin and Minoxidil on the Murine Hair Growth
Won-Soo Lee, Hyung Jin Ahn, and Young Hee Kim
Department of Dermatology.Yonsei UniversityWonju College of Medicine,Wonju, Korea
Capsaicin induces the release of substance P(SP) which is believed to play an important role in murine
hair growth and cycle. Minoxidil, the only approved topical hair drug having direct hair growth ef-
fect, has therapeutic limitation because it stimulates mainly vellus hair regrowth, not thick coarse
terminal hairs. So, we hypothesize that combined use of capsaicin and minoxidil may exert positive
e¡ects in terms of hair growth than minoxidil alone.We evaluated the e¡ects of coapplication of cap-
saicin and minoxidil on the hair growth and cycle, compared with application of capsaicin or minox-
idil alone.
We induced the anagen phase of the hair of back skin of ICR mice by depilation.We divided the
mice into 4 groups, i.e., control group, capsaicin group, minoxidil group, and coapplied group. And
then, we examined the hair growth macroscopically, and the percentage of the area of hair regrowth
by image analysis using phototrichogram at the 0, the 5th, 10th, 15th, 20th, 25th, and 30th day. Also
we examined the morphologic changes of hair follicles and subcutis, and the number of mast cells by
microscopy, and [methyl-3H] thymidine uptake by scintillation counter.
In this study, we observed that capsaicin can not only induce the anagen phase quickly, but also
sustain constant e¡ect on the linear hair growth. Minoxidil also induced the anagen phase fast, and
prolong the anagen phase of the hair cycle.
Therefore, it is concluded that the coapplication of capsaicin and minoxidil can grow hair quickly
and steadily.
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Diagnosis and Treatment of Androgenetic Alopecia inWomen
V.H. Price
Dept. of Dermatology, University of California San Francisco, San Francisco, CA, USA
Androgenetic alopecia (AGA) is caused by androgens in genetically susceptible women and men.
The thinning, also known in women as female pattern hair loss, begins between ages 12 and 40
years. Inheritance pattern is polygenic, and incidence is the same as in men. In susceptible hair follicles,
dihydrotestosterone binds to androgen receptor, and the hormonereceptor complex activates the genes
responsible for the gradual transformation of large terminal follicles to miniaturized follicles. As in
young men with AGA, young women have more androgen receptors, higher levels of 5 alpha reduc-
tase and lower levels of aromatase, in frontal than in occipital follicles. However, the process is milder
in women than in men because of di¡erences in these levels.
The miniaturized follicles produce shorter and ¢ner hairs of various lengths and diameters, and
these miniaturized hairs are the hallmark of the condition. In women, hair thinning is di¡use but
most marked on the frontal and parietal scalp.Women typically retain a rim of hair along the frontal
hairline. Increased spacing between hairs makes the central part look wider over the frontal scalp com-
pared to the occipital scalp. Diagnosis is supported by these features including miniaturized hairs,
pattern of thinning, and early age of onset.
Most women with AGA have normal menses, pregnancies. Extensive hormonal testing is usually
not needed unless symptoms and signs of androgen excess are present such as hirsutism, severe unre-
sponsive cystic acne, virilization, or galactorrhea. Androgen excess is assessed by measurment of serum
total or free testosterone, dehydroepiandrosterone sulfate, prolactin, and other causes of hair loss are
ruled out by serum thyrotropin, iron and ferritin.
Topical minoxidil solution is the only drug available for promoting hair growth in women with
AGA. E⁄cacy has been shown in double-blind studies using hair counts and hair weight. Minoxidil
solution must be applied twice daily directly to a dry scalp.Women are devastated by their thinning
hair and need reassurance that they may safely use hair cosmetics to make their hair appear fuller.
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Chronic Di¡use Alopecia in Japanese Females
RUeki, RTsuboi, and H Ogawa
Dept. of Dermatology, Juntendo University School of Medicine,Tokyo, Japan
Until recently, there has been a great reluctance on the part of many Japanese women a¥icted with
chronic di¡use alopecia to come forward for diagnosis and treatment. Lately, however, the mass media
have brought more publicity to the issue, and it was consequently reported that the number of wo-
men complaining of hair loss has increased 4-5% every year. Interestingly, the majority of the patients
were younger than a decade ago.
Chronic di¡use alopecia in women is caused by various factors including female androgenetic alo-
pecia (FAGA), chronic telogen e¥uvium (CTE), nutritional de¢ciency and systemic disorders. The
di¡erential diagnosis of FAGA and CTE, especially in cases with mild changes, is sometimes di⁄cult.
Hairs of Japanese female subjects are usually black, straight and grow less densely than those of Cau-
casians. These racial considerations, as well as the inadequacy of the oversimpli¢ed Ludwig classi¢ca-
tion system, have made the development of a new, more rigorous quantitative method for dividing
female alopecia patients into more speci¢c categories necessary.
Hair growth patterns in healthy Japanese female subjects as well as those with chronic di¡use alo-
pecia, of various ages, were examined by using phototrichogram analysis and the measurement of
excised hair diameter. The hair growth pattern of Japanese female subjects complaining of di¡use hair
loss was divided into six abnormal groups, two borderline groups and one normal group. It was
further found that hair density, hair diameter, short hair ratio and hair growth rate, but not anagen
hair ratio, were the most critical factors, in the order of decreasing signi¢cance, for grading the sever-
ity of female di¡use alopecia.
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Endocrine Controls Of Hair Growth: New Developments
Ralf Paus
Dept. of Dermatology, University Hospital Eppendorf, University of Hamburg, Hamburg, Germany
While the signi¢cance of androgens as major modulators of hair growth is well established, much less
is known on the exact follicular functions of other nuclear hormone receptor ligands (e.g. endogenous
estrogens, thyroid hormones, retinoids, calcitriols, glucocorticoids) and on non-steroidal, peptide hor-
mones and neuropeptides (e.g., ACTH, aMSH, CRH, prolactin, substance P, catecholamines, melato-
nin). This introductory synthesis begins by summarizing important relevant ¢ndings from the old
endocrine literature (mostly in rodents) that serve to highlight many of the most intriguing open
questions on the hormonal controls of hair growth, both in an endocrine and in a paracrine/autocrine
signalling context, which the overly dominant androgenocentric view of the hair follicle has tended
to obscure. This is followed by a discussion of more recent ¢ndings that document the hair follicle to
be both a source and a target of numerous hormones, neuropeptides and neurotransmitters, whose
expression (along with that of their cognate receptors) underlies tight, hair cycle-dependent regula-
tory controls. In particular, the hypotheses are explored that the hair follicle exploits several locally
generated and/or metabolized hormones for controlling its own growth, innervation, immune func-
tions, perfusion and/or pigmentation and that the hair follicle has established a miniature equivalent of
the hypothalamic-pituitary-adrenal axis, possibly as part of a complex, local stress response-system.
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Age-Related Changes in Scalp Hair Density
Olsen EA, Cote N and Can¢eld D
Hair density is a frequently used endpoint in clinical trials of hair growth promoters. However,
little information is available regarding age-related norms in androgen or nonandrogen dependent
areas of the scalp to help put study results in perspective.We therefore evaluated hair density in three
di¡erent age groups of Caucasian men in both the occipital (non-androgen dependent) and mid-
scalp (potentially androgen dependent) regions. In the 18^25 year old age group (Group I), 10 men
without a family history or any physical evidence of androgenetic alopecia (AGA) were compared
to 10 men with either early signs of AGA or a male ¢rst or second degree relative with 4III Ha-
milton-Norwood pattern of baldness. In the 35^45 year old (Group II) and 55^65 year old (Group
III) age groups, 10^12 men with Hamilton-Norwood IIIv or IV in each age group were compared to
10^12 men without any physical evidence of AGA. Hair density was determined in all groups from
photomacrographs of hairs in 1 cm diameter circular target areas clipped to B1 mm in length in
each of the two scalp locations. In one subgroup, the hair count methodology was repeated monthly
 2 and compared with hair weight data collected from the same sites.
Results:
Mean Scalp Target Area Hair Counts (per cm2)
Age Group
(years)
Non-AGA
(mean/standard error)
AGA
(mean/standard error)
Mid-top Occipital Mid-top Occipital
18^25 235 (12.03) 215.1 (17.68) 235.6 (13.43) 198.5 (15.05)
35^45 223.8 (14.76) 236.6 (10.99) 177.1 (10.54) 207.3 (11.81)
55^65 202.5 (15.9) 191.0 (11.83) 134.7 (12.87) 159.2 (12.49)
Conclusions:
The mean occipital hair density is similar in men with or without AGA in the 18^45 year old age
group and is a reliable normal comparator for the mid scalp target area hair counts used in clinical
trials of hair growth promoters in AGA. Hair counts and hair weights are both valid and reproducible
measures of hair density.
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Finasteride For Androgenetic Alopecia: A Review Of The Clinical Trials
Jerry Shapiro
Division of Dermatology, University of British Columbia,Vancouver, Canada
Drake et al showed that median scalp and serum DHT levels decreased with 0.2 mg, 1mg and 5 mg of
¢nasteride after 42 days of treatment.
Roberts et al con¢rmed that ¢nasteride 1 mg daily was the optimal dose, with 1 mg and 5 mg
superior to lower doses such as 0.2 mg/day. The 5 mg dose was not more e⁄cacious than the 1 mg
dose.
Three double-blind, randomized, placebo-controlled studies were conducted in 1879 men ages 18
to 41years with mild to moderate hair loss. Two of the studies enrolled men with vertex hair loss and
one with frontal hair loss. Finasteride 1 mg tablets or placebo tablets were taken once daily for 24
months in the vertex studies and 12 months in the frontal study. All three studies showed a signi¢cant
hair count increase in men treated with ¢nasteride, with a signi¢cant decrease in hair counts in men
treated with placebo. Finasteride stabilized hair loss in 83% of the cases with vertex hair loss after two
years. And in 70% of cases for frontal hair loss after one year. The chances of mild to moderate visible
regrowth are 661% on the vertex after 2 years and 37% on the frontal area after one year.
Van Neste et al. using the phototrichogram method provided direct evidence that ¢nasteride 1 mg
daily promotes the conversion of hairs into the anagen phase. A study of ¢nasteride in 136 post-me-
nopausal women with androgenetic alopecia (AGA) showed no bene¢t compared with placebo.
Finasteride is well tolerated and side e¡ects are rare. Side e¡ects include 1.8% decreased libido
(1.3% placebo), 1.3 % erectile dysfunction (0.7% placebo) and 0.8% decreased ejaculate volume
(0.4% placebo). There was no signi¢cant di¡erence from the placebo group for each of these side
e¡ects taken alone, but there is a statistical di¡erence when all side e¡ects are considered together
(3.8% vs 2.1%). Side e¡ects will subside spontaneously in 58% most of those who decide to continue
the treatment and are reversible upon cessation of treatment within days or a week.
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Hair Follicle Stem Cells: Past, Present, and Future
Robert M. Lavker1 and Tung-Tien Sun2
Depts. of Dermatology, 1Univ. of Pennsylvania Med. Sch., Philadelphia, PA; 2NewYork Univ. Med. Sch.,
NewYork, NY
The issue of keratinocyte stem cells is of central importance in epidermal homeostasis, wound repair,
and carcinogenesis. One of the most accepted means to identify keratinocyte stem cells takes advan-
tage of the fact that they are normally rarely cycling in vivo, and can be detected experimentally as the
‘‘label-retaining cells’’ (LRCs).When this approach was used to localize the rarely cycling cells of the
hair follicle, all of the follicular LRCs were exclusively con¢ned to the bulge ^ the part of the outer
root sheath marking the lowest point of the upper, permanent portion of the follicle. Although it was
customarily thought that the hair follicle and the epidermis were governed by separate populations of
stem cells, it was puzzling that (1) very few such LRCs were found in the interfollicular epidermis and
(2) interfollicular human epidermal cells had less in vitro proliferative potential than the upper follicu-
lar epithelial cells.We showed recently that the bulge stem cells give rise not only to the lower follicle,
but also to young transit amplifying cells that migrate into normal newborn mouse epidermis as well
as wounded adult mouse skin. This provides the ¢rst evidence that the bulge represents a major repo-
sitory of skin keratinocyte stem cells that may be bipotent as they can give rise to not only the hair
follicle, but also to the epidermis. This ¢nding has major implications on hair biology, the long-term
maintenance of the epidermis, the pathogenesis of skin carcinomas, and the mechanism and regulation
of skin wound repair.
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